var title_f14_52_15168="Gastric banding tubing around mesentery";
var content_f14_52_15168=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F57587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F57587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gastric banding tubing around mesentery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 443px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The gastric banding tubing is being pulled toward the right lower quadrant. The tubing is around the base of the small bowel mesentery. The patient complained of a right lower quadrant pulling sensation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15168=[""].join("\n");
var outline_f14_52_15168=null;
var title_f14_52_15169="Beau lines";
var content_f14_52_15169=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F62607&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F62607&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Beau's lines",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transverse grooves representing Beau's lines are present on the nail plates.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15169=[""].join("\n");
var outline_f14_52_15169=null;
var title_f14_52_15170="Nail melanoma Hutchinson sign";
var content_f14_52_15170=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85612&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Nail melanoma with the Hutchinson sign",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 405px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGVAhwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCEj1FVriBWHSrgGaCo71Bnc5y8tODxWFcp5bGuvvwAh4rkNWkCs1K4rXI1Py5FKD6VnR3IPU81YSUEA9RTJasXVIpciq6v+NSb6Yh+aTdTSefemluaAHkg0EcVHu/CkLYakFx1NY5FNZqjZutA9RzHBqFm4pJG6iq8kuBQNBK/XFZ882PWnzynBArOlkLEjNBSQ2WQs2Oc0+3tjIR1qW1ti5BIrf0/Tyx6UDbSRFpthkj5a6rTNPAA+UCpNN0/aF47VuQwhegpmTkJBAEAwBVgLj604ClxxRcQ3HtT0XmgCpoxQFx6rgVIRihcYpHNMVyNzULHJqSSmY9c1NxpgB0p9NHbingCgLjgM07HOMU0Cn9qoVxCBTWIANOY81A554oC42Q1Cx5605z71Cz8UFIRmqF5OookeqssmRjNAD3kHrVWWT8qjklqpLKcdam40E8oA61nXE/B9KW4lPNZdxLz1oKQlzNnNUZJM5BpssmT1qpJJ15oNEMuSAaoS4OTU9xLkVSeTJ96GXF2E4zTWGecU8UY9akvchI7YpNvHtUuKNnPSrTM5IhxSEVLtprDinYkhI596b3qUjrioyKBjlNaOnTBGHPSstTg1YjPT1pNFLsdzpt8AoHA4roLe+yOPSvNtOmczgAkiu20uN3QcZ471NjOasbP2pm6E1E5ZvWrEFntUEk1NBBvfGOKfKyOYzhbM55q9Z6f8wJFbFvYjAyK0YrTbjjFUoClMNNtyqLgdKvs6A4ZM1bs7cYAAHPanXFtxwBWqVtiLmTcGIqcJwa5S/ZBcsFUY9zXV3ibEIOK4+/AFy3I/Gpdy4nWfnSSHAzTv84qGdsL1rJsrqZGsThI2rzrWb5mkIzx2rrvENxhGGefSvPdRfdKefzrLqawXUdHdEN1rQt7rpg1zhkw1TwXIHetUTKJ1kcoIzmp1esO0us1pRyAjg0XMmrFzfSFqgD88ml3UhEu7jmk3cdRUWaa7cUNgSF8VG7+9RM5Heo3fHU0DsLJIMGqc0vFEsvUd6pO5Y4z1oKSCV9zHFS2lsXYZFPtbcuwJHNdHpthkjigbdhNN08krxXU2FgFAyBT9PsgoBK9K1UQKMDgVSMWxscYAAAxU6gAUgwO9G6gSHfrQAaBzU6LxSAaqVMq05F9qeRgUwGk4zUbn0pz1Ee9JsBD1oxSCpAM0kAgFPC0qjjnPNOOO9MBBxQTjNNY1GzUwB25qF2odutROxoGhrtxxVeRuDg09261WkbrzQMZI1VJX9adM5A/Sqc0nvSAbLJVOWX1pJpcDrVGaYeufpSuWNuZOvPFZc8hJqa4l4rMuJhzg0y0hssuOlUZZfekmmznmqE03PWgolllzkCoASTSZLHnmnAZqrASI3HvUn8NQLw1TryKlo0ixMU4UuMGk6UimrjiuelRsnBqdePoaUqDVJmEkUmXAqIjHFXJE9qrsvWmFyD3xT04HpQwpo4NDGmaekuFvYwe/avXPD9qjwq2PzrxeCTZKr+hr13wheiS2UZ7Uo6MmpsdO9mNuQO1QWtuRNgDjvWosmIhnrRbBRJnGK3sczLNla5xxWgLbaOlS2YUgYHFW3TC0/QCOCIgDHUUs2QORmp4DxUk5UIc0ugHNapIiofl5xXA6nJm7Yiu51yRAjD2rzbUbhPtb9fwqJOxrFHoXQdKoXz4jPOPpV1zheKxdVm2xmueTLSuzkfEM/zEZziuMn+eQ47mt/W5tztzWNbx+Y9TE3tZFcWxcZxVe5tZIvmQHb3FdhZacXA+Wrd3o/8Ao/K8n2q27GbZw1rcEcVs21z0GRiqOpaY8LlkGKqQTFGw2RVXuJq51McgYZp+T+NZNrOOP51oxSBhTIaJi2OtRuwx3pT+tQytSYhryAVWlkyKJH6mq7EmkNIRySeKntrcu2SKLaAuehrd0+0yRkZpXsNuxJptjkj5a6vT7PaASPzqHTrQKASP0rYjAAwO1UtNTKTHooA4FSdKQdKQkUCAnigcmgCpEWkA6LqKtoKiROnrVhRTEPWkdgKCeORUEj9cUNgKxHamkcdai3/N1qQMDSATHPWpFFN/rRn0pgS9KaTUe70oJGPrTAR2qFm5p7mq8h56UWARmqF360O3FVpH60XGEknvxVWaTrzSSy9cGqrufXigaQkknUk1Tnfg/nTpnAyaozzcE54pFIgupetZs03vUl1L1yay55cdaSNIoLibrWZPLk9akmYknvVOUZ7U0hkEshJIqEDJOamZCfrQEPIqx3EQYFSCgCgcjmkAh5OQfwp8Z55pDkcdaSga0JwcgCjtkGmIc4z1qTtUGsdRyEjpUoAxj1qEU9W655pomUQkHHvVdl5JqwetNb0qjFqxUZe9MYcVOwqNhnpTGQ9BxXZ+C9RMbqrN0OK40ir+jXBt7xMHGT0qWNq6Pd7O5Eqqc8VoxOhcYPFchoN4JIlwa6uxTfg5/GtYyuc0kdLYBdoC9K0CmU6VQ0xOFx0rZZcRcVRJnZKE1RvLnCtzVy9OxSa5u9lJ3ChuwJXMPxBdkIw3V57dys07HIrsNcOVbvxXGThvNbA4rCWpvFHq07YFctr0+FIzzXQXkgVTk1xWuz5JANYzfQ0gjl9Sky5FGlx7pKrXbFpT9a1tEiy4yKqJcmdjoluCFyK2ruzVo8Y6CodEiwi8VsSLQzFnCarpYYOdua43U9L2Fiq8+tevXdssimuc1PTg27A/GpTaGmeYRu8L7X4rTtrgcc1c1XS8FsD3rBKPbvg52jv/AErRSuVa50CyhhjNRydx2NZkVz06VaWfd3oZHKKVJzUkMBYjIp8ADnpnNbFpbD5T61EnYewyxtORgfSuisLUDHHSo7K05BxW3DHtGBTSMpO5JAu1cCrKjimRL2qYL3qiQxxigL704D3oouAKPapo15GBUQGMZ61MhxQG5MvSpAahDU3f707iJWb1qtK1OL8VE/zHjNLcEM71Ipp0dtLKR5cbE/StK30K+lwRCwHvRZlpN7FAHig9a34PC12wG8qoq6nhMDHnTcn0qkhqlN9DkGOCKZvruYvCdr3ctjrVhPDdgmSYy340WLVCR50756CoW3HgKa9RXR9PQAfZ1yPWpk0yy7W8YP0plLDPc8hkWTn5D+VVpUl7Rt+Ve1f2baL/AMu8Zz220v8AZtqRxBH/AN80tCvq77nhLxSkf6tvyqpMkg6ow/CvoD+y7UEgwR/9802TRbKQ/NaxH/gNGg/YPufN9y7AHgj8KzLmUg85r6Wm8NaXJw1lH+VVbjwZojr81knPpRp3BUZI+X7mfrWfLLknmvp26+HOgzZ/0TGfQ1mT/CXQZR8qOp9c0adxunJHzaW3E0qpnrXvl18GtMIPkXMqnpyKy7v4NMq5t74H2YU9O5DhJHjHle1I8PNelX/wu1m23GIJKo9DXOX3hnU7LIuLOUY7hc1VmS0+xybJg0wjBrTuLV4yRIjKfcVTeMjtSsNMrg+tIefenMvtTT6VJQgODU6nNQGnxtzz+dJocXYmxxzR7igdKKnY23FzjjpSE9aQ9abVowmhG9aYRTm+tNNMgjNNHysGHBFS4pjLQxo77wrdsPLIOc9q9I0yR2xtPFeOeFrrYyhjwp/KvaPDipLGnI5oh2Mpqx12mHMS881qk/LVSwgwgAq7MAFxWyRiYmpHhq5q8zuNdLfjhhWFdIM9KmRcTktZUhDgVyMyESGu21oYBrk5UBkJIzWUjZM67U5tqHmuE1aYszE+tdLrFxhGFcXqUlc27OiCsjMJ3zV1WgxfMvSuYtV3TA9a7bw/Dll4zWvQzmdppSYQcVfYe1Q2KbYRVgjIpPcxK7rVO4gDg561oMM5qFl68dKBnMajp4YHjn6VyWq6XwcCvS5ow4OQKx9QsQ+eKkaZ5LdW727ZA49KihuMnBrtdU0zIOBkVyGo6c0TFkBzWidy9zV02QMRmuu01N4AwK4PR2IcK3BFeh6Em4KKbREzatoQq57ntiriJSxpwKmVcCgxEVcCpB9KaKM80AOxzSkGkUZPepAOOlAEZ604HnrT1iaRwqKWY9gK6DSfCd1cgSXH7qLvnrQk3sNRcnoc+oLHgE/Sr9no17d48uJgp7niu90/Q7GyA2xh2x1atJQiKAoAUdAKaijpjh31OPsvB5IDXU23/ZHNa9t4e0+35Me8/wC1Ws7nkZA9qglkORT2OiFCK6CRwwQjEcaL9BTmk254FQSP1LEfhUAl+uOlI3VNdC6JiT8pHuKdvJBBIJrO80Lk+lPM4yevNBMoF5H5yVyMdKUsSTnp61TWYn1yO9PE3I5496aRHLYnC7hk4p+OflPXtUIYE5U84z9KmhO7ngnrTSuJseFOxcgkfyp7ISDxSRk8qM4qxErgDPyj0NUokuViAAk46kU4x8nripwmM56UowP4anl7hzXKuzJ5FDJ37VZYcDAI9aCQwxgcUrDUiptOeMkdhTQobhl/GrmwDBxSYVccd/Siwc9ykYxjGDimOg28jGegq8QCfu/lULRBwQp/OlYEZskXXufSqdxbK2d6Bh6EVrmIqxHHsaRkDgtgZHHFTaxWhxmq+F9Lv1IubSPn+JRg1wOtfC21lLNYXBjPUK3SvaWtw3vVOe1C5OODVqTRm4RZ8x634C1jTizGAyoP4k5rkri2lt2KyoykdQRX1zNAMEZz7GuZ1vwxpmpqReWqhz/GowafMnuR7J9D5m5owc16prvwvkXfLpcwdeojbrXAajoWoac5W7tnXHfHFFuqJem5no2RUhqLBU4OQakHSoaLiwIqNsipO3emN0oQSVyMnikWhs0CrMWhR6Uu3PFNFTKuRQK5Y0hil0Md69w8HSEwRA8HHevDLbMdxG3vXtHgmYNBHkc0luRUPVLAgxipbhu1VtNbMYqW4PBrdGDMm95JFY96QqnNa142B3rn7+YAEc0mykjnNafOQOo9K5/y89RW1qTq7HHeoILYtHnA/GsJamqMTV59z47Vy1/Jkmtm/lJLHNc7ctuf3zWMFc7HorFvS13OK9B8PxfdOMZrh9HTLLXo/h+PCrVswkzo4RiMDGKcQPwoHQUpqdzMa1ROvWpWFNYe1MRVdagkTPBFXHHGMYqu69aloZk3loGBwB9MVzOp6bkE7etdu4zVK6tgwzgUJjTPPodO2y5Uc12egxbVUEc00WI39OK2LC32Y4FaRd9CZM0EXK9KGPpUhAC+9QOaZAE4yOKFBJpnU1PEKQD0X2rZ0fRJ9QkBA2xd2NaXhvw41wVuLsbYeoU9TXbxQpDGI4lVVHQVW2pvSouWr2M/TNItdOUBEV3xy5q/uK4IxiiQjPcEc1C0yrIQRlDkYFLmO6NNJaDncYIOPaoGlI44x3qpJcBWIU5Hv2qlNcYBwQDnP0qedG6p3LzS5cgbgeo9qryThY1IPKms6S9JZghYk9xUO28lwI7dyvqRilz9jRQtuzTadSG5GDULXCqvBBNVVstQfOIDx2BFRGxui4EpEbeho5n2Ibgt5FpZwx5IPFTCQBU+YEe/WmrpJWIvIJGYDkjgYqpLbAcCR8dsGqu1uYutTb0ZsordtuCucZ5ApAVYAA4OeeeKy45UVQp8zdjAcnikkuWHlCJEYjO45+99KvmM+dG5Fk9F5qypOAQp/Cs/Sbu3nQK42MOK3II1JwHwT/e/xrWKTWhlOdmNiYMOh+npVtHO3ncc0PbFWB3AE96UBlY8571TVjJyTegLuHfAPrTirDODToyHyBjp3ofITrziloO+owPhuxPrimY5ByPpSg8YZfxpWUgDcPowqWtCxRhxggfh2qMoCcZH0NIrYYKRjPelfOMkdeKkdrMTbtGGH401+mOnepEbHy9AO9JOQMiRRn1Wiwr6kCzMCd6hl6dMZprRI+5oScdSp6inkbFz19zTUKgqD9eKXky2+pXZNmc5z64qCRCTg4zjoe9aExBOH5A4z3FU5VKO27kClKNhLUz54lDYA+pqjPACCMBh6GtR+evX3NVJVOeODU3GZEkQXLIM+oPeqstjb36Mk8SOuOVcZrYZQGw/Tp9apOhhm6fKc8imm0K99DzvxB8N7C9Z3sibeTrjqted614K1TTCx8kyRA/eXmvoxQrcPwOxFV54CBnAMZ/I1pe+5nbsfK8sLxkiRSp96hYcetfR+seDdL1OMyPAEbuyjHP0rzzW/hncxl306RZUHOO9S4X2GpW3PL2HJpprZ1LQtQsXIuLZxjvisllKthgRRZol6iIKmjHNNQfWrMa0GbECZPFemeALsGNVzyK86VMDn0rovCN79lvQrHGTmk9NSZK6PoXSpAYlIqzdH5fSuc0K+Vol57VttOGStomBm3x61zV+Mhq6O9PymsC8XeSBSkyonOSRtLLgDpWvbWmIRuXmpobUKwOOa2IYMRjC1CRVzwm+lwOax2O6WruoMQfaqMHMnWsUrHZJnS6FFllr0fRExGDXBaCq714/CvRNLXbECOeKGYyNNelLmo1PFPqdTMXimnvS9qDQBE/SoJBn1qy1QuOTQMquCKZjpUzioiPzqQGLGC3AwauwqAKrxirUfTNaRJkLJkVXc81NMar85+tNkoegycAHJrtfCXh0zJ9rvE/dr0U96reDtA+1SC7u1xCv3QR9413M88MMASSUIFH3B3pSkoLU6aNLm96Q9JAI8Rr8q8AY4ApJ5BHluAMcVjzawVBW3jOPfvWXcX9zLw0mxewFc7qtncuVG7c3yhMZ5HvWXJfbAcN16GslpsElmLZ65qJ7gKCAQBUuct2WqiWiRbmumJ+U/iajjZCT5wd/YHFVFuS2d2cewpCzNwoY81Ku9QlWlsbg1NTGEQLEq9lQA/nUUt78xPnO+RmspA27kj1waeFQZ3Bieua0vJ7nLJpmhFesrFkLKfUGrkmpSXlv5c6o0iglXIwTisVnG4c7QoxgmmvKvln97j/ZHWtItoxlZmrFqssqlJs7gMB/b3/xrNe5k8x12kFeSPQVTeaNFADP06f0qGO5TzVG1mUggjvirV3oyUrbFsXJZeDSpJz3zWWl0uT1FTQXaFuSaa2L1Rsh8KDkhuua6DTdSBCR+YGOAef1FckLlc8U6K4HmIY2G4HgetaXsxp30Z6XBckRrn5omOOexqxKOQynhuK53S7oyfumb5iAQGrdQb4CyHKjqvcV0LUzas9BSMdVwR3FIVJTkGk8wSYHocVYY8KR0zSsPmaI3bBANNlk2tiNhtJzjrVnhiSyhsCqsigGRo/ugUmVGxFKAVYqpBHoaax5RQ2d2CKnVSoVm+ZT1/GmQRjzmRhygP5GoaNE0VWkKk8YB6VZVhKqowywFVNp3MM52nNSBiAWAxk496Ww5WJ7ZQHkSTkNg801kWKaTjjOBTZD8scrfMemafKcELuyuOKCG9bkMhBQk5zmoZFDQkclsbgc9V9KmljJkVQck9Aahnc5ypG4fLihaiTM9h82D1PrVV2bnP0FT3OScLnJPGO1RznohI+UYrM1bKznKdqrTYZVJ6MOat7AQy+vIFQzIHg291PehEsqRAr0II6ipSzKgzkIeMVLFCRbgY+bGRTUCsuGGR0Pt700tBNphEuAUY8HofWomiEbNletSLlflkPIPFSY3ZBOBimQ0Z17aW864lhWRD1DLniuU1jwDo18GZIzC57AcV3AVwrZIC9h3zUKqv3eh9fSq5mhONzxvUvhfcRBmspRIB271zV34W1SyJEls+B3Ar6GKbXBbj1PrQ6KVw4DDPORRddiOXqj5qe0mjOHjYH3FEW6KRXXIINfQs+kWMxPm2sZz6DGKy7rwVpFxkiPZ9KTsxcrOT8J61uRVY8iu7t7wOoOetYEfgOO2l8y1mOB2rUi0y4tgBnd7043Whk4NF6dw61QaPJ5qRhInDg01WPTFU2SLHBucYFa0MIWMDj8qpW59Ktq+Bzg0xM+a7tsq2aowuA1OvJ9zELjFVAxB9Kxep3ep2WizgFecV6BpV4PKAJrx/Tr4xsATiuv0rVh8vzcVnJMiSPSY3DDI5qRW4rntP1HcFG6tqCZZMYPNJGTLQ5petMU8U4Hj3oEBqNh1qTrTSOv0oArOKgb61akHHrUDjNJj3ETr7VZj6VXQVYWriSxknWtXwvo7apfjep+zx8uf6VnxxNPOkSDLMcCvUdD01NLsFiT77DLH1NN6K5dKHO9SW6Y29usNogVAMZ/uisa5DZ+6GYdSTnNdBfKFjGBtOOc1zzny2L7N/PTNNwTep0RlfYpzOw6qc9sdqos7O+OAPStadmkT5kAGKzJgiBtzBcVE6RpCRWkDcZ71A+0en40s86ZAVvrj+dUnnjJJdiQegFZKFjTmLrSICApJH5UwTDaxyAScVRe5IXCfKM4571G1ywGCQvqKuzM20aZueOMnnrUctyd7ZOfrWa94ASQQAeMCqct8MnL/rUsj0NtroDHP5VWe7y46n1rKOoAYI25HNNe8wxJ3EnOCKqNmS0zRvr0mOKPsuWz65qBbh4XEqBGyNgB+lZt1P3JyeuD2qvJJueNVblxxV31uJI0Y3cAbuAc4NWIJjuyccfrWY8pFupkbJVym3+tFtPn14p7ML6G+9x0JP5UguACCvOPWsd7l0OCwFNjuc5y2PervcSR6Vp9ysd5asjHMkQOD69a7SBmO+SM54+ZcdRXlNreokGjgNubcybj7ngV6ZptyxijZgAWG08V1QRDeho26JISQcqR2pWJ8xY+euRimWSlDJhsKecHoasWy5dTyDyelJoafcQs0e9gMj+dQxuFiCnB3cnHrU7/ADTKucKxz9KguVBuAE6k8+hpNFKzAErIY2HQZyO9Nf8AeySyoeUA/Gkt8OJBKSHXhR3qFT5VuVJwxY5FQO9noOKhlEkeNp4I7imSqP4TuUcZpsMmwgqchvl+hpJFMUojxgH3ouHUczhLWRGyW6ikuZOEOPlKA01gCx7r71FcyMEjRsZGRUtDTuPhkyzSkn5RgfWoZBuiDdc9/SmCT90EUDBJbPrR5hETITnnPFJCsRhVY72PQEfU1SlHB61auH2xxxjggZP1NVZstyMZJqbDTdxseNpPXI/SqsmTvXnJHFWAOGK8dqickOhXGTngilYdx4O3CjHQcCoXGyTIwPUUqgkZNLN8yhsDI4NMVtRxVX+Y9B600AKwOPlzzjtTB90fnmpwhYgIQCe9NBsNcA8ZzjoR3FQSoSQRgr2NTN1AzgjpjvUbggA9BinoIiHK5P0pmBnDD2zUzqHTBGMCol+YbXHTgE1LTC19RoUh9uM0rfLjaeDzShCMgn6UoYEFXHbH40EgHJORgCnvtYDtnrUKqQxBGFPr2pA+CUamgFliAGGUMtVJbSJl3qpx7Va8wFcHkelPMQBHlng9R3ppku3UyxbAE+WelSCOQAYGankBSQhhx3NJu28U7sTpxZ8sX9pJCxOCVqlnivRNS03dn5fpXKajpLRsSg59KwjLuWmZAbirlnePCw54qi6Mh2sMGhTjir3KO40rVugzg11+nakG25bmvIraYxuCD+FdFpeqFdoJwaiUexLieuW10HAyauAgjPWuG03VAQMkV0tnegrjINQZtGrzRj0piyB+nNPBFMkYw4qBxVg1E680hkSg5yalU9abj6Uo54HU1cSGdR4E0/7RfPdSLlIun1rvJpFSSPnO5gMe1Z/hWy+yaPAgHzv8zfjV2Xa18pIJAYZxWqj7yOunHliN16IRhXLk4Hc8Vy012xJ8tBjpmup8VomzIO5sYA9q4idpDu3ui9sA960lG7MqUtNRt3cSEEGToPuqazXmj2hsM+RnNOlwhPGT6is/U5wkJBJxjJCnGfelyJGvP0K1zfYYsyHJyAPaqT6gCoIAGeAazrq6QoXlkIU8AKOlU5bqNWJCswHT3rKSZqmluaE2oOSQGGar/a2JGWyVP0rO+0PIflhxt75qCYybGZ3Vc9AO1RyMTmloab3Z5O4/4VCLgD7xrFmuFDKu88DnnioReKMYPTjiodIlz0OotplZ+O2OlNuLzbtHAxztrn4Lw+YT8xYjtxTnlkVvmjA3ccnkVpGFkQ5Gtc3n7nccbm6AelFvdxCeJnfZ5bJ74z1P8qwrmUuMrwQOR6mmEKbdXLMrblGB3GDmrUdSbm69y8qyMrKP3jPj6f8A66SO8K8lj68CsiRJBIYAXCDcACOTVm1DxkLJHgsAQT6etCiDLs13nBLE9qdFOHxgnBqmyE9MYFTWkbmVQvJzximooE7HYWN01xpdlNgE284Rh6g9/wBK9b0hxJbRhTkbuD6+9eQWIWHw1G4JDtPtcDsVr1LwsxktYizgrtBHvXVS7EVHpc6uHJVh26VYjJUjHcZqvETtGPTNSRtv6cYHNXJWIi+Ycvy7nzjPTPpUD5Em9ecjBqwAWOZG4HQUkoTaMtgDpjqfaoNE7FZgAwYZD7gCRUF2CZDn7pPBPcVYUFpRvG3qcemKrzZYITnHSs2ik7sjiQjlSB/I088tlwRj73rTZWKxIAPUH86dLh2PIBQYyO9Taw3qRJKEcf3e9Q3J3xSkHhX49gaa53DjGetRAFxKi9xz+FK4JWdyJZdrYxkHsKdITlQDlWbBNVT8pOR+FSuyiNQVzk9c0WuhsbO6mZySSc8VC7sE4A9AabdKqOyqcEGoY3JB7ACpDzHCRWTDfhUa/vLkAA7VGcDtSfeySMY54p1odrueuRjdnpSs9h3tqKjk5PU9aeWJH3crnGKREwcHipyNkQzjfk9KdtRcxTbAfBqRGOxTnkfe+lEwyuf4v1IpEfKMhHOc8fSlYrclXYJEIwytx9KR02HdnjuKjA2g88H9D604PmIAgc/rTQmuxE2zBOeKY7EYYYK1G25ZSyjI7ihzjlfuHqKVxuNifJdScc/zqHdxtfApI5GDAkHb2NE8eDu7N+tFrk2EDlcBjkdqV8SKCmCR1qpJkH1HXFSxkkYBznoaEDj1E3lGzjAqV5MYIyCe4qPAlzkgOP1ph3ICOoFCIaJ2fzotrD5x0qoVyeWx2o3Mrq2MgVbMXm/OjAA1a1C9jzS4tg4OAOaxL/TgQeK6bHFRSwhvSuN9yLnmup6QGB+Xr7VzdzaPbscg49a9bu7IMPuiuc1HSwdwCiqUi1I4BWx1qeKQqRjOfWr+oaW0ZZo/yrKYMjbSMGtE7lJm9p2otGQD0rrNL1bgfNXnMb46Ves7xojweM0nG47JnsNhqAfHNbMFwJBzgV5Zper4xluc11mm6oGA5qLGUo2OuPNMYVUtrsOOSCD71cBBAOc0iCMirejwC61O2hIJDOM4qselbvgWATa4jE8Rjd0rWCuxWuz0qJQkWBwFAFUbmTyir4+YHIx61ed9iMR61RuHLYXYW5zkCt4q7OqcrRZla/NMli0kyriRsE9T+FcbdXL/ADBejfxE1ueKrkmNIImZBksSeTXF3U4kbHzZPGF6Y9atGC0diWa7jCM0k+fZfWub1W9DK2wOR1BY9far17MThVgVB1yxz/k1zes3R+1tGHAEajkfnSk9DSG+pVmucDZszg5645qaN52XGVwecA5xWOsoklG5iSavI4WNyv0B75rKKbNJSikSSXEojZd4Afk47gVQZw6kHcfrUk0gjjkYBcAbBWeZsL15NHKzPnRO6gjIXHGOtNQDB6DPHrVae4CxoOcnk1FDOzK2Ac8BeOuTU8vQOY2bfAnbnKquSKW4wCDyW2bs+tUdPuJGaYFQSQQCelJJ5km8h8BEHfqK0srGbepPJt8nII9/amrMRYkk/uy4UiomXZCQTnP61FakbCvRQ4bnv1o6gm7G3qkijUldX6kr14+6MfpUdndYhijAOVZjn2PaqMamdUc7VwhYnPXC1a08bQjMBg/ypNa6DRowsXmhGVXPB7UQO8c6svDK20Zqudw56nnjHFWdPSV5wACI1IYmmtRnVviLw3bqZMrPcM6H2HB/rXp3g4f8Su1x02YGeuK8r1mN9ulWigAKCUGezHOTXqPh51it4I8/Kq4UdK6aXxGU2+X1OuWTgDvjFSodwAxgHvWXHIZFGOoPUVoQ/Ipzyewok22OPuoncKF3ByF796hw24FVbIOR61IeADwT1HoKasmxiqEu3UselSzRMTd5e8sCdwxkjkGoo3XcC4wOw9aeWTbmWTJPO0etVXYHBVcex71DGkK7M0KgYALEn2qNFXyZJGbBzgLjrTGYKuc856UkufJUg5zlsVL7l+Q2SUEggdsH/GqvneXIHXPynkHvTmJwvTmmTx5kPlsDx6dazfcCtcqRK4J6HOanQ5iVMBvmGDnnOaY67nJY5zwaWDiWIADhxVDeqIbhP3jc5Gc81GoG0jaPUYqSQ/vmPqab/Ec55HpQSQgASAspwO1TRoPspYEZeQ/L6YqItgE9RTofmiRcckkjjk0J2B7C4+bceo6cUsgPlxkjg8j86kmcBVXoAOT/AFpJzuig5HCdvrRsxWIZD8gXjJqNMrbKQBuJJyadIcgnByO9LHH+4TPpxip6lbEa/MhyOfTvUdw7LGrAYUkgAetTKdhbrUE37xTGTnHQDtQWtSIMDg9+hGaec/Lt4B602KNgnIHy8YFSYPy4Bx27fjSRTIiSjheStK8mUZDyp6e1I+5cDP1psmQM4478U9SHEjcK6ZBwy9Pf2qKN/n29D2zQeO/PWmSbtyuowPWhi20H+Z8/zdR1HrUzSAuN5XBHBqnuIbeBz3zRGwMoB9eKLkslk4YAgj0NPU/KASMimvIxAikwQvfvUZAB6E+4p7CsmtTj+wzRS9PrSdzXMzMawDDkVTuLUMDwDV3v7UlQK5y99poYHArmNT0gHOFxXpUsKsp4FZd5YhlPy9apOxSkeT3FrJAxDDj1qJWx3ru9Q0sEN8orlr/TGibKAj2rRSvuWpFWGdlIIzW7puqlGAYkVzJBRsNwalSTHem0Uen6Zqu4L83Wumsr4MBg147Y6g0RGW4rqdN1cHblqzasQ4npCyq4yDXY/Dhc3dzIT0UCvKrPUg4HzV6n8L2MltdyD+8K2gtbkRXvHbzMc4z1PWs0NeyPK1kANpIyT1q3dMRnGcZzVWCcpbkKcM5OADgk1rE1rO0UebeJdTuJ7l2dNjqdvPB+tcpLeyzMUjdscDKjBrT8VtNLqEzsCCWIKg4x+NcuihQokdiuchR3/GtlZJHNG7FW6DzTSyOSYzjLNnJrnL643vM6nLSHAxWvqSpbWwjMZwGLHLDn06da5q5cSSDYAo68c1nOV9DWMSS2chxgAn3rR84eUFYZAO44/SqdlZzeWZPKYjpk9Kle3mQFeFJNJOyE1cZeyBAsQySfm496rsAEHBVu+elWYrRnnzK2MHoKmNsjOdx4Xg0tRaIyZ/mc54A4q1bwtEJC4cCQLtyMEjqCKsXMIkmYxqFB6g+3f605pJnjjRnyEXauedv0qbj1Y3S4ZPmbAAOWJY9hTo42lZ1GADhR9aeSqwKitz39qsxKoj3QqzMM9e/vTv0FbqZ1yjPIEyTjjFP+zpsWNPnZud3oP/102MGbzihGUUuRnkgdanjaUsywnBkAZR6gdAKW5ZYgiHkSwquSVwDjsOtWrZVjxgAZ5FV3heOS3jYNvmHz8dOe1QSTNHLIpJypK0X6i3NN3HsAavaRIsbSDYJSV4XPU5BrnEucYyfyrV0OZmvrZlYAtIqrxkk59PSkpal20On1y7MfiNyB90Jxj2B4rs/D1/5nl7H+Rhuye1eZ67lNckkYsEZurHPTtXa+FTI8EXAUdz2ram25NA0uRHpNhMGwyjk/hitaE+/X1rC0sFlwMAKOa2VZgoAYgjmt5HPfoTknupPHXtimtuZQD0PQVGXcAbieB3pDdyHptHbpWbZrFNiO4VsYJx0A7UjnA3FM44GTTS537iQaYSCcdSe5qGaXGqxO4kLgfNzUBZnwefTipZmyCoIGBjNQqOFBYrjnNZspNbkLbgTzkjtSKSmCD8w6A9KXZ1bOSaYeCOeR7UgfkNIfPXPPSn4KmNh94EfzpCwO/dyxPWmozlsjoOPp2pk7jLjAlY84zUZYMODgAZ/GmzHa7BWzg85FMyd7KRnjI70X1HbQa3Pc5781JETHHG+TnGBiq4GQc8n0q7Im1xGrbx/DgU7CbEAEmQfxPpRLGIhGAS25c57fhRGcEDoAP84pbjLiJQcnaAM1IXI1xtYE5qzgGFB5e0qOuevvUJQgBMc9M1POflXjaQuDmiwEEijapYAA/Nz6VVR13hkGQKl1Bw6qI2PTBHoKr269R07UnYuOxM8ZJDDpjkDvVdpAGKjJAGMmrd1mNhHGeV6GqrQgAnj5f1oaY4vuLKuT83Ujgj+VCAcg/dIwc9qZKxKkKueOopIiEiAPIJ6VSE9EQXAKjIGD0Heq8bDLAYPrWjKiSR4OQRyMVQFuRKxJ5H+eKUl1RN7oaQCGVmweoP8ASq2f3mB0ByPerIHy5HVTkimpCfMJPPfANAriI2WIY/jTWZgcA/nT3jHmEqSR7ilAb3P0oaCKOQNJRzRiuZoxEpMc0tJUiFpjqG64p3ak+lAyjc2gYHArDv8ATg2TtzXU57VDLErg8UXC55rqWlA5OOawJreSB+eleqXlkGGcVzmo6YDnK1akaKRxSP71bt7hoyCpNSXunNESVGKoZZGweKvRlpnV6bqR4GfzNe9fBe687SbvBJIkHP4V8xwTlDwa9y/Z/wBWDy6jZliCQsg/lWkBNWdz2i+bg5POM5rHFkJQJHlZdoJGOQcVo3EmVAbBqmdRlisbgyrH9n2FVX3rRW1FWbsrHkniQrNK7LJ69B71jXcLSxCNWdpG4yxwNvpW7rN7FFMxiSM8Z54rkdRvn84gyxKMZwo5/Gm2rGMLlDU1C/uycgd+tVIlijI3HJPU8ACql3dmU8yOared8wwAMevNZN6m9tDomvVEQQEYH15qs06jkNyPbvWUszHjOCfQU8OQOppObJ5EXxOAWYZyfTtTPtA29sdetUi6nqfzo84YwMfgKnmHYu+eCMcenAqIzLu+bOPaqgbAJYnA6CmLKQxPQY7UXCxau5B9oKxnBHBX39qvxMy6VwfmkOSOc+2awDuaUNuy3UV00yRzaVcSlSvkKoXHR+PWmmS47GHFcGO5LAlGwev06fjWjbTSSy6bFEcSghVGf0rHgOfNdhuUIevbPSpdJkK6lbMOquG5PYcmi7KsbN/K9vqy/PukQljjnHIrJnmL3Eki/wATFuamuZFee9lzh5Gyo7gdqoIeX354XIpu73CKSLKSc4zmup8L7LQi/mBURAsGPr2xXLWsatC0rkbUGBjua6aeHyNPW1QN9omIJAOeMdPbmnFW1ByWw+zlbU9RDyFtmScE8nmvUPDyBFBA6DGK47w5ohjQFl+c9eOleg6ValQuB0ralFrVhOUbWR0lk+FUZ5rUSQjPzfjWVbjbjAORVpH5Geh6+1aNmSii87sFUb8tjPPamlmBUuob6VGGyDjBNIT82RxWbLTsPSQHPGDikZjnJYdKYXK5wSQeuaSSQHB2DPepuUxHOSOD0qIMuM54pBIM9/rmoy4GRweKm4WEc8E598UjfKmetD/McYIHrTP5D1oYXHO37kFQAc5qtIxJGG4brU8kpaJF7KMCqrYJGcYz+VJghkjfvD6etSo/lkkEEsuOmai3KC2Rk+9RFzuU89O1K6Q2TwsHuYy3PzZIA61alIDYXl+c47ewqtZMiuxYsCxK5GOmKNykgKTuzx/+uq5nbUnqPOFBwM8de9TSMPlK8/KB+PeqruFJBw3bnpRJKqkrG2cAAfSlcb1J4Obgc/dGTUbncSAcnPUmo4ZVCynOS2AP61Erq0pO7AXn6+1Lm0H1HysvnPuH0oh/4+UBGATVaWYMWyfx70+2lw/PJCnFDZXQtTSBnLgcg5x61Xuim5FUnDDIqOSTBPseRmqsx3Ojc59B2zT5ikiwrby7HgLgZFIzYI7HvSW6hImwTye4pGfBGOtF9BNakwb5drH/APXUFypcBscjABpU+ZMZ/E1Jwykse/pQQytyFJ6c8f8A16Yoyw7EVa2AF88rwR2zUEakuwPQU2haCEAn0z1B7U3IHDpk/WnEkMVYZUjgjqp/wp6KHXJPt0pbFpWOH7cUUAmkzntXMznAc0lLzSYqAD8aQnnig4pDTV0IKQ8/Wg0hoAayhgc1QubUOOlX8U0ng5oGmctfacGByK5rUNL64HNejTQq2cCsm7sQQcCqTsUnY80lheJuQcZ613fwW1E2fja3TdtWdGjx6nFZ1/pwwflrO01pNI1qzvYsjyJVf8M81rB6milfc+s3mDLzjH8qwtdvGj06eKLDOw+6Rj8jVmCdZ4EnRtySIG49CKwvFt9Hb2a7yvz5we/5Vpfox1VpoedeIJyHIYYyMHNcdq1zGZCQ7EjjGK6HXbyOa4+Zi3HGPSuM1C4R5mKjA7D0qZyCnBEDyhj3A/OmmTn5eB2NQNKO1JvJGcVOpWheVzwSx/GpVIIzu+tZyucj5hj69KsISTgHr2osJsvRqm3cTxnHWmSzIjYj6+oqJDtHzHn0xwfeoN29z644osK7J2kYngfMe5PWmM7YAz155pEwdm7dg5BCjp70jncB8pDpwcd/ehICaJkXJYgs3AB689DirrXU3/CPxW5dmM0hO3sAKzZF3Ro27cVPpzVp5GMEM6jbImYzxwe4NNEtakDyKZNqEkNzkeoq/pKRxPM8nIS3J3e5IH+NU4IyFSRFxtYkZ5xxViZvssLw4J8yNc8985qr2Fa5VvJi11KAQwJwG+nSo2eRzluvvTVTv3qWJC7qqgluw9aQ7Gz4XsZtR1G3ts5Rmzz0B9TXotlosYv8M5lYk5bHA5xwa5XwfYXB1uL7QqjyxgAjj8cfWvVNLtVMyEJ04H4VtBXMZuxe0+wEXyquADWzb26x5AGMnNFlEOCx4zV1owPukAfzrqbVrmEbrQRCB1zxyDUm8q+SeKijIJPXNPIx/hWMmdMdCcSgcqfwoMvp371UKkHIIpVfOMn8qybexryk/mZyB1HrUbPnH9KYzgHkUzcVbkc+tISHMw7cVGxwetNkOc4FQliB2qWUmTiQnjdikZ2HcH2NV8jJIxRuyf55oQmh7yZUDoR+tRO3rnmlLgAg44/WqsjDBw2D9aG+4JD92MnAz2NQs5aQdcYNQiTKnJwc0iuQ/mgnBOKzeuhWiZfXCqN5AH93uacZg2WwFAGAOgrOllK/ezu+lNnmaJFBYfMOnpV3JsTzXO5gR90etRSThep5NZ4uR824HB6A1E86SYUEA561DkaxjY2FuAIlHGSTyD1pGf7rLwT1z61keZhgqdM+vap5LgAjaRgDHpmlfuFuxcWQAnJAJ59qkV8oW5HO0Vkm5Pscnj2qdZy8YjX72aExtGltx94H6f8A16TdhtxwCF4rPa7Y8A84qS2nbafmxznJHFWmugrNalkzbYwGY5Jzili+duSOTVG4k/ebwwzjrjA+uKkt5SXUZ460XvoDWmhoyFYmKIT6detDnEKgnnJqoJPMlOMMfX0qRWzwcMaq/YjZalkHKjp93IGKbKgLRuvRhyO+aRn8s7lGQCOR7etNEquWc8ZOeKq9kZ2Eyec88c0m0tyFP4U/bk5IHT1qwoG0cE/SouXsedDrSUmaO3eudmAuelBNJRUiCj9aM0hNAwpDRmkPU9aBDW5/Gmn+lK3X6U04NADT161G4BGDxTycdqjJ+tMZRubZWHSsO+sAc8V1B7VVnhDA9/ansNM634bay1xoxsJ2zNafKDnqnb/CrHja2W708ug+eA7x9O9cTotydK1eO458s/JJ9D3rvLqdZIjgggjj3FXKXU6qfvqx49cyZcZVW5PPY4rlbk5kfBGMnFdx4psVtLovGmInOVA6A1xVwp3njvxVc3Mk0SouLaZVYHGSaFGTjrTmBGOQfoKQZzmmGg5FIB45qZQwVSe/Q0wZJzjkCpFGQOOvQ+lBI9cnOe9SbclTnBJ6jsaWJGxwB349aVWZTwcHr0pASoEiLFSRznpx9KjI3SH589efWpo4mK7ywReuW4/Kq8hJKllyG6UwuObAIVMAYB5HepYkknHlKxYEjcB068UyP5XDOflAxjvW34Wt1N15s8RaHaTuPGD2qoq4mx93BBBJBYA+YUU7yBwXPv6Vl6on71AVwccg9qlvbyT+0JJCQDkjHXIqCaf7RKWPK5HB/lmpY1oQRoNucZ/pWpoumyXjsIQTKoyAoz0qurGdljYLHgHn1rsPDWiXIMUkEjIzsCwB529gfWrirkSlZHZ6RpUVhFCAWNy6LvJ6jjpmuu06DaAo645xWdb2ZjlQlvMdhk+me/5V0FrH5KAMcZ6kda6Iqxyy1LSrxgDhaGfPbjvinFvl2qNq+neoHOM8inJ9Cox7k0Z7jrTsgd+D2quJPmJ44FPMgqNzWw5iPxFRsfw9qa7gZORioGkwR6VEtDRakofqOxpjS4ztP4VD5mVP86ieTsTj+lTsXYkknHGMg9Ka0vGRg+9V5Du4P55qFpSgIPQelJstRViyJg2QeffFBlwSMcjvVQyjGc81G8xwMnd6dqlMOUstNuyHODnt3qtJIM8scn1qGSRefX096qyuCM55qWJLUtec4BHBHSollAIxkY55qmZnKgc7RQJ8deaSY7FyS4GQR1GTVa4uWkcmQj6CoiwIA/i9agds5H3jQ2CQssu5uTVfzGL7hu255x2okQYzu5FRs7AEZ4NQ4tmnMTpcEFiMjsDSNdAsBuHvVdpzsCkDGKgYxntg/Sk0NIvJcqXxngVMtywfKEg/lWMAVJKE8VOkx6gg54xSV1uU0lsagu2Zxvan+d8pw1ZPnHd8wx2xSiU4GCOaL2Fa5q+b8y8gt61dglwAXJHb2rDt5Nozk/41ajmJGeAa0g9dSJI1vtGzG35fTFTwTbYy/wDEeAT2rIil2lTwTUwmBbPHH862TMmi+ZS52gnHQk1bhaNU+bOfeslZOfvDFWEfOMZ+tJy6iaNBJsHjBJ7VYUs4ySoI4rOiYBuBzVr7TsAVWJAHNCuS0cFnnijNOIpp7HFc7MQ70ZpDzQDyDUgLSH8aMUe1ACdKQ896Wm59aAG0ynH37U08jrTQhrc1GfrTyaYxyO+aLAMamHpxUjGo2z9aYFe4XKYxWz4cvxcwtZS/62IZU5+8P8ayJfuHNY13K9vMJYXKSKchhTSLpzcXdHT61brNGyOAVP5ivPdZsGhk4Xt1B4b/AAr0fQNds9ajEc6qLxB88Z/i9xRqmlwTBtqAIe2azV4aHorlrLQ8heNs/MpBpnlP0Kk12t/4cTLGNymBwGGaxrjRLtBkIGX1U1qqiMZ0ZIw1UjqrVPDHlwFHH16VbaxvFcB7eQk9OOtNjikVsFWQ988cVZlYk2CIqHVvm7jnBqvMsiSbowwHXNXWeMwttO5icbu/5VXEeRnGe9DdilG5WVWz8w5xnmrFtAQpmcfLnCr61NHbySyeXGC24jAA611NhpX2WyK3bxlz82zglaYmrGZoGhy384kuEEdoAQeeWx2FbOotJDaSWyJHEgxtEZPT396hOstL8tvBhk4B6ACqLmWZGaaeNRn5ueTTcuiEo63ZhPAxcnHPWrNvZvJhVTAHXjNa1nYGYf6PFNL77cD8zXWaB4VkeRXvJWgU/wAKcn8TQlcUtEc7puiNmMqPOuGI2Qpyee5PYV6V4f0g2dqiSY+0E5d/U+3pitTSNKs9OXEEcahudoyTn39a11TewCkeygHiuiMeXUwbuLbKsUaAcY4zirSyHIKqB7tUKiTJxt9OmKdudR8wUHoKfNcSikTlxyWYn6cVGzjkdqgkZ0wHVcdetR+b2A/DNQ2Wok7NjnvSNLgcVUebGMYGPWmmQZODxSVjTlLEknryKryPnjt6ionkP/1qgeTqQT70MqKLJkPAJ49ajMhPB5+lVTLgjGee1MMozkcCpbLsWWcY4wD3qJ5eORgioHlBBOcVXeYkcnj61m2Uok7SkHI79RUTzEt6Y96geUY4qB364qblJFl589yCKiMhIP8AEKrO2RyTUe49jSDlLgmVQR0qNmRjgkDqaqlx1OP8KjaQ5PPFDk+ouUncg/dYjFQMSMkvzUTSD1OfSkL4PeoumPUUu+7g8+9IS5HKimiTPUU5ZABxkn2o0GxrCTPTjvSMmD6Hvmnb5M9P0pwCsTvzmnuK5FjBwOT7U3y2zuU4PpVkoCchsdsU0I4+6wI96dkHMxmFcdOfemhCpGzFStGcAhgTT1DhWOBxwcHmjlFzDFYEnLY9sVIsgBHUCoD5ZOGBB9aYSU4PI6AinsGhca6AYbelPE5bqcf1qiqOTkDIHqalViGGRn8ai7HojRjk/vH9anjuNn0rLD8nb0qRJMcnn8atMlo1xOed/Wp1lGBjP4VkLLn696sLc4AC9PeqUkRYysU0in9OTSHBNSzkIyKQin4BPekI96yaHcZmilIpD70DEPB4pDxmlNNY+lCENPc01utKx9KQ0xEZ6+1NPvTmphpgM7c01vrzTz070wn0NAEM33awtS/i5rdlAIrE1IcGmho5aSeS2vEmgkZJFOVYdRXpvhPxJDrFuIpysd6owy/3/cV5hfptky3HtUUExhmV4so6nIbPIrS1zaE3HY9ruIRJnI59CKqvYBoiuFx/Ouc8PeLTIqRakfn6eaB1+tdekqyRhlIZG5BHep5UjtjVbXumdFC9v8vBXtkbsU2+0+O5jykKK2c8jP61qKQzDgdOlPChWI4yaLKwSs3exzo0VnYZih2gY4Qc+xqe20O2dSHtYEYc/vM9PaukiiB+6MA9Qe1SNHh2BOQPxFHLYznaXQ5+SzeC3WO2htSpO3KKcrVddHnk8xRbwpIRy5+8R7GutRAR2x9Kk2jqUXrTcU+olZdDkbfw3kgzs2wcY71s2Wg6faqNiRuH55Az+NapOeq4BPan4VvQ/hVWihNyfkFvbRxqBGqgdOgIq/EAn3Soxx0NUlAXocj3pxkI6HFX7Qj2dzSVwCGXbn1HFSid+CGYH2NZCynHNOW49D1o9pcPZGmbgZOSSfc0omJGMiss3GDg5BpjTA9/6UucPZGnLMwyuQAPSo2nJHJz6VltIwyQxpskjNxgn6GlzlKmXzMTyCR7UCfng1nGQ4HP6U0ysSSOeOtTzGnKaElxg7ifaommKnOapNMf4qjEmcjOaHJjUC48+SSOnfmozKPXrVMuOeajaXp7+9Q5lKKLrSjHJzioJJM8dqqmU45NRSSHGcj8DUOVylGxZeTGe9RtL6mqbSt25IqGSfGc1Nx8heaYeppjSZ7jAql52f4himtOAMU+YfIWmlycA5oznrVRZACBnt1pwfPApXE4k+7PQ8U0ke5xUeenegOB1OT9KVxcpIGBPSn7yOOPeoC9APPQ1VyeUseYRyRz796US9QSMVX3MegHHrTwrk9hT5ugnFEymIfWnbkPaoRu/wDr4pQD/fp8xDRKFByFBFSMCEARge/NRAZ4JJxT/lPYg+lWmS0RNuzg4oRQR2A7irATjp+Zp4RfbFPl5hczRXWMrnDAj0pwAJ5BH1pzQjOQT+FSCMjnqKOVhciKf8CFCr6gg1ZEanqpGepzUnkbeo3Cnyi5rFdcj39xVmJVKfOWz7VIsQx8vBpuB60OKJ5rmZmlzTBS+lSzlHcUce9IKAahgB9qaR7080hpBcjIphqUjmmsKLDIm46U0/y9acwwOtMPftQAw9O9NbI9qefWmN1poBjU089KeeaY1AiKTp6e1Y2pDgmtpxlaydSHBoW40cbqfMpJOfeqa53Ve1RcPxVEdfatUUjRtCeO4rptJ1WezTYPniP8LHp9K5i17VrQ/dyPSh6jvyu6OystXhuSBu8tx/C1aAmYMHyP8a4FWI5BwRV2DUrmM/6zcPQ1k4djeniukzu4b0Z5YjHrU8d4ATg8e9cZFrCOMSqVPqKtw6pDIAqyjPvSbl1OmMqc9mdktyh7jnpUgnxwOD9a5eC7Oc5BHrmrMd2pGNxB9zU+0ZoqaOgWf1FI02fukgdsGsb7Qc8Hr2NH2knoeKPaNFezRsGdgeTkU03KkAHp7VkNO3Zvr7U0zEDGeTQqjGqRrG5GeDTBckcA5H86zVuDnqMCni4AHODRz3B07Gn9ox1zg0q3C+o/Gsvzl9SKQyErkEU/aMn2ZqmQdVYg57dKjaZlJOPxFZJlkXP16ZpPtbA5Y8Ue0D2fY1BdDPUH2NNNwpHcVlvdBhg4zUP2jGSpPPpT9oP2RrPOCpO7NQtPx3/Cs4zn1yfcVGbgdwPzqXMahY0DcAEncc1G05/w9KoPcLnkcetQm6TPX8KlyHymg02e+aZJLt4GTVA3Q6/zoN4D14NJAW/MJ9VPuaazlu+TVT7QXb5AW/Cp44byU/JbuR6kYouDkkLkgUhPPrU39n3mRvCoPrmoZoGi4LkmnexHtF3HocckdfSpFcceorOkmkQcGoReSBc4BFFxXubCuO1LuA6EYNYy6mOQUI+lTJqETAdvqKBGpu54Ip27jpWel1Cf4hzUqzR8YPX3pq4WLYOemQKeGfPUZqp5iDADGlBfdxISPSi4+VFwM5zkCnbnBHyg1DGWx24qZXOzGzP1qr3M3ElSQ8fKc9+anSVD95cfWqoZcjqPqKnQnIAwaalYiUS0iq/QinGMjoAcVEi4YcEfhVhBJn5WBHpWikYtEITJA2Gp44l6MKtoGYAPHx/eqxFbBuhwfStU30IbZUWBWGFANTC2HrtI7VdW3UYDjA9R3qb7KgGev1NOzZDZmtbjPGCfrSMAD86/NV97cdVYD2qPyE53FgaTuik11OPGBSgnPrTQaN1YswHg+tLmo880oOKkCTsKKZmgHIpAO5ppFKTz060h5OO1MBpGajI+mamppGetICuw54NRnP0qwRUbD8KAIce+aQ/SnEUh6UwI26Vlaivyt6VrMMiszUAdpFA0cbq4wxx61mCtXVxyfWsvFaopF227VrwHjBNY1t2rXtulAMn4B6c0o7U1jQp4oM2PI71E6+nBqb6U1Y3lkCRo0jnooGTSBEaSTxnMcjgfWpl1G7QjLhseorbs/COs3AytoUU93OK1Yvh3qTgb5oEPccmpcos6IRqfZOai190UCWI4H901bi162blpSh9GFdGvwznYkS3yg/7MeRUUnwtd1YLfDPY+XUOMH0OqEqqM2LVbeUnZcIc9iamFyxGUcEfWpE+Ec/nKW1FQo+8BGc/nVmH4UXcTbo9bcJ2Hl5NS4o2jVl1RnNcsDkn8KQ3QGOcD1zW+vw81CIY/tgSf70P/ANeq8vgjVo+RNazfgVqeU2VV9jG+2f7Zo+3P0yPYVNeeHNagBP2LzFP/ADycE/lWTNb3Nvn7TbXEJBx80Z4/GlyvoDqx6mn9vI6nmj7YpPXnvWLks3BBNAWQgZB/Ciz6h7WHRmx9oTp37Ux5VOcHHrWWFm6bTUiJOcdh70WJdWK6l1peOGqNpRjliaRLWRiMsBxV2HTAR88jE+wxRYh4mHcoNIOvU0scU0xxHGxz6Vu2+nW6AER5b1NaVvGExtUAfSjVGTxN9jHs/D80wBnfYO4HWtuz8PWcWC6mQ/7VX7ZckcVoRpxUmbqSe5QNnBCAI4kX6CgjAxVq5+/iq0pwK1p7GbKs4yDmsi9i4rVlbIqhc8gg/nVSsy43Rh3UfGMVRK4BBrWuxluOg9qz2ALGosbJlBkIakXjj9KsMvJHWomTD9Ofeg0TGEjPrmnDcDkE04x/MOKl2HHHelcdxIZ2U4JP9DV2Gck53VVERYcDGKsxQngEYPqKi/YTZdSfPB6+1WYyxX5Cce9QW8XQN19avxwEEH+VWlczbSCHccBgfyzV6FEbhxg+1PtgQMMAfSrkdsrYIGCe1XGJnKVxII9mM8j161cVUOMqPaoViZDyCParUcJwNpDZ5xWkXYhpPUmijGcLVqPaBh0GB3FV42AAAwD3NWEc49R7VomZSQ8oCORkH0NNPy/d5Hv2oBA4XI9qQP1VgD71VybAEDKfmGfSlEfAznNJtAIwcHsaUlwcEMfcUCemxwJFJmpmj600rWLdzMZnpQDmjHtTaliH/nQD+dNoz1NIB2aM+2KaG+tGcU7gOzxQMcetJnNITx3oAVvao29zTu9IRQBGwqMgZFT4PtTGXg0AV2BFZ1+PlNazL1rO1BcKQaAOL1hcZOKyBW7q4yGrCPFaotE9ucEVsWx6HpWLAfm61q2zZApgy8Qd3H50gHtinKM4ra8L6FPrmpLBEp8lTmV/QVJna7sSeGPDdzr1wQh8q3Q/PIf5CvWdB0HS9JCLbwqW/idvvH8au2ljbabZx29suyNRjCjk+9IttJJKFAC5559K56lTWyVzupU1FXNeeK2SJHjlR2PUL0AqNfKI6gE1WdmjbYCCx7CmSxyFuE8vA5zR7RrVI2g1s2aywRMfkPy+9TJYE4wVA9yKx43uI8eU272PetrT5HC/ONj91br9c966Kcoy6CldbMF08A/OQo9RzTTbRDgBm961kfdycg/pUpVSF2ylT3JFa8iMnUa3MP7IrdFz6dajbTskbUHPvW8Yyf8AlqD+NVng+Y8rn61EoDVUxJNPOPmUVXl0xWQ5Uke9b7xEfe5H+yagkQAEgsPwqeVD52zj77wxY3AbzLaFm9dmDXPXXge2BJiaaP0wcj9a9KeMEdQageL1GR7UnEWj3R5VP4Mu1z5UyP7MMZqlJ4Y1SI5+ylv91ga9h8g9CMfhTGtwpOBS5GZunDoePHTbqJiJbaZcdcrU0MTLjerD6g1619lDchc/Q1E1kj5BjGPcVPKwVNLqeaooGOKnjXmu9fS4GIzCh9cLTG0W12g+SB7gYqXTZXLY5SBML6Gr0f3efpWu2ixKMLvH40z+zCo+Xd6E1m6Uh2Vjnbh8yGoJG9a3Z9DZvmWUqfRhVZ9BnPWRQfpWsU0hWOdnfHbis+V8gg9a6Sfw9dnJUofqazJtA1IF8W4OO4Yc0m2aKxz0v3iR0qmR85rcm0fUAG/0SXj0Gaovpd5gMbaYDsdlSzRWKWzgHFRvF6dq0haTqPmhkUjrlTThYyuuVjkYdiFJp2bDmsZkUO49CBV6K1BIB4z0q7Dp8wBzDJnv8pqxHAysAysCDg8UKBDmVVsucbeRVmO2HBC49a04rRnU+WrEfSpvIITgMOw4rVUyHU7FSK1R2QBdrZq6LVt/3duOuKsRwHIYYJxyPT3q9HFs28FlzknHerUCHMowQxu5DZAq6YERFaJiQOoPapDahsbBtbPA7CrEVsQoaU7W6DHUU7E3K0Ks6cgMPQ9aeYWhQEEZPbuKnX5WAThTwDjrThhSysOnrSsUQqADnAqVVBOV+X2FNwSMqCQDg1KMqMcHI6nilYTGkEjjk0z7rYIyehHrTgR0HP0NKSCBnn3FUTaxEw5Pb60pLDjn8Kew3dMUhY55/QU0iWcOr56U/giqCS+pqdZKyauYkrLmomT8qkEnFLkEc1DQyv3NJnGanK8cUxk69KVwI6TPrTiMdqaaYgz70u7rSUUwFopBxQfemAtIen86DxyarT3AVcdfWkDQ+eRUXjtWJqNwMNzS3t6BuxXP316DnB5qrDSKupShsisthmp5HMhzTMCrRZHGCG4rStTyOaogc8Vv+E9Futf1SKys1+duXc9EXuTTEze8I+HrnxDeCOHMdunMsxHCj2969s0fSrTSbJLayj2KO/dj6mn6FpVvo+mw2Fog8uNfmboWb1rSAwRldyetTJX0NqcbalUQNuzjnsc1OFVI228yNwdvapooDIxWEke1JJG9u2GUqemccVMaZTlfQqeWIWDuBv7AVHh5Gy3PfFXvIJ5OG96GjAB7fhWipC5yugC9sfSr1uwkAV+qD5c9qrbMDt+dSR5GBg5PFVy2He5t2nKdM1ZKgHrx6Y6VDpy5iXJ59a0MbskKpPQ57VoloYyepVkRAMhhnHIFVjtJwYy36Zq+/mDlNmRxwKiZl4Ekkit346GpauVF2MuU9toFR7jnI4X9KtXG1gMMXNZ0hIJ7VnJ2NlqieRt2QU565pvkhcMpOD1zTISXVsuQQMDirUCqSqyMyg9/Q0LUmWgwR5B5/OkKHHJH41YEIJIViOxyae0eEx8ufpzVIz5ij5fOcflQI06OpI9R1FWnGB82B7jimMOACOcZ+tKxSkVzFjoxK0ixn14P61YGd2Tjb6UHGCVwAe3pTsK5XMa5xnb+oqOSIrzgkH06VYmKgdNpqEZ4KZyO9J9hq5VeJQ2fmOegzSNEOMqM/WrYI3fOM+4OKayZ+4d4+mCPrS5Srsp7FU4AH5UvkKRn5fTpVnYAD6+9IEwDnoaOUGyq9qp6ED6VG1kCMVcPGAOvtTwuOv50uW/QTk0ZLaeDnIDZpgtBGAF6ewrYdQOSP0quwBOeKORFKTZn+QCemD64prWoHOwH1rQZR3PFNI4o5QuZrQKv3fl9MHFRPEAc5x7AVpSKMgHGKryKBwMfjR0BMonAbdgFj1OOtDEr8y/yqV4/mzzntiomb1FLUq5PDckFS6K2OnFS+ZFNgtn1xjpVA+o4+lO3AgMCM+tNNolxTNBIo3BjjdCp7H19qfFaHa8cq/d5BPGPrWdk4U+35Vbt7uWPmNskDBDcg1SkupLhbYfcK8abYlwufmK81VEJ580YI6Z4zWgt3HNGFlQI3940skcWwNJGT/tbu1PR7E3a0Zlsu09D+FSKilSWJ3dgKnmQ/fjbI9utVslW5JFK1hN3FIYqQBjB9OtVnYq2PLLe+cVZ3uD944PUg9ajlDb+OlOzewk0t0eajNODYIpKQisbmJKsnTmpll5AzzVTGKASKdxF9Xz9adnPBqir/WpVkqLDLO0HpUbR+vSlR81IDnrSsBWI554ptWmAI461AwwaYEftQzbRyaZLKqDjpWbc3eByaaAs3NyFHBrEvL3Oear3l7x96sG6uzIxCn8afKNInvb3cSFNZzuXOSaTqaTvV2LFzinKMkelKkZIz1HvVmOPOAOn0oAjjjr3j4PaQml+HG1CRR9qvTwT1CDpXjVnbedPFGBnewXHrk19J2kSQW1vbou1Io1Ue3FUnpcEruxfgzjCsM5zhu9SgSH5R9xj1FVyRs4wT6Yq1aArxkj19KI66G0tFc0oLdYowSSr9Qy9RQ5eQ5k2Sj1Xg/lUUdw6gnIZB0z1H0NIXQnJ3Kcdc1ukrGF23cjeOMcDKNnoeKilUqR8wNWkdhlnIdcdxmqcrRs7MAVHbaaLWGmV3PzHcv1qSB1XJIJwPy96ZjuGzSx5JlLr0WpZrE39JYkHPIHrWjCctuBC49ehrN0gqIN2cM3Aq/xuB5J7VS2MprUmbbnaQOTk1RusxhvlDoe3UinTXBVj0IHbFUprosCqowB5JPeolYqKZUuHB5j+XtgVRkJLgZ5NWbgnJPK/WqrMC2cjNYM2THpI69AMdOKsqztt3qVHv3qnET82BjtzWtZqZLWMdVGeM96uMWyZMljuEaIJJglTwcdqCwc4jDEdQKrqF37hUxmYjIAK9enIqjJrsRPuI5H0zUhcryijb6Z703cu5iCNqjP4mqzXGOByCego2KSZMQcE44qPcqYKt8wpG3SQbmYKBxjvUI2oQBwT26mh3KS0J1O9zuBI9vWmOpDD7o/rUiZMW5e/UelMZx5ZDH3FCQru5DLg4H6U5BtXH5+tNQheX6ntQD1yvHY0JK479EI5HO7mmlwOOtRSg4BJoyCAASPel1HZEi8c9zSsTtAJqJnz9PWlDcdRVITQ4n1zURI3YFKXwMZ61FnnJPPTmhpDSHNkAgg1GSMEEdPSnStjqOfWmk5Tjk0rDI3IPH9KrsARkceoqSTdg+/vVeQkg+oqLDI3bHGagkIJyOKeGJz3wOarSvgk9sUvUdiOWQjPWqJvVjfDk4q1IwI54zWFq8LZ3ZIxUTb6FwSbszorecSJ8p3KemKss+5FG3DYri9NvpIZlAY7en1rqbeQv0PB7VNOopBOHKy2rEYyefaneaUfKsemQKi43D5uaQv85Gcn0rQzuXo5wp6fXFOkTIDLhl6VnhsuMdRU6XG1iMHDdQapSM3HsTrEhYksU9cDNR+UT2/IkUMQOEOf609ZFCgMMnHetFZmTueXDjrnFGORSLz0pfXrXOyAH5Uhp3f2pOaSAbj3pRmlAOelSJGScUrjFQnn0qwocjipbe1J5IwPSrnlBV6c1S1IM5yy9RxVSecDIq5fyhFNcrqF7tLc0NAnclvrwDODWDeX/B+bNVdQvzggHmskyM7ZJzTSNIruT3E7SsfSoeT1opQpbNUUJ16VNHHxk9+1Oji9uatxRYYZoAjjjOeatxRYNOVQBTs+lBLfY0NDQNq9kvrMv86+gg+HbnnAHNfP2iNs1izYHpKv86973gnOAMihvRF0lqXY5AGXf16Zq2JNqHJ681jxS4YAjINWpJOAUOBTg9TWaL7uQwA546ikMrHknOKox3BHB4yc1IJg3pW6Zi1YtNMAnVgarPOSPUfSmyOMcE1VZjnt+FNsaRO8obABKmpIG2hlLbtxwTVJ3yRnmprb5i5GdirUs2S6m9ZzhIVVick9q1IHwC+do/pXP2kuWy2PlGOKumYyNtyQB3NVfQzktS886IOuSewqpJK8j7hkgdz/AEqDzFySCeO9V5JWI5cgZ6ZxWbfcaiFwzc7vl9B6VSlY+me/FTNI3J3Z9jVaW42sCcA/SoaKVyxASWycLV23kbZ5e/bk4wO9ZqS7gC5zVuycLKzgj5emTTiJ+Ze2KmFZ8Y4+WkJRWP3iAM9aqCXMh3HJ9hxTJXL4UHgd6bsSk+pZd0VCDnJOfaojMEA2nnsBSzPlvlUEDioTP5ZLbQM9BSKTLCXGIXXaxYnI4qHc2d+ADSrKSh3d8H6VGHAY9Ke+4/QseYwQbmwuO1NUjAY8LngetVg+9gSSY16470rSAyMxOABwBVLUTRK0oJLcBewFML5G48ZNVjKvQn6DrSNLyBnOB+FTdBaxK8vc/lTo+YpHI9sH3qFCCC7/APAR6+9BkYw45+Zic0ykActIoHQU4EluPwqurhcAcGpd/UA8elCYNFiRcQRsTgsOlMhUu+GGdoLGpbk8KuPuqBUcT4iPY/0qm9hJuwx054xyaRzgYoL8ZyMVWmlznrwMmkPV6A7c9qgMg3c98iqstz2yPrUaSB2I9Bmpb1L5GkLNhc8VWlbcM5GfpUtw+5g3qOfrUD4IHFJiI2OcZqrdRmRCAAR6VK7/AJ+tRM3fv3FRYH5GCISl1gqR9a6S1kxEMj61VZVkxkD8RU0JCsAM496zhT5XcqU+bcvo5P096UlSwwTmq3mYBGRilWTsSOPWtbdGZehZZtoyOKRHBO7OT3NQGTeOelIjfNgcAUCuXoic4b7v8qmAlx+7yR+dZwmG75uVNWluMDHX3ppESVzzrPTFGaQH1pR1rJ7mIopyjmlVeQRmp4YSzCpAbFFuI4rRtrUDDOKlt7cIAeM1YJCryRQkABQvXoKqXlwqA81DfXyxIx3AYrjda1wsSqNxV7CLWt6mq7gpBNcbf3xZjhuar318XY85P1rP+ZzluapItRHO7SPk05fTjNIqZNWI4sfeplCRx5bkVahizTo4x1NW40HpSE2JHEAM4qcAKOlOWkOaCW7jWORQKRge9OUcdqBFnT223kDd1kU/rXvgbAjI6EcH8K+fgdrAjrXtWg6kl3pFpK3KsgBx2NS1oa0tzUaQhgATjqKnMmTwaqTqRtZDuT1FI7jaoPBNOGjOlq6Lqy+vejfk9R+FUfMIAwcim+cMnqK3TMnHUuvM2Dzn61H9oPcYFU3mJPHNR+fyMnHtRcaiaYkDMBkVeT5USNf4jlh79qxLeQecuSNu4ZFXYrgPLNIB1PABouUo9DVtZckoKuOyqNobk9fWs2Fm8s4ABPc1OHbHzdaT2CS1JnK4JB5Heq8jgE55qOVxg8gkVBLLxjPPcCs7gkOlm+Xjr3qszFiOmfemNIe+KhJO7OaL3HaxoQuOmRxVu3kCo/GcnrWSj8EgVft2/dk985FaIzkTq+05zjcOtKD02t+NVi2WGTjBqVM53cBfX1+lTYL6EyMWHU4HB4qNmDOACSepqGSTOcdPSmxtjcwzubimUiwsu1mGSTjnimCQO+0Ngdz6VWebaeOppd4VAkefVj60Nq9gSsWJJ1wET7i/rUYk+XA6k5qscgjAPNCuVPK47AUXKsSA7WJyPqaFYdXIAB596gL54HP1prSkoQeam1h2uWJLjceOQKHkKogJPTOKp7uvoadM43EdumaLt6lcqJzNz15FSQyFpVUg4qiGwc1LbyEFiTnA60huNjQeYsx+b/69KJP3TA9DVEPvbJxU4bJCnv1q73Zk1YdI+EC4xVJyTu5qadxyDUErbUUY4PP1plRM+ZSM7eSaZZ8+bk5wvAqyy7jjHFMjULLIOxQ5NJq5rz6WZXeYEAEYx3FMMnyfe5BqGXIbjn3qMsQq+4NQyGkLKwJ7DjtUBcg4Jz7012DZxx7VEzYPXipEWkcEDHSnM3B596qoeDnr9adnOfmq0T5kwcnn8adE+5yB9cVTBIYg8jtTo5SsvCmluDLhc7uOnrSrLgkVXaTBwAcmmGQ59KNmQ9S8JMrj3qxu4GSAR6Vmo+BnuKlVyR16VV7bkXOUHWnqufao43VuPWr1tDvPB4rF+Rh1C3hLnpWpDEqCiKMIvGKZLOIweRStYLkzyKg5NY2pamkKNlhVLV9XWFSAwzXDarqjzMxZjzT32Dcv6xrDzscN8tcvdXRkJ2mopZWlbAPFNVcelWkWlYRRyakjUt246c06OPOSelWoo+OPxoGJHF0FWY46fEmDUuAKBNiKMAHtUiH0qME+tPXOBQRuSj0/WhulN3YFBfNIB46807HFMH1p1ACjOe1dV4K1Z7ac2b5Mchyg9Grll61seGSia7ZmT7u/FFr6Di7STPVYLxZF+XAbv6H/AAqeVlYjB7dKqXtmrSk2h64JA71W3snyuDmsoyadpHelfYvncBxx9ajZz3Garm4ZR1OKQXKMBuGPpXTFiaY6Rxnrj61AZGBOOeaezK2cMDVdlOf8KGwRct5Mnd3HOa3NLjIAkcAnrg96xLSMldoG7cRXUWiKkPzqzN0+gqoq5MpWHqctkmnl8jA7dqTPygkYGKhZ/l6fjmkyU7jZOCcceoqm4IfOTj0NTSP14/Wq00n+TWbNExpfnmmM/wAwA4qN5DnjHvUYfLA8ChMlovx9MdqtK4ROv4Vmxvlsjk1eiOME4Ln9K0TuZtdydFLLuIwD0BqWSQDAwSCKheXOAB04phbjJY49KL2EOY9O1PbcBtB6fpUKAuRzhfWpZBGvWRj9BQn1KETYHBA+b1NJJcEggng+lRngkqc8d6aMsvXIPTHai40hd7Y4BpzB8A7Rz703+EAEHHrTQc+vpTXmDdhGR1AJAx9ajKM3J21I3A6jP501mwuaVilMSJC0gBwQuOlJMP3h6D69qdEcK5/iOKhkOcgUrJIpO7BVOCcj61LEP3PPJY9qgJBXBOfSpwNsaduM9etK2pTbJ1QoBhTzRlg2SMEjio95PrkDikLliATx7mrskZ7simkIkC4PNLIwJJUYHb2qFgCxZjgdqRX3DHAAoRcttCbJCdz71W3fvCc8YNPfO3r096qFmD5GenWmZXuV5s56/lVWdyuBU07ZOBVOd889BWL6midyCRjng81HubPGCKa7jnJ5qLf0HapuUy2spwBihJQCT+eaq+cAfcU/zcnAHHvVrUzZZSRAxI60ySVsjAPFQmXa3BpjSEjkcd6bEWfMbI3HFKJMnsT9aptcdhSGYhDkYqQ3LyTfMSRxUyyLzkVnpkYyafuJ6DiqTM2jlbe4zjr+dbtlc8DFcjC+OhNaltcbQO1c17M5mdT9sCL2xiud1nWFjDBDk1T1XUTHFhTzXIajeNhiWz+NaRdwSuSajftI5JJOayXZnPOQDUYYuSxzUg6mrNUrAo56VIid6EXGPWrMSE85oAWNCT04q1GuKaq4AJOKkB9OlNIhskHTilIpAQOBTj0pCEVc+lPA496F5Ap2OMUMBj+9IOp54ocZoAxSAeD2Bpd2OM02mhvmoAnTtVqCRkkR0OGU5FUk6VOpoQHsuiXaX1hbyg5Vhk47H0qa6tJJQWXaR2B7Vw3gDVfKmkspTw3zJnse9egw3O0HoQeoH8xT5FLc7qVS6uY1xDLGPuGqe9y2DG270rrEuoc5kiR1PY1BLHYySfLGyqewOaPYtbM3VRbNHOfPu4Bx0PtViGGRm54FbsUEGSI3UgDgMP0zSwCNVHyjHQ1cab6mUprsGmWxAVnyuPatdndV+XkCq0Mm3IDMo9+lEkjY4cE+laWsjmbuxXlZgdwIx6VDK2BwfwphkbdknHFQTScHOQT+tZyNUOaXB5yeelRSP3HA9KiLYIPcflTHfjJ/KoKY2TJJwf1pi5yM8ihjnmmofmH6YpIVzShYAcAAH0qeJ1BLZwBVGEE/eBA9KuRGLHzLnHXnFaoylYnDKRx3oGTx1UdfekEluv8AyzJ9iacZIj91FA9cmnYm4meM4wPrSN0+bvQzxEYBYH06io2bPA4FJ7FLccpG4g4x7UHA5zzUedpPIJ9aXPPFIq4GQDvzSBjjk4pjNl8CkLevHeqQE2R1J78Co2bPXgVGXPqTUTMcZAJHc05SSGkWGfCttHGahZu5wDRvO045z0qJ2x3pN3GiVGywAA546VYlfL9hiqSfeGT05zTg4zljmmrDe5bDj61GGy/PaofMHHc0gIVznv6UNAnYSRyx4PSmsTkYP5UFk3H5iM+1RlgeAVpOLKch7ykjHUVW8wAnJ7dKdI2F9c9hVOQ5zwMdM5pMy3GSylmyfSqM82SST0qaYEAknrWdOMkAH61Emy42uI8gqIvzUTYxwTn+VMyw6EGoLJ2YHkj6Upc+tVWkOMHPNNDnHXAzVIllhZixxjvTnmJ4AxkVW81RnHf0pFYtg9PrTTsS2WFcZy1TCQsDgcVTbrw2T9aVJG3YHT1oJepcVtoPc5xThIR1qr8y8ilE3qOfc0Alc5BDhuecVejY4Hr60UVzdjnZlaxId305rlrtiXHpRRWkBxCPoKmXHpRRWg2Wo1HWrEagAkUUUAx/JJxxihTRRR1M0SClB4oopdRkinFSZoooYhG64PcUnGcYoooWwDSeKRfvCiikBKODT88iiigCa0uZLa4SaI4dDkV6np101zYwTkBWdQSOtFFUtjbDt81i1HKcZ705pOeBwe2aKKpbHctx4kIB9PTNTxXDgBex7UUVcehnMmjlLKRjBB7H+lNlmZGI44ooobMrajC5xn9KRmJAwcZoorJspEWDnbnpTZFwBgnpmiipQnuIEU4yD+dSBUUZUEH60UVokiG2O3tt6mpUY4oooT1F0Ju3NLGefrRRVgGSpIzQ7Z6jpRRQtgRGzEZI6dcU4OdoooqEaMaTg8Cmu2BnHXiiihCQzdkZIppOSw7D9aKKT2KF3cE4FMdvmHFFFWJArc5pjOT2wKKKI7miHqevtSZyeaKKEQ9yKX5DxVWUlX4ooptspDHkYRnnvVaSc7QAMc0UUNisVbqRgPXtWZLIc/WiisWUkkQeYWJ4qN5SF6UUUCIfNY0i5cgEnk0UVF2KWiJB+7461NG24HI6GiitUZsGC9gR+NKEwmQTk5NFFOSsLoIkhBweRT2GTn1oopFpI//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15170=[""].join("\n");
var outline_f14_52_15170=null;
var title_f14_52_15171="Female anatomy PI";
var content_f14_52_15171=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80271&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 565px\">",
"   <div class=\"ttl\">",
"    Female reproductive anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 545px; height: 497px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These are the internal organs that make up a woman's reproductive system.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15171=[""].join("\n");
var outline_f14_52_15171=null;
var title_f14_52_15172="Penicillin V potassium: Pediatric drug information";
var content_f14_52_15172=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Penicillin V potassium: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?22/46/23269?source=see_link\">",
"    see \"Penicillin V potassium: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?18/32/18948?source=see_link\">",
"    see \"Penicillin V potassium: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F207857\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Pen VK&reg;;",
"     </li>",
"     <li>",
"      Novo-Pen-VK;",
"     </li>",
"     <li>",
"      Nu-Pen-VK",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1049295\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Penicillin",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1049288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?22/46/23269?source=see_link\">",
"      see \"Penicillin V potassium: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Systemic infections:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &lt;12 years: 25-50 mg/kg/day in divided doses every 6-8 hours; maximum dose: 3 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;12 years and Adults: 125-500 mg every 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Primary prevention of rheumatic fever (treatment of streptococcal tonsillopharyngitis):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &le;27 kg: 250 mg 2-3 times/day for 10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &gt;27 kg, Adolescents, and Adults: 500 mg 2-3 times/day for 10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Prophylaxis of pneumococcal infections in children with sickle cell disease (SCD) and functional or anatomic asplenia: Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Before 2 months of age or as soon as SCD or asplenia occurs up to 3 years of age: 125 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &gt;3 years: 250 mg twice daily; the decision to discontinue penicillin prophylaxis after 5 years of age in children who have not experienced invasive pneumococcal infection and have received recommended pneumococcal immunizations is patient and clinician dependent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Recurrent rheumatic fever, prophylaxis: Children and Adults: 250 mg twice daily",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F207833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for solution, oral: 125 mg/5 mL (100 mL, 200 mL); 250 mg/5 mL (100 mL, 200 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 250 mg, 500 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F207817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1049299\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: Administer with water on an empty stomach 1 hour before or 2 hours after meals; may be administered with food to decrease GI upset",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1049292\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refrigerate suspension after reconstitution; discard after 14 days",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1049298\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of mild to moderately severe susceptible bacterial infections involving the upper respiratory tract, skin, and urinary tract; prophylaxis of pneumococcal infections and rheumatic fever (FDA approved in ages &ge;12 years and adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F207884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Penicillin V procaine may be confused with penicillin G potassium",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F207882\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Mild diarrhea, nausea, oral candidiasis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Acute interstitial nephritis, convulsions, hemolytic anemia, positive Coombs' reaction",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1049302\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to penicillin or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1049287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with renal impairment, hypersensitivity to cephalosporins, or history of seizures; dosage adjustment may be necessary in patients with renal impairment; oral solution may contain aspartame which is metabolized to phenylalanine and must be avoided (or used with caution) in patients with phenylketonuria",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1049286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral solution contains sodium benzoate; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse; use oral solution containing sodium benzoate with caution in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate displaces bilirubin from protein binding sites",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F207826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fusidic Acid: May diminish the therapeutic effect of Penicillins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Penicillins may increase the serum concentration of Methotrexate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: Penicillins may decrease serum concentrations of the active metabolite(s) of Mycophenolate. This effect appears to be the result of impaired enterohepatic recirculation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Penicillins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetracycline Derivatives: May diminish the therapeutic effect of Penicillins.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Penicillins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1049305\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food or milk may decrease absorption",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5720583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Penicillin crosses the placenta and distributes into amniotic fluid. Maternal use of penicillins has generally not resulted in an increased risk of adverse fetal effects. Due to pregnancy-induced physiologic changes, some pharmacokinetic parameters of penicillin V may be altered in the second and third trimester. Higher doses or increased dosing frequency may be required.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1049294\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Periodic renal and hematologic function tests during prolonged therapy",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1049285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Interferes with bacterial cell wall synthesis during active multiplication by binding to one or more of the penicillin-binding proteins; inhibits the final transpeptidation step of peptidoglycan synthesis causing cell wall death and resultant bactericidal activity against susceptible bacteria",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1049301\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: 60% to 73% from the GI tract",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Widely distributed to kidneys, liver, skin, tonsils, and into synovial, pleural, and pericardial fluids; appears in breast milk",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 80%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: 10% to 30%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 30 minutes and is prolonged in patients with renal impairment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Within 30-60 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Penicillin V and its metabolites are excreted in urine mainly by tubular secretion",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1049303\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     0.7 mEq of potassium/250 mg penicillin V; 250 mg = 400,000 units of penicillin",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;American Academy of Pediatrics. Committee on Infectious Diseases. Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar&trade;), Pneumococcal Polysaccharide Vaccine, and Antibiotic Prophylaxis,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2000, 106(2 Pt 1):362-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/52/15172/abstract-text/10920169/pubmed\" id=\"10920169\" target=\"_blank\">",
"        10920169",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dajani A, Taubert K, Ferrieri P, et al, &ldquo;Treatment of Acute Streptococcal Pharyngitis and Prevention of Rheumatic Fever: A Statement for Health Professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1995, 96(4 Pt 1):758-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/52/15172/abstract-text/7567345/pubmed\" id=\"7567345\" target=\"_blank\">",
"        7567345",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gerber MA, Baltimore RS, Eaton CB, et al, \"Prevention of Rheumatic Fever and Diagnosis and Treatment of Acute",
"      <i>",
"       Streptococcal pharyngitis",
"      </i>",
"      : A Scientific Statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2009, 119(11):1541-51.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/52/15172/abstract-text/19246689/pubmed\" id=\"19246689\" target=\"_blank\">",
"        19246689",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shulman ST, Bisno AL, Clegg HW, et al, \"Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?14/52/15172/abstract-text/22965026/pubmed\" id=\"22965026\" target=\"_blank\">",
"        22965026",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12689 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-EA571C30FB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15172=[""].join("\n");
var outline_f14_52_15172=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207857\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049295\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049288\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207833\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207817\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049299\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049292\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049298\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207884\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207882\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049302\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049287\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049286\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299843\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F207826\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049305\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5720583\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049294\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049285\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049301\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1049303\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12689\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12689|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?22/46/23269?source=related_link\">",
"      Penicillin V potassium: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?18/32/18948?source=related_link\">",
"      Penicillin V potassium: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_52_15173="MDS abnormal megakaryocytes";
var content_f14_52_15173=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F59897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F59897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Myelodysplastic syndrome with abnormal megakaryocytic maturation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 430px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bone marrow aspirate from a patient with myelodysplastic syndrome. The megakaryocytes are abnormal, with multiple small lobes seemingly disconnected from each other (\"Pawn ball\" changes, arrows). (Wright-Giemsa).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David S Rosenthal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15173=[""].join("\n");
var outline_f14_52_15173=null;
var title_f14_52_15174="High-resolution manometry achalasia";
var content_f14_52_15174=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F67060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F67060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 484px\">",
"   <div class=\"ttl\">",
"    High-resolution manometry achalasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 464px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This high-resolution manometry depicts the findings of achalasia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15174=[""].join("\n");
var outline_f14_52_15174=null;
var title_f14_52_15175="Contents: Pediatric infectious disease";
var content_f14_52_15175=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Pediatric infectious disease",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Pediatric infectious disease",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Antimicrobial therapy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/38/6758\">",
"           Antibiotic failure in the treatment of streptococcal tonsillopharyngitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/41/18072\">",
"           Pathogenesis and prevention of aminoglycoside nephrotoxicity and ototoxicity",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Bacteremia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/14/11494\">",
"           Blood cultures for the detection of bacteremia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/23/375\">",
"           Diagnosis of intravascular catheter-related infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/61/28632\">",
"           Epidemiology of and risk factors for Staphylococcus aureus bacteremia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/14/22762\">",
"           Fever without a source in children 3 to 36 months of age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/54/3944\">",
"           Group A streptococcal (Streptococcus pyogenes) bacteremia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/28/9672\">",
"           Microbiology, pathogenesis, and epidemiology of coagulase-negative staphylococci",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/18/37159\">",
"           Treatment of Staphylococcus aureus bacteremia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/16/23815\">",
"           Treatment of infections due to coagulase-negative staphylococci",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/20/7498\">",
"           Treatment of intravascular catheter-related infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/42/44710\">",
"           Vibrio vulnificus infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Bone and joint infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/30/14826\">",
"           Bacterial arthritis: Clinical features and diagnosis in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/30/40423\">",
"           Bacterial arthritis: Epidemiology, pathogenesis, and microbiology in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/33/28186\">",
"           Bacterial arthritis: Treatment and outcome in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/4/18506\">",
"           Bone and joint complications in sickle cell disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/39/20087\">",
"           Clinical features of hematogenous osteomyelitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/0/17416\">",
"           Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/32/33289\">",
"           Evaluation and diagnosis of hematogenous osteomyelitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/9/24730\">",
"           Treatment of hematogenous osteomyelitis in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiovascular infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/53/34647\">",
"           Clinical manifestations and diagnosis of myocarditis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/37/2647\">",
"           Treatment and prognosis of myocarditis in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Central nervous system infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/16/21769\">",
"           Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/54/31590\">",
"           Acute viral encephalitis in children and adolescents: Pathogenesis and etiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/18/23848\">",
"           Acute viral encephalitis in children and adolescents: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/2/28713\">",
"           Central nervous system tuberculosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/8/28810\">",
"           Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/47/7928\">",
"           Clinical features and diagnosis of bacterial meningitis in the neonate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/52/37704\">",
"           Clinical manifestations of meningococcal infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/21/4442\">",
"           Dexamethasone and other measures to prevent neurologic complications of bacterial meningitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/41/27285\">",
"           Diagnosis of meningococcal infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/50/27432\">",
"           Epidemiology of Neisseria meningitidis infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/32/44552\">",
"           Infections of central nervous system shunts and other devices",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/32/7688\">",
"           Microbiology and pathobiology of Neisseria meningitidis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/40/41608\">",
"           Microbiology, epidemiology and treatment of Haemophilus influenzae",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/58/31656\">",
"           Neurologic complications of bacterial meningitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/43/24246\">",
"           Neurologic complications of bacterial meningitis in the neonate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/41/38549\">",
"           Pathogenesis and pathophysiology of bacterial meningitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/42/12970\">",
"           Pneumococcal meningitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/47/16121\">",
"           Treatment and outcome of bacterial meningitis in the neonate",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/0/25609\">",
"           Treatment and prevention of meningococcal infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/35/38458\">",
"           Treatment and prognosis of acute bacterial meningitis in children older than one month of age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/21/10586\">",
"           Viral meningitis: Clinical features and diagnosis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/17/22809\">",
"           Viral meningitis: Epidemiology, pathogenesis, and etiology in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/51/35640\">",
"           Viral meningitis: Management, prognosis, and prevention in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Clinical features",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/22/33128\">",
"           Approach to the child with peripheral lymphadenopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/47/30458\">",
"           Approach to the child with recurrent infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/1/30744\">",
"           Causes of peripheral lymphadenopathy in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/26/29098\">",
"           Fever and rash in the immunocompetent patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/31/15864\">",
"           Vesiculobullous and pustular lesions in the newborn",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fever",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/30/9706\">",
"           Approach to the child with fever of unknown origin",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/17/28951\">",
"           Definition and etiology of fever in neonates and infants (less than three months of age)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/63/38905\">",
"           Etiologies of fever of unknown origin in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/3/20537\">",
"           Evaluation and management of fever in children with non-chemotherapy-induced neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/26/28074\">",
"           Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/33/15898\">",
"           Fever in children with chemotherapy-induced neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/14/22762\">",
"           Fever without a source in children 3 to 36 months of age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/8/18570\">",
"           Pathophysiology and management of fever in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/8/15494\">",
"           Periodic fever syndromes and other autoinflammatory diseases: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/11/8377\">",
"           Periodic fever with aphthous stomatitis, pharyngitis and adenitis (PFAPA syndrome)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/20/30022\">",
"           Risk of infection in children with fever and non-chemotherapy-induced neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/38/40550\">",
"           Strategies for the evaluation of fever in neonates and infants (less than three months of age)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/56/28551\">",
"           Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Fungal infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/6/25703\">",
"           Clinical features and diagnosis of candidemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/11/12469\">",
"           Clinical features and diagnosis of sporotrichosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/47/31481\">",
"           Overview of Candida infections in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/16/3336\">",
"           Treatment of candidemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/0/34822\">",
"           Treatment of sporotrichosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Gastrointestinal infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/8/26761\">",
"           Approach to the patient with nontyphoidal Salmonella in a stool culture",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/55/35704\">",
"           Clinical manifestations and diagnosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/40/38535\">",
"           Clinical manifestations and diagnosis of Shigella infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/63/41974\">",
"           Clinical manifestations and diagnosis of Yersinia infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/57/14232\">",
"           Clinical manifestations, diagnosis and treatment of enterohemorrhagic Escherichia coli (EHEC) infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/19/19769\">",
"           Clinical manifestations, diagnosis, and treatment of Campylobacter infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/48/26376\">",
"           Clinical presentation and diagnosis of rotavirus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/6/28777\">",
"           Clostridium difficile infection in children: Approach to diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/16/11528\">",
"           Clostridium difficile infection in children: Clinical features",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/22/16745\">",
"           Clostridium difficile infection in children: Microbiology, pathogenesis, and epidemiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/5/14426\">",
"           Clostridium difficile infection in children: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/14/43241\">",
"           Epidemiology, clinical manifestations and diagnosis of norovirus and related viruses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/28/33224\">",
"           Epidemiology, clinical manifestations, and diagnosis of giardiasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/1/42008\">",
"           Epidemiology, microbiology, and pathogenesis of Shigella infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/2/42024\">",
"           Epidemiology, microbiology, clinical manifestations, and diagnosis of typhoid fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/56/14216\">",
"           Epidemiology, pathogenesis, clinical presentation and diagnosis of viral gastroenteritis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/2/16426\">",
"           Food poisoning in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/4/18502\">",
"           Infections due to non-O1/O139 Vibrio cholerae",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/19/14649\">",
"           Microbiology and epidemiology of salmonellosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/19/18745\">",
"           Microbiology, pathogenesis, epidemiology, and prevention of enterohemorrhagic Escherichia coli (EHEC)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/14/36073\">",
"           Overview of Vibrio cholerae infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/37/19033\">",
"           Pathogenesis of Salmonella gastroenteritis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/4/29768\">",
"           Pathogenesis of Vibrio cholerae infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/6/21607\">",
"           Pathogenesis of typhoid fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/43/9912\">",
"           Prevention and treatment of viral gastroenteritis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/29/29145\">",
"           Travelers' diarrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/16/8457\">",
"           Treatment and prevention of Shigella infections in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/7/32885\">",
"           Treatment and prevention of Yersinia enterocolitica and Yersinia pseudotuberculosis infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/17/6424\">",
"           Treatment and prevention of giardiasis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/58/18345\">",
"           Treatment and prevention of typhoid fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/59/30649\">",
"           Treatment and prognosis of Shiga toxin associated (typical) hemolytic uremic syndrome in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/14/27878\">",
"           Vibrio parahaemolyticus infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Head and neck infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/0/11273\">",
"           Acute bacterial rhinosinusitis in children: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/58/42921\">",
"           Acute bacterial rhinosinusitis in children: Microbiology and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/16/5385\">",
"           Acute mastoiditis in children: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/5/16471\">",
"           Acute mastoiditis in children: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/35/8760\">",
"           Acute otitis media in children: Diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/60/29642\">",
"           Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/54/42857\">",
"           Acute otitis media in children: Prevention of recurrence",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/0/21514\">",
"           Acute otitis media in children: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/4/35913\">",
"           Cochlear implant infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/17/24857\">",
"           Diagnostic approach to and initial treatment of cervical lymphadenitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/27/8632\">",
"           Etiology and clinical manifestations of cervical lymphadenitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/58/26537\">",
"           Microbiology and antibiotic management of chronic rhinosinusitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/36/22089\">",
"           Moraxella catarrhalis infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/25/11674\">",
"           Orbital cellulitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/40/22153\">",
"           Otitis media with effusion (serous otitis media) in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/16/15619\">",
"           Patient information: Ear infections (otitis media) in children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/61/31705\">",
"           Peritonsillar cellulitis and abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/6/27751\">",
"           Preseptal cellulitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/61/43992\">",
"           Retropharyngeal infections in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         HIV infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/55/20345\">",
"           Diagnostic assays for HIV infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/44/35525\">",
"           Diagnostic testing for HIV infection in infants and children younger than 18 months",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/0/31749\">",
"           Epidemiology of pediatric HIV infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/51/19255\">",
"           Fever in human immunodeficiency virus-infected infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/3/3130\">",
"           Natural history and classification of pediatric HIV infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/4/13384\">",
"           Non-antiretroviral interventions to reduce perinatal HIV transmission in the developing world",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/44/1737\">",
"           The adolescent with HIV infection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Immunizations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/10/13480\">",
"           Clinical trials of human papillomavirus vaccines",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/27/34233\">",
"           Diphtheria, tetanus, and pertussis immunization in children 7 through 18 years of age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/37/5722\">",
"           Diphtheria, tetanus, and pertussis immunization in infants and children 0 through 6 years of age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/38/1641\">",
"           Hepatitis A virus vaccination and postexposure prophylaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/60/31690\">",
"           Hepatitis B virus vaccination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/37/601\">",
"           Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/32/23050\">",
"           Meningococcal vaccines",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/14/7402\">",
"           Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/38/13926\">",
"           Pneumococcal (Streptococcus pneumoniae) polysaccharide vaccines in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/52/17223\">",
"           Poliovirus vaccination",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/16/22793\">",
"           Prevention and treatment of measles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/31/42489\">",
"           Prevention of Haemophilus influenzae infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/26/37289\">",
"           Prevention of varicella-zoster virus infection: Chickenpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/17/19738\">",
"           Recommendations for the use of human papillomavirus vaccines",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/62/40937\">",
"           Rotavirus vaccines",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/18/27946\">",
"           Seasonal influenza vaccination in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/61/19418\">",
"           Standard childhood vaccines: Parental hesitancy or refusal",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/56/39818\">",
"           Standard immunizations for children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/39/26229\">",
"           The life cycle, natural history, and immunology of human papillomaviruses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/36/23110\">",
"           Treatment of varicella-zoster virus infection: Chickenpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/7/40057\">",
"           Vaccinia virus as the smallpox vaccine",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Immunocompromised hosts",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/3/20537\">",
"           Evaluation and management of fever in children with non-chemotherapy-induced neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/33/15898\">",
"           Fever in children with chemotherapy-induced neutropenia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/9/1177\">",
"           Prevention of sepsis in the asplenic patient",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/20/30022\">",
"           Risk of infection in children with fever and non-chemotherapy-induced neutropenia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Kawasaki disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/34/11814\">",
"           Incomplete (atypical) Kawasaki disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/61/12248\">",
"           Kawasaki disease: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/51/16183\">",
"           Kawasaki disease: Complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/19/11575\">",
"           Kawasaki disease: Epidemiology and etiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/2/42025\">",
"           Kawasaki disease: Initial treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/52/40775\">",
"           Treatment of refractory Kawasaki disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Lyme disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/48/28425\">",
"           Diagnosis of Lyme disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/41/26263\">",
"           Evaluation of a tick bite for possible Lyme disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/51/40759\">",
"           Lyme carditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/3/7225\">",
"           Lyme disease: Clinical manifestations in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/7/9336\">",
"           Musculoskeletal manifestations of Lyme disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/17/32022\">",
"           Patient information: Lyme disease symptoms and diagnosis (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/10/13474\">",
"           Patient information: What to do after a tick bite to prevent Lyme disease (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/55/3960\">",
"           Prevention of Lyme disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/58/26533\">",
"           Southern tick-associated rash illness (STARI)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/54/27498\">",
"           Treatment of Lyme disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous bacterial infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/36/37448\">",
"           Botulism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/55/16248\">",
"           Clinical features and diagnosis of Bordetella pertussis infection in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/44/1736\">",
"           Clinical manifestations and diagnosis of Listeria monocytogenes infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/3/7224\">",
"           Clinical manifestations and diagnosis of anthrax",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/43/16058\">",
"           Clinical manifestations, diagnosis, and treatment of brucellosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/10/30888\">",
"           Clinical manifestations, diagnosis, and treatment of tularemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/31/17914\">",
"           Congenital syphilis: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/11/37049\">",
"           Congenital syphilis: Evaluation, management, and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/48/9993\">",
"           Epidemiology and pathogenesis of Listeria monocytogenes infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/53/14166\">",
"           Epidemiology, microbiology, and pathogenesis of tularemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/27/20918\">",
"           Microbiology, epidemiology, and pathogenesis of Bordetella pertussis infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/61/33751\">",
"           Microbiology, epidemiology, and pathogenesis of Brucella",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/47/23289\">",
"           Microbiology, epidemiology, clinical manifestations, and diagnosis of cat scratch disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/54/43879\">",
"           Microbiology, epidemiology, clinical manifestations, and diagnosis of leptospirosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/60/5065\">",
"           Microbiology, pathogenesis, and epidemiology of Campylobacter infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/10/39079\">",
"           Microbiology, pathogenesis, and epidemiology of anthrax",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/35/6713\">",
"           Mycoplasma pneumoniae infection in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/0/13321\">",
"           Pasteurella infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/48/11016\">",
"           Prevention of anthrax",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/24/1413\">",
"           Rat bite fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/14/25833\">",
"           Treatment and prevention of Bordetella pertussis infection in infants and children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/31/4597\">",
"           Treatment and prevention of leptospirosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/2/37925\">",
"           Treatment of cat scratch disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/46/745\">",
"           Treatment, prognosis, and prevention of Listeria monocytogenes infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/42/31401\">",
"           Zoonoses from cats",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/24/29065\">",
"           Zoonoses from dogs",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/22/26986\">",
"           Zoonoses from pets other than dogs and cats",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Mycobacterial infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/24/37257\">",
"           Overview of disseminated nontuberculous mycobacterial (NTM) infections and NTM bacteremia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/42/13994\">",
"           Overview of nontuberculous mycobacterial lymphadenitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/17/282\">",
"           Overview of nontuberculous mycobacterial pulmonary infections in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/34/7722\">",
"           Overview of nontuberculous mycobacterial skin and soft tissue infections in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Parasitic infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/12/43208\">",
"           Congenital toxoplasmosis: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/31/7672\">",
"           Congenital toxoplasmosis: Treatment, outcome, and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/1/13338\">",
"           Treatment of severe falciparum malaria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/41/25241\">",
"           Treatment of uncomplicated falciparum malaria",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Perinatal infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/21/27992\">",
"           Chlamydia trachomatis infections in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/16/6410\">",
"           Clinical features and diagnosis of sepsis in term and late preterm infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/49/10010\">",
"           Congenital rubella syndrome: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/63/36855\">",
"           Congenital rubella syndrome: Management, outcome, and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/34/39462\">",
"           Gonococcal infection in the newborn",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/16/18698\">",
"           Group B streptococcal infection in neonates and young infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/31/2552\">",
"           Management of the infant whose mother has received group B streptococcal chemoprophylaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/31/35321\">",
"           Neonatal herpes simplex virus infection: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/48/40713\">",
"           Neonatal herpes simplex virus infection: Management and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/0/21512\">",
"           Neonatal pneumonia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/24/28041\">",
"           Overview of TORCH infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/59/14264\">",
"           Urinary tract infections in newborns",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/1/40984\">",
"           Vaccines for the prevention of group B streptococcal disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/19/26936\">",
"           Vertical transmission of hepatitis C virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/31/15864\">",
"           Vesiculobullous and pustular lesions in the newborn",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pneumococcal infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/37/601\">",
"           Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/14/7402\">",
"           Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/42/12970\">",
"           Pneumococcal meningitis in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/11/35001\">",
"           Pneumococcal pneumonia in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/44/16074\">",
"           Bronchiolitis in infants and children: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/19/27962\">",
"           Bronchiolitis in infants and children: Treatment; outcome; and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/3/38970\">",
"           Clinical features and diagnosis of community-acquired pneumonia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/56/9098\">",
"           Diagnosis of pulmonary tuberculosis in HIV-negative patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/55/2938\">",
"           Epidemiology, pathogenesis, and etiology of pneumonia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/34/9770\">",
"           Epidemiology; clinical presentation; and evaluation of parapneumonic effusion and empyema in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/48/25354\">",
"           Inpatient treatment of pneumonia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/14/27882\">",
"           Management and prognosis of parapneumonic effusion and empyema in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/38/23143\">",
"           Microbiology and pathogenesis of Streptococcus pneumoniae",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/0/21512\">",
"           Neonatal pneumonia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/46/27369\">",
"           Outpatient treatment of community-acquired pneumonia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/11/35001\">",
"           Pneumococcal pneumonia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/18/33062\">",
"           Pneumonia caused by Chlamydophila (Chlamydia) species in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Rickettsial infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/40/31364\">",
"           Biology of Rickettsia rickettsii infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/62/23525\">",
"           Biology of ehrlichiae",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/51/14135\">",
"           Clinical manifestations and diagnosis of Rocky Mountain spotted fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/5/6234\">",
"           Human ehrlichiosis and anaplasmosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/24/14725\">",
"           Treatment of Rocky Mountain spotted fever",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Sepsis and septic shock",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/39/17018\">",
"           Approach to the septic-appearing infant",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/61/28632\">",
"           Epidemiology of and risk factors for Staphylococcus aureus bacteremia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/29/6616\">",
"           Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/14/22762\">",
"           Fever without a source in children 3 to 36 months of age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/54/3944\">",
"           Group A streptococcal (Streptococcus pyogenes) bacteremia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/20/5449\">",
"           Pathophysiology of sepsis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/33/4634\">",
"           Septic shock: Rapid recognition and initial resuscitation in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/6/10346\">",
"           Systemic inflammatory response syndrome (SIRS) and sepsis in children: Definitions, epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/18/37159\">",
"           Treatment of Staphylococcus aureus bacteremia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/20/8519\">",
"           Treatment of streptococcal toxic shock syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/42/44710\">",
"           Vibrio vulnificus infections",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Sexually transmitted diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/0/1032\">",
"           Clinical features and diagnosis of pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/24/28041\">",
"           Overview of TORCH infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/45/11992\">",
"           Pathogenesis of and risk factors for pelvic inflammatory disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/51/37689\">",
"           Sexually transmitted diseases: Overview of issues specific to adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/63/35832\">",
"           Treatment of pelvic inflammatory disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Skin and soft tissue infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/33/12825\">",
"           Cellulitis and erysipelas",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/55/22387\">",
"           Folliculitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/21/21846\">",
"           Impetigo",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/57/20377\">",
"           Initial management of animal and human bites",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/52/5962\">",
"           Management of Crotalinae (rattlesnake, water moccasin [cottonmouth], or copperhead) bites in the United States",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/36/4680\">",
"           Mastitis and breast abscess in infants, children, and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/0/13321\">",
"           Pasteurella infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/44/31431\">",
"           Principles of snake bite management worldwide",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/51/43831\">",
"           Skin abscesses, furuncles, and carbuncles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/24/28038\">",
"           Soft tissue infections due to dog and cat bites",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/46/5865\">",
"           Technique of incision and drainage for skin abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/31/15864\">",
"           Vesiculobullous and pustular lesions in the newborn",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Staphylococcal infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/21/30042\">",
"           Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/61/28632\">",
"           Epidemiology of and risk factors for Staphylococcus aureus bacteremia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/32/33290\">",
"           Evaluation and management of suspected methicillin-resistant Staphylococcus aureus skin and soft tissue infections in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/13/15575\">",
"           Microbiology of methicillin-resistant Staphylococcus aureus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/28/9672\">",
"           Microbiology, pathogenesis, and epidemiology of coagulase-negative staphylococci",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/10/26792\">",
"           Prevention and control of methicillin-resistant Staphylococcus aureus in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/52/8010\">",
"           Staphylococcal toxic shock syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/18/37159\">",
"           Treatment of Staphylococcus aureus bacteremia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/16/23815\">",
"           Treatment of infections due to coagulase-negative staphylococci",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/6/29802\">",
"           Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Streptococcal infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/38/6758\">",
"           Antibiotic failure in the treatment of streptococcal tonsillopharyngitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/28/41417\">",
"           Approach to diagnosis of acute infectious pharyngitis in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/20/23879\">",
"           Clinical manifestations and diagnosis of acute rheumatic fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/30/27110\">",
"           Complications of streptococcal tonsillopharyngitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/8/8327\">",
"           Epidemiology and pathogenesis of acute rheumatic fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/29/6616\">",
"           Epidemiology, clinical manifestations, and diagnosis of streptococcal toxic shock syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/54/3944\">",
"           Group A streptococcal (Streptococcus pyogenes) bacteremia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/16/18698\">",
"           Group B streptococcal infection in neonates and young infants",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/38/23143\">",
"           Microbiology and pathogenesis of Streptococcus pneumoniae",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/29/37337\">",
"           PANDAS: Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/31/22007\">",
"           Sydenham chorea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/2/44070\">",
"           Treatment and prevention of acute rheumatic fever",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/38/2666\">",
"           Treatment and prevention of streptococcal tonsillopharyngitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/20/8519\">",
"           Treatment of streptococcal toxic shock syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/1/40984\">",
"           Vaccines for the prevention of group B streptococcal disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tuberculosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/53/13143\">",
"           Latent tuberculosis infection in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/4/23625\">",
"           Tuberculosis disease in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Upper airway infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/26/31144\">",
"           Approach to the management of croup",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/49/32536\">",
"           Bacterial tracheitis in children: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/55/28534\">",
"           Bacterial tracheitis in children: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/25/10649\">",
"           Clinical features and treatment of uvulitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/32/43529\">",
"           Clinical features, evaluation, and diagnosis of croup",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/50/11046\">",
"           Diagnosis and treatment of diphtheria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/38/29287\">",
"           Epidemiology, pathophysiology and clinical manifestations of diphtheria",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/45/4826\">",
"           Epiglottitis (supraglottitis): Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/16/12553\">",
"           Epiglottitis (supraglottitis): Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/28/2500\">",
"           Patient information: Croup in infants and children (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/11/31928\">",
"           Pharmacologic and supportive interventions for croup",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/55/2932\">",
"           Tracheal infections associated with tracheostomy tubes and endotracheal intubation in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Urinary tract infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/59/42937\">",
"           Acute cystitis in children older than two years and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/1/27674\">",
"           Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/40/21129\">",
"           Clinical features and diagnosis of urinary tract infections in infants and children older than one month",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/47/26360\">",
"           Epidemiology and risk factors for urinary tract infections in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/29/43479\">",
"           Evaluation of dysuria in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/27/7606\">",
"           Long-term management and prevention of urinary tract infections in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Viral infections",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/16/21769\">",
"           Acute viral encephalitis in children and adolescents: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/54/31590\">",
"           Acute viral encephalitis in children and adolescents: Pathogenesis and etiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/18/23848\">",
"           Acute viral encephalitis in children and adolescents: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/60/10183\">",
"           Acyclovir: An overview",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/7/26746\">",
"           Antiviral drugs for the prevention and treatment of seasonal influenza in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/35/21045\">",
"           Characteristics of the hepatitis B virus and pathogenesis of infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/5/29780\">",
"           Characteristics of the hepatitis C virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/49/24346\">",
"           Clinical features and diagnosis of seasonal influenza in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/44/33480\">",
"           Clinical features of varicella-zoster virus infection: Chickenpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/49/34585\">",
"           Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/59/29624\">",
"           Clinical manifestations and diagnosis of rabies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/54/22377\">",
"           Clinical manifestations and pathogenesis of human parvovirus B19 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/55/14202\">",
"           Clinical manifestations and treatment of Epstein-Barr virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/11/43192\">",
"           Clinical presentation and diagnosis of measles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/48/26376\">",
"           Clinical presentation and diagnosis of rotavirus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/13/41176\">",
"           Coronaviruses",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/51/36664\">",
"           Cytomegalovirus infection and disease in newborns, infants, children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/40/37513\">",
"           Diagnosis and treatment of adenovirus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/21/39257\">",
"           Epidemiology and clinical manifestations of adenovirus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/35/32312\">",
"           Epidemiology and laboratory diagnosis of parvovirus B19 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/16/42246\">",
"           Epidemiology and transmission of measles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/58/15272\">",
"           Epidemiology of influenza",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/2/31786\">",
"           Epidemiology of pandemic H1N1 influenza ('swine influenza')",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/48/22278\">",
"           Epidemiology of varicella-zoster virus infection: Chickenpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/59/19383\">",
"           Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/61/8154\">",
"           Epidemiology, clinical manifestations, diagnosis and management of mumps",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/26/41383\">",
"           Epidemiology, pathogenesis, treatment, and prevention of enterovirus and parechovirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/48/14090\">",
"           Epidemiology, transmission, and pathogenesis of avian influenza",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/31/4602\">",
"           Epidemiology, transmission, and prevention of hepatitis B virus infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/35/23097\">",
"           Gianotti-Crosti syndrome (papular acrodermatitis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/2/6186\">",
"           Hepatitis C virus infection in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/63/37881\">",
"           Hepatitis viruses and the newborn: Clinical manifestations and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/27/31160\">",
"           Herpetic gingivostomatitis in young children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/53/31577\">",
"           Human herpesvirus 6 infection in children: Clinical manifestations; diagnosis; and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/55/14201\">",
"           Human herpesvirus 7 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/33/33304\">",
"           Human metapneumovirus infections",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/18/31018\">",
"           Infectious mononucleosis in adults and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/43/6842\">",
"           Molluscum contagiosum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/58/16295\">",
"           Overview of hepatitis A virus infection in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/41/31386\">",
"           Overview of hepatitis B virus infection in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/60/36808\">",
"           Parainfluenza viruses in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/29/40408\">",
"           Parvovirus B19 infection during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/11/19640\">",
"           Pharmacology of antiviral drugs for influenza",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/16/22793\">",
"           Prevention and treatment of measles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/26/37289\">",
"           Prevention of varicella-zoster virus infection: Chickenpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/21/2393\">",
"           Rabies immune globulin and vaccine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/56/7050\">",
"           Respiratory syncytial virus infection: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/17/15640\">",
"           Respiratory syncytial virus infection: Prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/27/38327\">",
"           Respiratory syncytial virus infection: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/19/28982\">",
"           Roseola infantum (exanthem subitum)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/14/26855\">",
"           Rubella",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/18/27946\">",
"           Seasonal influenza vaccination in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/48/22281\">",
"           The common cold in children: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/53/13146\">",
"           The common cold in children: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/21/38234\">",
"           Treatment and prevention of pandemic H1N1 influenza ('swine influenza')",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/1/31767\">",
"           Treatment and prevention of parvovirus B19 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/58/33703\">",
"           Treatment of rabies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/36/23110\">",
"           Treatment of varicella-zoster virus infection: Chickenpox",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/2/3114\">",
"           Virology of Epstein-Barr virus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/14/40167\">",
"           Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/39/20088\">",
"           When to use rabies prophylaxis",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-7CA4DD0F1D-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f14_52_15175=[""].join("\n");
var outline_f14_52_15175=null;
var title_f14_52_15176="Severe combined immunodeficiency (SCID) with JAK3 deficiency";
var content_f14_52_15176=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Severe combined immunodeficiency (SCID) with JAK3 deficiency",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/52/15176/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15176/contributors\">",
"     Fabio Candotti, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15176/contributors\">",
"     Luigi D Notarangelo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/52/15176/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15176/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/52/15176/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15176/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/52/15176/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic mutations affecting the gamma chain of the IL-2 receptor and the associated downstream signaling enzyme JAK3 result in T cell negative, B cell positive, NK cell negative severe combined immune deficiency (T-B+NK- SCID) (",
"    <a class=\"graphic graphic_table graphicRef77724 \" href=\"UTD.htm?17/53/18268\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef82391 \" href=\"UTD.htm?26/2/26668\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef77023 \" href=\"UTD.htm?43/6/44137\">",
"     figure 1",
"    </a>",
"    ). Defects of the JAK3 gene result in a type of T-B+NK- SCID that is transmitted via an autosomal recessive mode of inheritance (MIM #600802) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with SCID due to JAK3 deficiency typically present at a few months of age with classical clinical features of SCID, including recurrent or severe respiratory infections, intractable diarrhea, thrush, and failure to thrive [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link&amp;anchor=H7#H7\">",
"     \"Severe combined immunodeficiency (SCID): An overview\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pathogenesis, clinical features, diagnosis, and treatment of T-B+NK- SCID with JAK3 deficiency are presented in this topic review. An overview of the different forms of SCID can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): Specific defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;SCID due to JAK3 deficiency is rare, accounting for only about 6 percent of all cases of SCID [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/3,7\">",
"     3,7",
"    </a>",
"    ] and approximately 1 percent of all cases of immunodeficiency of known genetic origin [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Signal transduction by the hematopoietic cytokines, interleukin (IL)-2, IL-4, IL-7, IL-9, IL-15, and IL-21, is of critical importance for the development and function of the cells of the immune system [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Cellular receptors for all these cytokines share the \"common\" gamma chain (gamma c) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/11-19\">",
"     11-19",
"    </a>",
"    ] that lacks intrinsic catalytic activity, but mediates signal transduction via its physical association with a member of the Janus family of protein kinases (JAK), JAK3 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/16,20\">",
"     16,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mutations of gamma c result in the X-linked form of T-B+NK- SCID (SCIDX1) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/21,22\">",
"     21,22",
"    </a>",
"    ] and JAK3 gene defects cause a T-B+NK- SCID with an autosomal recessive mode of inheritance (MIM #600802) (",
"    <a class=\"graphic graphic_figure graphicRef77023 \" href=\"UTD.htm?43/6/44137\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Genetic mutations affecting the integrity of the gamma",
"    <span class=\"nowrap\">",
"     c/JAK3",
"    </span>",
"    signaling pathway are characterized by virtual lack of circulating T lymphocytes and normal or increased proportion of B cells (",
"    <a class=\"graphic graphic_table graphicRef82391 \" href=\"UTD.htm?26/2/26668\">",
"     table 2",
"    </a>",
"    ). NK cells are usually also severely reduced in numbers.",
"   </p>",
"   <p>",
"    SCID with JAK3 deficiency can be regarded as a failure of multiple cytokine-mediated signaling pathways, similar to SCIDX1. In particular, impaired IL-7 signaling appears to be responsible for the pronounced defect in T cell development and impaired IL-15 signaling [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/23\">",
"     23",
"    </a>",
"    ] is most likely responsible for the usual lack of NK cells in patients with JAK3 deficiency. This was demonstrated in a patient with atypical JAK3 deficiency who had NK cells and functionally impaired CD4+ T cells that transduced IL-2, -4, -15, and -21 signals, but failed to respond to IL-7 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/24\">",
"     24",
"    </a>",
"    ]. It is also corroborated by findings in IL-7 and IL-7 receptor alpha chain (IL-7Ralpha) knockout mice [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/25,26\">",
"     25,26",
"    </a>",
"    ] and in humans affected with T-B+NK+ SCID due to IL-7Ralpha mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=see_link&amp;anchor=H3#H3\">",
"     \"Severe combined immunodeficiency (SCID): Specific defects\", section on 'Interleukin-7 receptor alpha chain (CD127) deficiency'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By comparison, B cell development is preserved, suggesting redundancy of the cytokines using the gamma",
"    <span class=\"nowrap\">",
"     c/JAK3",
"    </span>",
"    axis for B cell lymphopoiesis. However, B cell activation, proliferation, and differentiation are impaired, resulting in the profound hypogammaglobulinemia characteristic of JAK3 deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/1,2,4,28\">",
"     1,2,4,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is unclear whether an intrinsic cellular defect or inadequate T cell-derived signals are responsible for the functional B cell defects in JAK3 deficiency. In vitro studies with EBV-immortalized lymphoblastoid B cell lines have shown impaired responses of JAK3-deficient B cells to IL-2 and IL-4 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Response to IL-21 is critical for B germinal center B cell differentiation and proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].However, experience from bone marrow transplantation has indicated that JAK3-deficient B cells can mediate normal humoral immune responses after engraftment of HLA-identical, allogeneic T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/33\">",
"     33",
"    </a>",
"    ], pointing to the lack of adequate T cell helper function as the main cause for B cell dysfunction in JAK3 deficiency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The human JAK3 gene maps to chromosome 19p12-13.1 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/34\">",
"     34",
"    </a>",
"    ], is organized in 23 exons [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/35\">",
"     35",
"    </a>",
"    ], and contains an open reading frame of 3372 bp [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/36\">",
"     36",
"    </a>",
"    ]. Many different types of mutations (deletions, insertions, missense, nonsense, and splice site mutations) affecting this sequence have been described in patients with JAK3 deficiency, with no evidence for preferential hot spots or founder effects [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/3,37\">",
"     3,37",
"    </a>",
"    ]. Both \"null\" mutations and defects compatible with residual expression of a mutated JAK3 protein have been observed. In all cases, however, these mutations interfere with normal cytokine signal transduction and result in severely reduced phosphorylation of the JAK3 molecule itself",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    downstream players, such as the signal transducer and activator of transcription, STAT5 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/2-5,29,30,33,38-40\">",
"     2-5,29,30,33,38-40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with SCID due to JAK3 deficiency typically present at a few months of age with classical clinical features of SCID. This includes recurrent or severe respiratory infections, intractable diarrhea, thrush, and failure to thrive [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link&amp;anchor=H7#H7\">",
"     \"Severe combined immunodeficiency (SCID): An overview\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Graft-versus-host reaction from transplacentally acquired maternal T cells often contributes to the severity of the clinical phenotype. Infections are frequently sustained by opportunistic pathogens and are often recurrent and life-threatening.",
"   </p>",
"   <p>",
"    Most JAK3-deficient patients present with the typical clinical features of SCID and therefore come to clinical attention early in life as a true pediatric medical emergency [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/3,6,37\">",
"     3,6,37",
"    </a>",
"    ]. However, mutations of the JAK3 gene can lead to a broad spectrum of clinical presentations, including mild immunodeficiency and uncontrolled lymphocyte proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/40\">",
"     40",
"    </a>",
"    ]. It is hypothesized that \"leaky\" JAK3 mutations compatible with the expression of low and variable levels of functional JAK3 protein are responsible for the differences in disease severity and the unique and almost paradoxical clinical features observed in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/40\">",
"     40",
"    </a>",
"    ]. In one affected family, for example, compound heterozygote mutations in the JAK3 gene resulted in a severe lymphoproliferative disorder in an eight year old child, but his 18 year old sibling with identical defects was nearly asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/40\">",
"     40",
"    </a>",
"    ]. The genetic defects were associated with low amounts of functional protein.",
"   </p>",
"   <p>",
"    Thus, partial JAK3 defects may be the basis for the immunologic problems in patients with increased, but not overwhelming, susceptibility to infection",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    disorders of immune regulation who do not meet the classic phenotypic characteristics of SCID patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     LABORATORY FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymphopenia is a common, although not universally present, laboratory finding in patients with T-B+NK- SCID due to JAK3 deficiency. Flow cytometry analysis of lymphocyte subsets usually shows low to undetectable numbers of T cells and NK cells (&lt;1 percent of total lymphocytes), while B cell numbers are normal or increased, which accounts for why some patients with JAK3 deficiency are not lymphopenic [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/4,6,37\">",
"     4,6,37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link&amp;anchor=H8#H8\">",
"     \"Severe combined immunodeficiency (SCID): An overview\", section on 'Laboratory abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immunoglobulin levels are markedly decreased despite the presence of B cells, and antibody responses are not elicited following immunization. The severe reduction in the number of T and NK cells is associated with a lack of in vitro proliferation to mitogens and of NK in vitro cytotoxic activity, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/3,6,28,37\">",
"     3,6,28,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4140793\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Only tests specific for JAK3 deficiency will be discussed here. The diagnosis of severe combined immunodeficiency (SCID), including newborn screening for SCID based on enumeration of T cell receptor excision circle (TREC) levels, is discussed in detail separately (",
"    <a class=\"graphic graphic_table graphicRef67948 \" href=\"UTD.htm?33/33/34331\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef69679 \" href=\"UTD.htm?13/48/14092\">",
"     table 4",
"    </a>",
"    ). Neonatal screening can identify JAK3 deficiency at birth, before appearance of clinical symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link&amp;anchor=H9#H9\">",
"     \"Severe combined immunodeficiency (SCID): An overview\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link&amp;anchor=H6#H6\">",
"     \"Severe combined immunodeficiency (SCID): An overview\", section on 'Newborn screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The genes that should be considered for sequencing in a patient with T-B+NK- SCID are gamma c in males and JAK3 in both males and females (",
"    <a class=\"graphic graphic_table graphicRef77724 \" href=\"UTD.htm?17/53/18268\">",
"     table 1",
"    </a>",
"    ). X-linked SCID, caused by mutations of the common gamma chain of the IL-2 receptor, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/18/1316?source=see_link\">",
"     \"X-linked severe combined immunodeficiency (SCID)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A definitive diagnosis of JAK3 deficiency requires demonstration of mutations of the JAK3 gene",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    biochemical analysis of JAK3 expression and function in patient lymphocytes. Biochemical studies (Western blot analysis of JAK3 expression, assessment of JAK3",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    STAT5 phosphorylation in response to cytokine stimulation) are usually performed on lymphoblastoid B cell lines obtained from affected patients after EBV-mediated immortalization, because a limited sample size is usually available from lymphopenic infants [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/3-5,33,38-40\">",
"     3-5,33,38-40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Performing these biochemical assays on cell lines requires several weeks, during which screening assays based on single strand conformation polymorphisms (SSCP) techniques can be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/35\">",
"     35",
"    </a>",
"    ]. Direct sequencing of the abnormal genomic fragments identified by SSCP leads to the identification of the specific gene mutations, which allows definitive diagnosis as well as the possibility of genetic counseling and prenatal diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    JAK3 deficiency is compatible with the presence of significant numbers of circulating, although mostly poorly functioning, T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/37,40,43\">",
"     37,40,43",
"    </a>",
"    ]. Thus, screening for JAK3 expression",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mutations should not be limited to T cell lymphopenic patients. Such screening should also be considered in all undefined cases of combined immune deficiency (CID), especially those presenting with high proportions of peripheral B cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4141741\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of severe combined immunodeficiency (SCID) is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link&amp;anchor=H10#H10\">",
"     \"Severe combined immunodeficiency (SCID): An overview\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical and immunologic phenotype of JAK3 deficiency has features distinct from SCIDX1 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/44\">",
"     44",
"    </a>",
"    ] and IL-7Ralpha deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/27\">",
"     27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Parental consanguinity and presentation in female subjects can distinguish JAK3 deficiency from SCIDX1 [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The absence of NK cells in patients with JAK3 deficiency (with the exception of some patients with atypical JAK3 deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/24\">",
"       24",
"      </a>",
"      ]) can aid the differential diagnosis with IL-7Ra deficiency, with the latter being compatible with NK cell development [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A general overview of the management of SCID, including precautions that are undertaken prior to therapy while the definitive diagnosis is being determined, is discussed separately. The treatment of choice for SCID due to JAK3 deficiency is hematopoietic cell transplantation (HCT). Gene therapy is under investigation. HCT (including preferred donor source and complications after HCT) and gene therapy are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link&amp;anchor=H11#H11\">",
"     \"Severe combined immunodeficiency (SCID): An overview\", section on 'Treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8633?source=see_link\">",
"     \"Medical management of immune deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/2/1066?source=see_link\">",
"     \"Hematopoietic cell transplantation for primary immunodeficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33590?source=see_link\">",
"     \"Gene therapy for primary immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4141872\">",
"    <span class=\"h2\">",
"     Hematopoietic cell transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;No extensive data series are available on the specific results of HCT in JAK3-deficient patients, because of the rarity of the disease and its relatively recent discovery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/2/1066?source=see_link\">",
"     \"Hematopoietic cell transplantation for primary immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A small series of ten patients with JAK3 deficiency received HCT at a single institution [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/3\">",
"     3",
"    </a>",
"    ]. Transplantation was from an HLA-identical family donor in two cases, from an unrelated cord blood in one case, and from a haploidentical parent in seven cases. Pre-HCT chemotherapy was used only in the patient who received cord blood transplantation. Nine of the ten patients had attained robust T cell reconstitution and were reported to be alive and no longer prone to recurrent or opportunistic infections between 4 and 18 years after HCT. However, only three patients were able to discontinue treatment with intravenous immune globulin, and donor B cell engraftment was achieved only in the child who received pre-HCT conditioning. In addition, seven of the nine patients continued to have poor NK cell number",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    function.",
"   </p>",
"   <p>",
"    All forms of T- B+ SCID (including JAK3 deficiency) have been grouped together in larger series of patients. In the European series, for example, 10-year survival after HCT was 70 percent for 345 patients with T- B+ SCID [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Successful reconstitution of T cell numbers and function can be obtained after transplantation of bone marrow-derived hematopoietic progenitors obtained from HLA-identical siblings, matched unrelated volunteer donors, and haploidentical parents [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/7,28,37,46,47\">",
"     7,28,37,46,47",
"    </a>",
"    ]. The lack of NK cells (and NK cell function) in JAK3-deficient patients makes graft rejection improbable, thereby facilitating the success of HCT. In addition, the early block in thymic T cell development characteristic of JAK3 deficiency probably favors thymic repopulation by donor's normal lymphoid precursors and their differentiation into mature T cells.",
"   </p>",
"   <p>",
"    The situation is quite different with regards to the reconstitution of the humoral immune response. Differentiation proceeds up to mature B cells in patients with JAK3 deficiency. The presence of these B cells, although functionally deficient, and that of their progenitors creates competition between autologous and donor-derived B lymphopoiesis following HCT. Thus, the reconstitution of humoral immunity following haploidentical HCT is often incomplete, leading to the need of continuous administration of intravenous immune globulin [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/3,28,46\">",
"     3,28,46",
"    </a>",
"    ]. Development of effective B cell function is more common following HCT from HLA-identical sibling donors and has been observed even in some patients who maintained autologous B cells following HCT [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/28,33,46\">",
"     28,33,46",
"    </a>",
"    ]. Reconstitution of NK function also seems unpredictable in patients with JAK3 deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An important complication of HCT in patients with SCID due to JAK3 deficiency is the appearance of warts due to papillomavirus infection even several years after transplant [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/48\">",
"     48",
"    </a>",
"    ]. This long-term complication has been observed only in patients with SCID due to gamma-c defects or to JAK3 deficiency, but not to other genetic causes, suggesting that warts reflect an incomplete correction of defective gamma c-mediated signaling defect in particular cell types, such as keratinocytes. However, the possible contribution of incomplete or vanishing immune reconstitution cannot be formally excluded.",
"   </p>",
"   <p>",
"    Altogether, these results clearly indicate that HCT is a life-saving procedure for SCID due to JAK3 deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/3\">",
"     3",
"    </a>",
"    ]. However, in the absence of an HLA-identical family donor, the procedure is imperfect and leaves room for improvement.",
"   </p>",
"   <p>",
"    While waiting for HCT, it is essential that patients are maintained free from infections that could compromise their health status and ultimately the outcome of transplantation. If possible, reverse isolation should be used to protect these patients from environmental pathogens. In addition, prophylactic administration of antibiotics (eg, co-trimoxazole, intravenous immune globulin) is of utmost importance to prevent overwhelming bacterial and Pneumocystis jirovecii (carinii) infections. Some centers also routinely administer preventive antivirals (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/7/31856?source=see_link\">",
"     acyclovir",
"    </a>",
"    ) and topical antifungal medications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8633?source=see_link\">",
"     \"Medical management of immune deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link&amp;anchor=H11#H11\">",
"     \"Severe combined immunodeficiency (SCID): An overview\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4141879\">",
"    <span class=\"h2\">",
"     Gene therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is arguable that genetic correction of JAK3 deficiency may also result in clinical benefit in light of the success of gene therapy in a series of SCIDX1 patients, and because of the phenotypic and biologic similarities between JAK3 deficiency and SCIDX1 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. On the other hand, one potential concern of using a \"gene addition\" approach is that the expression of the transferred gene is evicted from the cellular mechanisms of regulation and is constitutively expressed under the control of strong viral promoters. JAK3 has an important role in cell proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/20,29\">",
"     20,29",
"    </a>",
"    ], and deregulated JAK3 expression could potentially result in uncontrolled cell division causing malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33590?source=see_link&amp;anchor=H2#H2\">",
"     \"Gene therapy for primary immunodeficiency\", section on 'Gene therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Preclinical experiments in vitro [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/29,30\">",
"     29,30",
"    </a>",
"    ] and in vivo [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/51-53\">",
"     51-53",
"    </a>",
"    ] have illustrated the potential of gene therapy for JAK3 deficiency. Retroviral-mediated JAK3 gene transfer was able to correct the biological abnormalities of JAK3-deficient human B cell lines leading to reconstitution of IL-2 signaling as assessed by IL-2-induced phosphorylation of IL-2Rbeta, JAK1, JAK3, STAT5, as well as IL-2-mediated cell proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A series of in vivo experiments were performed and showed that ex-vivo retroviral-mediated JAK3 gene transfer into hematopoietic progenitors from JAK3 knockout mice was able to restore specific T and B cell functions in mice transplanted with gene-corrected cells. Treated mice developed T cells able to respond to mitogens and develop specific cytotoxic responses. In addition, good reconstitution of humoral immunity was achieved following the procedure, with increased numbers of B cells and antibody production. More importantly, the same mice showed generation of specific antibody responses upon immunization, and improved survival after exposure to influenza virus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another crucial finding of these experiments was that myeloablation was not necessary for the achievement of these significant improvements [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/53\">",
"     53",
"    </a>",
"    ]. The strong selective advantage of JAK3-corrected lymphoid cells over unmodified autologous counterparts is probably responsible for these results that suggest that preparative conditioning is needed in the case of JAK3 gene therapy protocols in humans.",
"   </p>",
"   <p>",
"    A single JAK3-deficient patient who had failed HCT was enrolled in a gene therapy trial. The results of that experience were only published in abstract form and showed no evidence of immune reconstitution at seven months post-treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/54\">",
"     54",
"    </a>",
"    ]. This trial was placed on clinical hold and no additional patients were enrolled, because of the occurrence of leukemia in two children treated with gene therapy for X-linked SCID [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15176/abstract/55\">",
"     55",
"    </a>",
"    ]. It is reasonable to assume that expression of JAK3 could have similar consequences. For these reasons, in February 2003, the FDA Biological Response Modifiers Advisory Committee has made the recommendation that, until more information is acquired, gene therapy for SCIDX1 and JAK3-SCID should be performed only on patients for whom alternative therapies are not available or have already failed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33590?source=see_link&amp;anchor=H7#H7\">",
"     \"Gene therapy for primary immunodeficiency\", section on 'Limitations of gene therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4141909\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Affected patients typically die within the first year or two of life unless the underlying defect is corrected. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Treatment'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/2/1066?source=see_link\">",
"     \"Hematopoietic cell transplantation for primary immunodeficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33590?source=see_link\">",
"     \"Gene therapy for primary immunodeficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2757112\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Defects of the Janus kinase 3 (JAK3) gene result in a type of T cell negative, B cell positive, NK cell negative severe combined immunodeficiency (T-B+NK- SCID) that is transmitted via an autosomal recessive mode of inheritance (MIM #600802). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      JAK3 is expressed in hematopoietic cells and is required for signal transduction of several cytokines. It is essential for lymphoid cell development. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with SCID due to JAK3 deficiency typically present at a few months of age with classical clinical features of SCID. This includes recurrent or severe respiratory infections, intractable diarrhea, thrush, and failure to thrive. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A definitive diagnosis requires demonstration of mutations of the JAK3 gene",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      biochemical analysis of JAK3 expression and function in patient lymphocytes. The clinical and immunologic phenotype of JAK3 deficiency has features distinct from SCIDX1 and IL-7Ralpha deficiency. (See",
"      <a class=\"local\" href=\"#H4140793\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of choice for SCID due to JAK3 deficiency is hematopoietic cell transplantation (HCT). Gene therapy is under investigation. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/2/1066?source=see_link\">",
"       \"Hematopoietic cell transplantation for primary immunodeficiency\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33590?source=see_link\">",
"       \"Gene therapy for primary immunodeficiency\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/1\">",
"      Macchi P, Villa A, Giliani S, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995; 377:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/2\">",
"      Russell SM, Tayebi N, Nakajima H, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995; 270:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/3\">",
"      Roberts JL, Lengi A, Brown SM, et al. Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation. Blood 2004; 103:2009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/4\">",
"      Candotti F, Oakes SA, Johnston JA, et al. Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood 1997; 90:3996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/5\">",
"      Mella P, Schumacher RF, Cranston T, et al. Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain. Hum Mutat 2001; 18:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/6\">",
"      Buckley RH, Schiff RI, Schiff SE, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 1997; 130:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/7\">",
"      Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000; 343:1313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/8\">",
"      Vihinen M, Arredondo-Vega FX, Casanova JL, et al. Primary immunodeficiency mutation databases. Adv Genet 2001; 43:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/9\">",
"      O'Shea JJ, Notarangelo LD, Johnston JA, Candotti F. Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency. J Clin Immunol 1997; 17:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/10\">",
"      Parrish-Novak J, Dillon SR, Nelson A, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000; 408:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/11\">",
"      Takeshita T, Asao H, Ohtani K, et al. Cloning of the gamma chain of the human IL-2 receptor. Science 1992; 257:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/12\">",
"      Kondo M, Takeshita T, Ishii N, et al. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 1993; 262:1874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/13\">",
"      Russell SM, Keegan AD, Harada N, et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 1993; 262:1880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/14\">",
"      Noguchi M, Nakamura Y, Russell SM, et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 1993; 262:1877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/15\">",
"      Kondo M, Takeshita T, Higuchi M, et al. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 1994; 263:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/16\">",
"      Russell SM, Johnston JA, Noguchi M, et al. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 1994; 266:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/17\">",
"      Kimura Y, Takeshita T, Kondo M, et al. Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex. Int Immunol 1995; 7:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/18\">",
"      Giri JG, Ahdieh M, Eisenman J, et al. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994; 13:2822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/19\">",
"      Asao H, Okuyama C, Kumaki S, et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol 2001; 167:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/20\">",
"      Miyazaki T, Kawahara A, Fujii H, et al. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 1994; 266:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/21\">",
"      Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993; 73:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/22\">",
"      Puck JM, Desch&ecirc;nes SM, Porter JC, et al. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 1993; 2:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/23\">",
"      Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998; 9:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/24\">",
"      Li J, Nara H, Rahman M, et al. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID. Cytokine 2010; 49:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/25\">",
"      von Freeden-Jeffry U, Vieira P, Lucian LA, et al. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995; 181:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/26\">",
"      Peschon JJ, Morrissey PJ, Grabstein KH, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994; 180:1955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/27\">",
"      Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/28\">",
"      Buckley RH, Schiff SE, Schiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/29\">",
"      Candotti F, Oakes SA, Johnston JA, et al. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction. J Exp Med 1996; 183:2687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/30\">",
"      Oakes SA, Candotti F, Johnston JA, et al. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 1996; 5:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/31\">",
"      Zotos D, Coquet JM, Zhang Y, et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med 2010; 207:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/32\">",
"      Linterman MA, Beaton L, Yu D, et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med 2010; 207:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/33\">",
"      Bozzi F, Lefranc G, Villa A, et al. Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatment. Br J Haematol 1998; 102:1363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/34\">",
"      Riedy MC, Dutra AS, Blake TB, et al. Genomic sequence, organization, and chromosomal localization of human JAK3. Genomics 1996; 37:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/35\">",
"      Schumacher RF, Mella P, Badolato R, et al. Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphism. Hum Genet 2000; 106:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/36\">",
"      Kawamura M, McVicar DW, Johnston JA, et al. Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci U S A 1994; 91:6374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/37\">",
"      Notarangelo LD, Mella P, Jones A, et al. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency. Hum Mutat 2001; 18:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/38\">",
"      Cacalano NA, Migone TS, Bazan F, et al. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain. EMBO J 1999; 18:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/39\">",
"      Chen M, Cheng A, Candotti F, et al. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol Cell Biol 2000; 20:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/40\">",
"      Frucht DM, Gadina M, Jagadeesh GJ, et al. Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun 2001; 2:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/41\">",
"      Hale JE, Bonilla FA, Pai SY, et al. Identification of an infant with severe combined immunodeficiency by newborn screening. J Allergy Clin Immunol 2010; 126:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/42\">",
"      Schumacher RF, Mella P, Lalatta F, et al. Prenatal diagnosis of JAK3 deficient SCID. Prenat Diagn 1999; 19:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/43\">",
"      Brugnoni D, Notarangelo LD, Sottini A, et al. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase. Blood 1998; 91:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/44\">",
"      Puck JM, Pepper AE, Henthorn PS, et al. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 1997; 89:1968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/45\">",
"      Gennery AR, Slatter MA, Grandin L, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol 2010; 126:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/46\">",
"      Haddad E, Landais P, Friedrich W, et al. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998; 91:3646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/47\">",
"      Bertrand Y, Landais P, Friedrich W, et al. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency. J Pediatr 1999; 134:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/48\">",
"      Laffort C, Le Deist F, Favre M, et al. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gammac cytokine receptor subunit or JAK-3 deficiency. Lancet 2004; 363:2051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/49\">",
"      Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/50\">",
"      Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/51\">",
"      Bunting KD, Sangster MY, Ihle JN, Sorrentino BP. Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer. Nat Med 1998; 4:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/52\">",
"      Bunting KD, Flynn KJ, Riberdy JM, et al. Virus-specific immunity after gene therapy in a murine model of severe combined immunodeficiency. Proc Natl Acad Sci U S A 1999; 96:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/53\">",
"      Bunting KD, Lu T, Kelly PF, Sorrentino BP. Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation. Hum Gene Ther 2000; 11:2353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/54\">",
"      Sorrentino BP, Lu T, Ihle J. A clinical attempt to treat JAK3-deficient SCID using retroviral-mediated gene transfer to bone marrow CD34+ cells. Molecular Therapy 2003; 7:S449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15176/abstract/55\">",
"      \"The Pink Sheet\". Gene therapy trial clinical hold will be topic of FDA, NIH meetings. January 20, 2003; 65:7.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3961 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-110.137.129.113-5655BEDDC5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15176=[""].join("\n");
var outline_f14_52_15176=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2757112\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      LABORATORY FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4140793\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4141741\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4141872\">",
"      Hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4141879\">",
"      Gene therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4141909\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2757112\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/3961\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3961|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/6/44137\" title=\"figure 1\">",
"      Combined immunodeficiency gene defects and functional categories",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/3961|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/53/18268\" title=\"table 1\">",
"      SCID classification and gene defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/2/26668\" title=\"table 2\">",
"      Alterations of periph blood lymphocyte populations in SCID",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/33/34331\" title=\"table 3\">",
"      Diagnosis of SCID",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/48/14092\" title=\"table 4\">",
"      Diagnosis of X linked SCID",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33590?source=related_link\">",
"      Gene therapy for primary immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/2/1066?source=related_link\">",
"      Hematopoietic cell transplantation for primary immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/27/8633?source=related_link\">",
"      Medical management of immune deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=related_link\">",
"      Severe combined immunodeficiency (SCID): An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=related_link\">",
"      Severe combined immunodeficiency (SCID): Specific defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/18/1316?source=related_link\">",
"      X-linked severe combined immunodeficiency (SCID)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_52_15177="Evaluation and management of colic";
var content_f14_52_15177=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation and management of colic",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/52/15177/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15177/contributors\">",
"     Teri Lee Turner, MD, MPH, MEd",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15177/contributors\">",
"     Shea Palamountain, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/52/15177/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15177/contributors\">",
"     Marilyn Augustyn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/52/15177/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15177/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/52/15177/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent or excessive crying is one of the most distressing problems of infancy. It is distressing for the infant, the parents, and the clinician [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/1\">",
"     1",
"    </a>",
"    ]. The parents of the infant may view the crying as an indictment of their caregiving ability or as evidence of illness in their child [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/2\">",
"     2",
"    </a>",
"    ]. Colic is a benign, self-limited condition that resolves with time. However, the family's beliefs concerning the cause of crying and their interactions with the healthcare system related to the crying may affect the way in which they view the child and the healthcare system long after the crying has resolved.",
"   </p>",
"   <p>",
"    The evaluation and management of prolonged or excessive crying in young infants are reviewed here. The clinical features and etiology are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/27/10680?source=see_link\">",
"     \"Clinical features and etiology of colic\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colic is a diagnosis that typically is confirmed in retrospect after it has run its characteristic course. However, it is a diagnosis of exclusion and must be differentiated from identifiable causes of prolonged crying in infancy (",
"    <a class=\"graphic graphic_table graphicRef79185 \" href=\"UTD.htm?0/27/445\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The infant's diet, stooling, urination, and sleeping patterns should be evaluated for abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The infant's social situation and parent-infant interactions must be evaluated. In addition, the perceptions and interactions of extended family members must be assessed because they may play a prominent role, positive or negative, in the parenting styles and management practices. Seven key questions should be posed to the family:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When does the crying occur, and how long does it last? Crying that occurs directly after feeding may be associated with aerophagia or gastroesophageal reflux.",
"     </li>",
"     <li>",
"      What do you do when the baby cries? Determining the methods that the parents use to console their infant may alert the provider to techniques that are not helpful or practices that may exacerbate the crying or be harmful to the infant.",
"     </li>",
"     <li>",
"      What does the cry sound like? Is it a cry of pain or hunger?",
"     </li>",
"     <li>",
"      How and what you feed the baby? Underfeeding, overfeeding, and inappropriate feeding all have been described as etiologies of colic.",
"     </li>",
"     <li>",
"      How does it make you feel when your baby cries? Familial perceptions of crying may be vastly different. Emotions vary from inadequacy and blaming to fear of harming the infant if the crying continues. The increased crying contributes to the discrepancy between the infant the family dreamed of having and the infant that they have [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      How has the colic affected your family? Colic is a family issue, and everyone has an opinion regarding the etiology.",
"     </li>",
"     <li>",
"      What is your theory of why the baby cries? In order to best help the family, one must first understand what they fear most about the crying.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Important aspects of the examination include [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plotting of growth parameters to look for deviations from the normal patterns (eg, failure to thrive) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=see_link&amp;anchor=H3#H3\">",
"       \"Normal growth patterns in infants and prepubertal children\", section on 'Normal patterns'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=see_link&amp;anchor=H3#H3\">",
"       \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\", section on 'Patterns of growth'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Assessment of hydration and subcutaneous fat (to evaluate adequacy of feeding)",
"     </li>",
"     <li>",
"      Assessment for tongue-tie (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44615?source=see_link&amp;anchor=H3#H3\">",
"       \"Ankyloglossia (tongue-tie) in infants and children\", section on 'Clinical features'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Assessment of temperament and responsiveness to stimuli (ie, does the infant cries in response to touch or movement?)",
"     </li>",
"     <li>",
"      Assessment for identifiable causes of prolonged crying in infants (",
"      <a class=\"graphic graphic_table graphicRef79185 \" href=\"UTD.htm?0/27/445\">",
"       table 1",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colic typically stops as mysteriously as it starts. Symptoms resolve in 60 percent of infants by three months of age and 80 to 90 percent of infants by four months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/6\">",
"     6",
"    </a>",
"    ]. Management of the infant with prolonged or excessive crying should be individualized based upon the history, examination, and environmental milieu. Colic affects the whole family. Therapy should be aimed at the crying, as well as at bolstering the infant-family relationship to maximize outcomes. The goals of management are to help the parents cope with the child's symptoms and to prevent long-term sequelae in the parent-child relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/7\">",
"     7",
"    </a>",
"    ]. Some basic elements in the management of all infants with persistent or prolonged crying in infancy exist (",
"    <a class=\"graphic graphic_table graphicRef62869 \" href=\"UTD.htm?22/54/23403\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Although the evidence for specific management strategies may be provided by randomized controlled trials, many of these trials have methodologic weaknesses (eg, were not adequately blinded). This lack of strong supporting evidence for any one strategy, combined with the number of proposed etiologies, may lead practitioners to recommend any or all of a number of interventions (",
"    <a class=\"graphic graphic_table graphicRef73784 \" href=\"UTD.htm?43/35/44603\">",
"     table 3",
"    </a>",
"    ). Most of the interventions work in approximately one-third of infants, and no treatment works for all infants [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several systematic reviews of the medical literature regard the effectiveness of various management strategies for colic [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/3,8,9\">",
"     3,8,9",
"    </a>",
"    ]. The interventions may be categorized according to the available evidence as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Likely to be beneficial &ndash; whey hydrolysate milk",
"     </li>",
"     <li>",
"      Likely to be beneficial but with unacceptable risks &ndash; anticholinergic drugs",
"     </li>",
"     <li>",
"      Unknown effectiveness &ndash; soy milk, casein hydrolysate milk, low-lactose milk, low-allergen diet by breastfeeding mothers, sucrose, herbal tea, reduced stimulation",
"     </li>",
"     <li>",
"      Unlikely to be beneficial &ndash;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"       lactase",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/9/27795?source=see_link\">",
"       simethicone",
"      </a>",
"      , increased carrying",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Parental support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parental support is an important aspect of therapy and will influence the way the parents view their abilities to take care of their child. Parents of infants with colic may feel frustrated, angry, exhausted, guilty, and helpless. Parents need to know that these feelings are normal. In addition, explaining what colic is and acknowledging that the baby is difficult to soothe is essential to prevent the parents from feeling as if they have failed. The parents should be supported and told that they are doing the best they can with a challenging baby. Finally, they should be urged to take breaks from the crying infant [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parents of crying infants may resort to hurting the infant to try to stop the crying. In a community-based sample, parents of 3259 infants anonymously responded to a questionnaire about their actions to stop their infant from crying [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/12\">",
"     12",
"    </a>",
"    ]. Among parents of one- and three-month-old infants, 2.2 and 3.7 percent, respectively, reported having smothered, slapped, or shaken their baby at least once because of its crying [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/12\">",
"     12",
"    </a>",
"    ]. In multivariate analysis, these behaviors were more likely if the parents were worried about the crying or judged it to be excessive, and were unrelated to the amount of crying (defined by more than three hours per day on more than three days per week in the week before the survey).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Reducing parental stress",
"    </span>",
"    &nbsp;&mdash;&nbsp;A home-based nursing intervention reduced parenting stress and overall crying time in families with irritable infants. One hundred twenty-one infant-family pairs were randomly assigned to receive a four-week, home-based intervention program based on REST (reassurance, empathy, support, and time-out) or routine care. Another 43 infants who did not meet the infant age criteria served as a post-test-only control group. Following the four-week intervention, the treatment group infants cried 1.7 hours less per day than the control infants [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Formulas",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Hypoallergenic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some randomized studies and systematic reviews suggest that infants with colic may benefit from hypoallergenic formulas [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/3,8,9,14-17\">",
"     3,8,9,14-17",
"    </a>",
"    ]. These include casein hydrolysate formulas (eg, Alimentum&reg;, Nutramigen&reg;, Pregestimil&reg;).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one randomized controlled trial, 15 of 22 infants with severe colic improved clinically with two casein hydrolysate formulas as compared to control groups [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study randomly assigned 38 bottle-fed infants to either casein hydrolysate or cow's-milk formula [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/15\">",
"       15",
"      </a>",
"      ]. Infants on the hypoallergenic diet were more likely to have reduction in distress (mean daily duration of colic symptoms) than were infants on the control diet (odds ratio 2.3). However, no attempt was made to make the two infant formulas indistinguishable from one another [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A double-blind, crossover, randomized clinical trial also reported significant improvements in colic while infants were receiving the casein hydrolysate formula compared to cow's-milk formula [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/16\">",
"       16",
"      </a>",
"      ]. However, the effect diminished with time and was consistently reproducible in only one infant.",
"     </li>",
"     <li>",
"      In a double-blind trial in which 43 infants with colic were randomly assigned to whey hydrolysate or standard formula, mean daily crying decreased by approximately 60 minutes in the whey hydrolysate group compared to controls [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further investigation is needed to determine if hypoallergenic formulas are effective in the management of infants with colic. However, many practitioners attempt a one-week trial of hypoallergenic formula. The original formula is resumed if no change occurs in the infant's symptoms, because hypoallergenic formulas are expensive in comparison to cow's-milk-based formulas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Soy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effects of soy protein compared to cow's-milk formula were compared in a randomized controlled trial [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/18\">",
"     18",
"    </a>",
"    ]. The mean weekly duration of colic symptoms decreased during periods of feeding with soy compared with control periods (8.7 versus 18.8 hours). Other studies have shown a decrease in symptoms in colicky infants during feeding with soy formulas [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/19\">",
"     19",
"    </a>",
"    ] and an increase in symptoms when challenged with whey protein, a protein in cow's milk [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/14\">",
"     14",
"    </a>",
"    ]. However, neither of these studies was adequately double-blinded [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further investigation is needed to determine the effectiveness of soy formula in the treatment of colic. Studies comparing the effects of soy and hypoallergenic formulas on the reduction of colicky symptoms are lacking.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Fiber-enriched",
"    </span>",
"    &nbsp;&mdash;&nbsp;The study of the effect of fiber on colic symptoms is based upon the hypothesis that colic is similar to irritable bowel syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/20\">",
"     20",
"    </a>",
"    ]. Twenty-seven term infants with colic were randomly assigned to be fed placebo (soy formula) for nine days followed by fiber-supplemented soy formula for nine days, or the reverse sequence. Ingestion of fiber-supplemented formula did not affect average daily duration of crying. However, the parents of two-thirds of the infants found the fiber-rich formula helpful in alleviating colic symptoms. Thus, the evidence does not support the use of fiber-enriched formulas to treat colic [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Other formula types",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of a partially hydrolyzed whey protein formula supplemented with fructo- and galacto-oligosaccharides with a high beta-palmitic acid content was found to reduce the number of crying episodes after 7 and 14 days when compared to standard formula and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/9/27795?source=see_link\">",
"     simethicone",
"    </a>",
"    . Two hundred and sixty-seven formula-fed infants younger than four months of age were randomized in this trial [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Maternal diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data regarding the effects of maternal hypoallergenic diet on infant colic are conflicting.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study randomly assigned breastfeeding mothers to a hypoallergenic (no milk, eggs, nuts, wheat) or a control diet [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/15\">",
"       15",
"      </a>",
"      ]. In a combined analysis (with bottle-fed infants on a hypoallergenic formula) the mean daily duration of colic symptoms was reduced by more than 25 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another randomized trial, infants of atopic mothers (eg, mothers who had eczema, asthma, or allergic rhinitis) experienced more colic symptoms on the days their mothers drank cow's milk. However, the small sample size rendered the differences insignificant. Infants of non-atopic mothers differed from the control group only in that the symptoms of colic occurred more frequently on days when their mothers ate fruit or chocolate [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A decrease in maternal milk product consumption or a hypoallergenic maternal diet may be beneficial in decreasing the symptoms of colic, particularly if the mother is atopic or the baby has symptoms of cow's-milk allergy (eg, eczema, wheezing, diarrhea, or vomiting) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14808?source=see_link\">",
"     \"Clinical manifestations of food allergy: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Feeding techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Feeding the baby in a vertical position (using a curved bottle) in combination with frequent burping may reduce swallowed air. Using a bottle with a collapsible bag also may help reduce air-swallowing [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effects of two breastfeeding methods on infantile colic were examined in a comparison study [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/25\">",
"     25",
"    </a>",
"    ]. An opportunity sample of subjects was assigned to prolonged emptying of one breast at each feed (experimental) or equal drainage of both breasts at each feed (control group) and followed prospectively for six months. The experimental group had a lower incidence of colic (12 versus 23 percent); no differences were found in the incidence of mastitis or the duration of breastfeeding between the two groups.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Carrying or front carrier",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neither carrying infants nor holding infants in front carriers had any effect on colic in several randomized controlled trials [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/3,26,27\">",
"     3,26,27",
"    </a>",
"    ]. Nonetheless, parents may be encouraged to hold their colicky infants because allowing the infant to cry in their arms may decrease parental and infant anxiety [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Alternate sensory stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other modes of alternate sensory stimulation may be beneficial to the infant with colic. The parent may try a pacifier, a ride in the car, a change of scenery, a swing, a warm bath, or a belly massage. However, these methods are not supported in randomized trials. As an example, the use of a car ride simulator did not affect daily hours of crying or maternal anxiety in one randomized controlled trial [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Decreasing stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The studies on reduced stimulation as a treatment of colic are limited. In one randomized controlled trial, 93 percent of infants improved with decreased stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/28\">",
"     28",
"    </a>",
"    ]. However, the results in this study were based upon subjective parental diaries, and colic was not clearly defined [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although more research is needed to confirm that decreasing stimulation is beneficial in the management of colic, the parents may try several methods to calm hypersensitive babies. Swaddling may calm a baby who is hypersensitive to body movements or touch [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/6\">",
"     6",
"    </a>",
"    ], who has had cerebral insults [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/29\">",
"     29",
"    </a>",
"    ], or who is younger than eight weeks of age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Use of a heartbeat tape or device that generates white noise and vibrates the bed, or placing the baby in the car seat on the dryer, may soothe an infant who is hypersensitive to noise [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/6,27\">",
"     6,27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Focused counseling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conflicting evidence exists regarding the effects of focused counseling on infantile colic. One randomized controlled trial found no significant difference between counseling and a specific measure versus counseling alone [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/27\">",
"     27",
"    </a>",
"    ]. However, a small randomized control found that counseling decreased the duration and extent of the crying in comparison to elimination of cows' milk or soy milk protein with a casein hydrolysate formula [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Herbal remedies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Herbs such as chamomile, fennel, and balm-mint have been shown to have antispasmodic properties. Their effects on colic were studied in a randomized, double-blind, controlled trial [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/34\">",
"     34",
"    </a>",
"    ]. The study compared a tea made of chamomile, vervain, licorice, fennel, and balm-milk to a placebo with the same qualities of taste, odor, and appearance. Compared to the infants in the placebo group, after seven days of treatment, more infants in the tea group no longer met Wessel criteria (57 versus 26 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/34\">",
"     34",
"    </a>",
"    ]. Long-term response was not studied. The infants in the study were given up to 150 cc of tea or placebo three times per day and consumed a mean of 32",
"    <span class=\"nowrap\">",
"     cc/kg",
"    </span>",
"    per day. Thus, prolonged treatment with tea may lead to decreased intake of milk. This concern should be emphasized to parents to whom the use of herbal tea is recommended.",
"   </p>",
"   <p>",
"    The effectiveness of fennel seed oil emulsion in infantile colic was evaluated in 125 infants (2 to 12 weeks of age) who met Wessel criteria for colic [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/35\">",
"     35",
"    </a>",
"    ]. The infants were randomly assigned to fennel seed oil (maximum dose 12",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) or placebo. Compared to those who received placebo, a greater proportion of infants in the fennel seed oil group had resolution of colic, according to the Wessel criteria (65 versus 24 percent). No side effects of fennel oil were reported during the trial.",
"   </p>",
"   <p>",
"    Another randomized controlled trial evaluated the effects of a standardized extract of",
"    <em>",
"     Matricariae recutita",
"    </em>",
"    (German chamomile),",
"    <em>",
"     Foeniculum vulgare",
"    </em>",
"    (fennel seed), and",
"    <em>",
"     Melissa officinalis",
"    </em>",
"    (lemon balm), called ColiMil in the treatment of colicky breastfed infants [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/36\">",
"     36",
"    </a>",
"    ]. Ninety-three infants were observed for three days and then randomized into treatment with ColiMil or placebo twice a day for one week. The ColiMil was given at a dose of 2",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per day twice a day before breastfeeding for seven days. Those infants who received the treatment had decreased crying time within one week of the treatment without noted side effects.",
"   </p>",
"   <p>",
"    Gripe water is a mixture of herbs, primarily dill, and water that has been promoted for its ability to cure colic. However, various types of gripe water have been found to contain dangerous ingredients, including glass particles and alcohol.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Homeopathic remedies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Homeopathic remedies have not been proven to be effective for the treatment of colic. Homeopathic remedies often are considered nontoxic because of the low concentrations of active ingredients [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/37\">",
"     37",
"    </a>",
"    ]. However, the labels of such products may not report all of the ingredients, some of which may have toxic effects [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/38\">",
"     38",
"    </a>",
"    ]. As an example, gas chromatography-mass spectrometry analysis of a homeopathic remedy for colic that was associated with an increased risk of apparent life-threatening events found that it contained ethanol, propanol, and pentanol, in addition to three potentially toxic substances that were listed as active ingredients (",
"    <em>",
"     colocynthis",
"    </em>",
"    ,",
"    <em>",
"     Veratrum album",
"    </em>",
"    , and",
"    <em>",
"     strychnos nux-vomica",
"    </em>",
"    ).",
"    <em>",
"     Colocynthis",
"    </em>",
"    is also found in Cocyntal and Hyland colic tablets.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Sucrose",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sucrose has been studied as a treatment for colic because it may produce an analgesic effect on infants through the release of endogenous opioids [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. In one double-blind study of 19 infants with colic, 12 improved subjectively with sucrose [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/41\">",
"     41",
"    </a>",
"    ]. However, the effect was short-lived (30 minutes to 1 hour maximum). Another randomized controlled trial showed that the duration of response of colicky infants to sucrose was three minutes or less [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Simethicone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Existing data show little possible benefit of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/9/27795?source=see_link\">",
"     simethicone",
"    </a>",
"    in the treatment of colic. One of three randomized controlled trials comparing simethicone and placebo noted a decrease in crying with simethicone [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/43\">",
"     43",
"    </a>",
"    ]. However, the case definition for colic was not provided [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/3\">",
"     3",
"    </a>",
"    ]. The other two studies showed no benefit to therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/44,45\">",
"     44,45",
"    </a>",
"    ], even when the results were analyzed for the subset of infants described by their parents to be gassy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/45\">",
"     45",
"    </a>",
"    ]. The presence of gas may serve as a marker for infants with colic who swallow air during crying. Simethicone may interact with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?30/47/31480?source=see_link\">",
"     levothyroxine",
"    </a>",
"    resulting in hypothyroidism [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Antispasmodics",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/22/16740?source=see_link\">",
"     Dicyclomine",
"    </a>",
"    performed better than did placebo in three randomized controlled trials [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. However, the adverse effects (eg, apnea, seizures, and coma), which are most common in infants younger than seven weeks old, preclude its use in the treatment of colic [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/50\">",
"     50",
"    </a>",
"    ]. The manufacturer no longer considers colic as an indication for the use of dicyclomine, and its use is contraindicated in infants younger than six months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Lactase enzymes",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     Lactase",
"    </a>",
"    has not been shown to improve colic symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. In a double-blind randomized controlled trial with 15 breastfed infants with colic and high breath hydrogen levels, yeast lactase had no effect in comparison with placebo on duration of crying. The relationship between high breath hydrogen levels and colic is still unexplained [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/51\">",
"     51",
"    </a>",
"    ]. Lactase is not a proven therapy for colic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Probiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential benefits of treatment with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?1/5/1108?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    <em>",
"     reuteri",
"    </em>",
"    in the treatment of colic have been demonstrated in two randomized trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The first was an open trial in which 90 breastfed infants with colic were randomly assigned to treatment with",
"      <em>",
"       L. reuteri",
"      </em>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/9/27795?source=see_link\">",
"       simethicone",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/53\">",
"       53",
"      </a>",
"      ]. At baseline, median daily crying time was 197 minutes in both groups. Among the 83 infants who completed the trial, median daily crying time was lower in the",
"      <em>",
"       L. reuteri",
"      </em>",
"      than in the simethicone group on day 7 (159 versus 177 minutes) and day 28 (51 versus 145 minutes).",
"     </li>",
"     <li>",
"      The second was a blinded trial in which 50 breastfed infants were randomly assigned to",
"      <em>",
"       L. reuteri",
"      </em>",
"      (10",
"      <sup>",
"       8",
"      </sup>",
"      colony-forming",
"      <span class=\"nowrap\">",
"       units/day)",
"      </span>",
"      or placebo for 21 days [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/54\">",
"       54",
"      </a>",
"      ]. Crying in both groups decreased to &lt;3",
"      <span class=\"nowrap\">",
"       hours/day",
"      </span>",
"      by day 21. However, the",
"      <em>",
"       L. reuteri",
"      </em>",
"      group had a greater reduction in median crying time between days 0 and 21 (370 to 35",
"      <span class=\"nowrap\">",
"       minutes/day",
"      </span>",
"      versus 300 to 90",
"      <span class=\"nowrap\">",
"       minutes/day).",
"      </span>",
"      Treatment with",
"      <em>",
"       L. reuteri",
"      </em>",
"      was associated with an increase in fecal lactobacilli and decrease in fecal",
"      <em>",
"       Escherichia coli",
"      </em>",
"      and ammonia. The amount of weight gain, stooling frequency, incidence of constipation, and incidence of regurgitation did not differ between groups. Adverse events related to",
"      <em>",
"       L. reuteri",
"      </em>",
"      were not observed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional studies are needed to confirm these results and to determine whether other probiotic strains may be more beneficial in the treatment of infantile colic.",
"    <em>",
"     L reuteri",
"    </em>",
"    is available over-the-counter as drops (not regulated by the Food and Drug Administration).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Infant massage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colicky infants younger than seven weeks of age were randomly assigned to an infant massage group or a crib vibrator group. Over the four-week study period, the amount of crying decreased significantly from baseline in both groups [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/55\">",
"     55",
"    </a>",
"    ]. The authors attributed the decrease in crying to the natural course of colic (eg, resolution by three to four months of age) rather than to the specific interventions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Spinal manipulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two randomized, controlled trials reported conflicting evidence about the effects of spinal manipulation in the treatment of colicky infants [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. One study where 41 infants were randomly assigned to two weeks of spinal manipulation or two weeks of daily treatment with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?27/9/27795?source=see_link\">",
"     simethicone",
"    </a>",
"    found that spinal manipulation reduced crying [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/56\">",
"     56",
"    </a>",
"    ]. Another study that examined the effect of spinal palpation by a chiropractor versus holding of the infant by a nurse three times over eight days found no significant difference for crying reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/57\">",
"     57",
"    </a>",
"    ]. A systematic review of these trials concluded that there is no evidence that spinal manipulation is effective for infant colic [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Cranial osteopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized controlled trials evaluating the effectiveness of cranial osteopathic manipulation to treat infantile colic. One prospective controlled study of 28 colicky infants found that those treated with osteopathic manipulation once a week over a four-week period demonstrated a statistically significant decline in crying time and an improvement in sleeping compared to those who did not receive the treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parents of colicky infants experience stress, fatigue, guilt, and depression [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/60\">",
"     60",
"    </a>",
"    ]. Some researchers have postulated that colic may disturb the child-parent interaction and thus have long-term effects on the family and child [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/61\">",
"     61",
"    </a>",
"    ]. The data on the sequelae of colic are conflicting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Temperament and behavior",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies show that temper tantrums are more common occurrences among formerly colicky infants. In two follow-up studies, parents of formerly colicky infants reported more frequent temper tantrums at three and four years of age than did parents of control children [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. In a meta-analysis of longitudinal studies, the risk of behavior problems in later childhood was increased when colic persisted at 5 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/63\">",
"     63",
"    </a>",
"    ]. The risk was greatest when persistent colic was accompanied by other regulatory (eg, feeding, sleeping) problems and psychosocial risk factors, which makes it difficult to establish a causal relationship [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parents of formerly colicky children perceive their toddlers' temperaments as more difficult than did parents of noncolicky children. In one study, parents described their formerly colicky children as more emotional (eg, \"cries easily\" or \"tends to be somewhat upset\") [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/62\">",
"     62",
"    </a>",
"    ]. Mothers in another one-year follow-up survey also rated their formerly colicky children as more difficult. However, these children did not differ from control children according to the Toddler Temperament Scale [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/64\">",
"     64",
"    </a>",
"    ]. The discrepancy between the mother's perception of the child's temperament and the child's actual temperament may reflect the long-term effects of colic on mother-child interaction [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/65\">",
"     65",
"    </a>",
"    ]. Another possibility is that factors that predispose an infant to colic also cause problems with mother-child interactions [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a prospective study, 48 infants (31 to 87 days of age) who were hospitalized with severe colic and 48 infants without chronic or severe illness who were hospitalized for problems unrelated to colic, gastrointestinal, allergic, or psychologic disease were followed up with at 10 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/66\">",
"     66",
"    </a>",
"    ]. Fussiness, aggressiveness, and feelings of supremacy were reported more often by the parents of colicky infants than of controls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Sleep patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prospective studies regarding the relationship between colic and the development of childhood sleep problems have conflicting results [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/61,66-69\">",
"     61,66-69",
"    </a>",
"    ]. The conflicting results may reflect differences in parental perception or in parent-child interaction for parents of children with and without histories of colic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Family functioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies also differ regarding the effects of colic on family functioning. In a case-control study, family functioning was assessed at one year of age in families of infants with and without colic [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/64\">",
"     64",
"    </a>",
"    ]. Families in the severe colic group had more difficulties than did the control group in communication, unresolved conflicts, dissatisfaction, and lack of empathy and flexibility. However, another case-control study, performed when the child was three years old, found no difference in family psychological characteristics between case and control families [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/67\">",
"     67",
"    </a>",
"    ]. Perhaps the effects of colic on family functioning are present early on but do not persist to three years of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Asthma and atopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a large, prospective study, 983 infants were followed from infancy through 11 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/70\">",
"     70",
"    </a>",
"    ]. The prevalence of colic was similar among breast- and formula-fed infants (9.2 percent). No association was found between infantile colic and asthma, allergic rhinitis, peak flow variability, or markers of atopy (total serum immunoglobulin E and allergy skin prick test) at any age. However, in a smaller prospective study of 96 infants, there was an association between infantile colic and recurrent abdominal pain and allergic disorders, such as allergic rhinitis, conjunctivitis, pollenosis (hay fever), atopic eczema, and food allergy [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Cognitive development",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colic does not appear to influence long-term cognitive development. In one prospective study, 327 children who were born to a cohort of 561 women and assessed for crying behavior at 6 and 13 weeks of age were available for follow-up intelligence quotient (IQ) testing at five years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15177/abstract/71\">",
"     71",
"    </a>",
"    ]. Approximately 15 percent of the children had a history of colic (defined as \"daily uncontrolled crying without any obvious cause, persisting for at least two weeks\"), and 5 percent had a history of prolonged crying (colic-like crying that was reported at both 6 and 13 weeks). At five years of age, adjusted mean IQ scores were similar among children with a history of colic and children without a history of colic. In contrast, children with a history of prolonged crying had adjusted mean IQ scores that were nine points lower than those of infants without a history of colic. This finding must be interpreted with caution, since it is based on only 15 children with prolonged crying, and the mechanism of association between prolonged crying and impaired cognition is unclear.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/53/38738?source=see_link\">",
"       \"Patient information: Colic (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/7/1140?source=see_link\">",
"       \"Patient information: Colic (excessive crying) in infants (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The word \"colic\" is used broadly by parents and clinicians to refer to prolonged and excessive crying for no apparent reason during the first three months of life. The most widely accepted definition for colic (the Wessel criteria or \"rule of three\") is crying that lasts for more than three hours per day, occurs on more than three days per week, and persists for more than three weeks, although few parents or clinicians wait three weeks before evaluation or intervention. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/27/10680?source=see_link\">",
"       \"Clinical features and etiology of colic\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Colic is a diagnosis of exclusion and must be differentiated from identifiable causes of prolonged crying in infancy (",
"      <a class=\"graphic graphic_table graphicRef79185 \" href=\"UTD.htm?0/27/445\">",
"       table 1",
"      </a>",
"      ). Important aspects of the evaluation include the infant's diet, elimination patterns, sleep patterns, growth parameters, and social situation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical evaluation'",
"      </a>",
"      above.) Specific questions related to crying should include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      When does the crying occur, and how long does it last?",
"     </li>",
"     <li>",
"      What do you do when the baby cries?",
"     </li>",
"     <li>",
"      What does the cry sound like?",
"     </li>",
"     <li>",
"      How and what you feed the baby?",
"     </li>",
"     <li>",
"      How does it make you feel when your baby cries?",
"     </li>",
"     <li>",
"      How has the colic affected your family?",
"     </li>",
"     <li>",
"      What is your theory of why the baby cries?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptoms resolve in 60 percent of infants by three months of age and 90 percent of infants by four months of age. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Management should be individualized based upon the history, examination, and environment. The goals are to help the parents cope with the child's symptoms and to prevent long-term sequelae in the parent-child relationship (",
"      <a class=\"graphic graphic_table graphicRef62869 \" href=\"UTD.htm?22/54/23403\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Overview'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of strategies are available (",
"      <a class=\"graphic graphic_table graphicRef73784 \" href=\"UTD.htm?43/35/44603\">",
"       table 3",
"      </a>",
"      ). Most work in approximately one-third of infants, and no treatment works for all infants. Potentially harmful therapies include anticholinergic drugs (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/22/16740?source=see_link\">",
"       dicyclomine",
"      </a>",
"      ) and certain homeopathic remedies (which may contain harmful ingredients not listed on the product label). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Antispasmodics'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Homeopathic remedies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The data on the sequelae of colic with respect to temperament, behavior, sleep patterns, family functioning, asthma, and atopy are conflicting. However, colic does not appear to be related to cognitive development. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Outcomes'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/1\">",
"      Taubman B. A new answer to the old question of colic. Contemp Pediatr 1991; 8:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/2\">",
"      Lehtonen LA, Rautava PT. Infantile colic: natural history and treatment. Curr Probl Pediatr 1996; 26:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/3\">",
"      Garrison MM, Christakis DA. A systematic review of treatments for infant colic. Pediatrics 2000; 106:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/4\">",
"      Douglas P, Hill P. Managing infants who cry excessively in the first few months of life. BMJ 2011; 343:d7772.",
"     </a>",
"    </li>",
"    <li>",
"     Lester BM. Introduction. In: Colic and Excessive Crying. Report of the 105th Ross Conference on Pediatric Research, Lester BM, Barr RG (Eds), Ross Products Division, Columbus, OH 1997. p.1.",
"    </li>",
"    <li>",
"     Parker S, Magee T. Colic. In: The Zuckerman Parker Handbook of Developmental and Behavioral Pediatrics for Primary Care, 3rd ed, Augustyn M, Zuckerman B, Caronna EB (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2011. p.182.",
"    </li>",
"    <li>",
"     Lester BM. Definition and diagnosis of colic. In: Colic and Excessive Crying. Report of the 105th Ross Conference on Pediatric Research, Lester BM, Barr RG (Eds), Ross Products Division, Columbus, OH 1997. p.18.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/8\">",
"      Wade S, Kilgour T. Extracts from \"clinical evidence\": Infantile colic. BMJ 2001; 323:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/9\">",
"      Lucassen PL, Assendelft WJ, Gubbels JW, et al. Effectiveness of treatments for infantile colic: systematic review. BMJ 1998; 316:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/10\">",
"      Fleisher DR. Coping with colic. Contemp Pediatr 1998; 15:144.",
"     </a>",
"    </li>",
"    <li>",
"     Weissbluth M. Is there a treatment for colic?. In: Colic and Excessive Crying. Report of the 105th Ross Conference on Pediatric Research, Lester BM, Barr RG (Eds), Ross Products Division, Columbus, OH 1997. p.119.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/12\">",
"      Reijneveld SA, van der Wal MF, Brugman E, et al. Infant crying and abuse. Lancet 2004; 364:1340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/13\">",
"      Keefe MR, Lobo ML, Froese-Fretz A, et al. Effectiveness of an intervention for colic. Clin Pediatr (Phila) 2006; 45:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/14\">",
"      Jakobsson I, Lothe L, Ley D, Borschel MW. Effectiveness of casein hydrolysate feedings in infants with colic. Acta Paediatr 2000; 89:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/15\">",
"      Hill DJ, Hudson IL, Sheffield LJ, et al. A low allergen diet is a significant intervention in infantile colic: results of a community-based study. J Allergy Clin Immunol 1995; 96:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/16\">",
"      Forsyth BW. Colic and the effect of changing formulas: a double-blind, multiple-crossover study. J Pediatr 1989; 115:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/17\">",
"      Lucassen PL, Assendelft WJ, Gubbels JW, et al. Infantile colic: crying time reduction with a whey hydrolysate: A double-blind, randomized, placebo-controlled trial. Pediatrics 2000; 106:1349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/18\">",
"      Campbell JP. Dietary treatment of infant colic: a double-blind study. J R Coll Gen Pract 1989; 39:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/19\">",
"      Lothe L, Lindberg T, Jakobsson I. Cow's milk formula as a cause of infantile colic: a double-blind study. Pediatrics 1982; 70:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/20\">",
"      Treem WR, Hyams JS, Blankschen E, et al. Evaluation of the effect of a fiber-enriched formula on infant colic. J Pediatr 1991; 119:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/21\">",
"      Savino F, Palumeri E, Castagno E, et al. Reduction of crying episodes owing to infantile colic: A randomized controlled study on the efficacy of a new infant formula. Eur J Clin Nutr 2006; 60:1304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/22\">",
"      Evans RW, Fergusson DM, Allardyce RA, Taylor B. Maternal diet and infantile colic in breast-fed infants. Lancet 1981; 1:1340.",
"     </a>",
"    </li>",
"    <li>",
"     Schmitt BD. Crying Baby (Colic). In: Instructions for Pediatric Patients, 1st ed, WB Saunders, Philadalphia 1992. p.141.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/24\">",
"      Balon AJ. Management of infantile colic. Am Fam Physician 1997; 55:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/25\">",
"      Evans K, Evans R, Simmer K. Effect of the method of breast feeding on breast engorgement, mastitis and infantile colic. Acta Paediatr 1995; 84:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/26\">",
"      Barr RG, McMullan SJ, Spiess H, et al. Carrying as colic \"therapy\": a randomized controlled trial. Pediatrics 1991; 87:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/27\">",
"      Parkin PC, Schwartz CJ, Manuel BA. Randomized controlled trial of three interventions in the management of persistent crying of infancy. Pediatrics 1993; 92:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/28\">",
"      McKenzie S. Troublesome crying in infants: effect of advice to reduce stimulation. Arch Dis Child 1991; 66:1416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/29\">",
"      Ohgi S, Akiyama T, Arisawa K, Shigemori K. Randomised controlled trial of swaddling versus massage in the management of excessive crying in infants with cerebral injuries. Arch Dis Child 2004; 89:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/30\">",
"      van Sleuwen BE, L'hoir MP, Engelberts AC, et al. Comparison of behavior modification with and without swaddling as interventions for excessive crying. J Pediatr 2006; 149:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/31\">",
"      van Sleuwen BE, Engelberts AC, Boere-Boonekamp MM, et al. Swaddling: a systematic review. Pediatrics 2007; 120:e1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/32\">",
"      Taubman B. Parental counseling compared with elimination of cow's milk or soy milk protein for the treatment of infant colic syndrome: a randomized trial. Pediatrics 1988; 81:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/33\">",
"      Kilgour T, Wade S. Infantile colic. Clin Evid 2005; :362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/34\">",
"      Weizman Z, Alkrinawi S, Goldfarb D, Bitran C. Efficacy of herbal tea preparation in infantile colic. J Pediatr 1993; 122:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/35\">",
"      Alexandrovich I, Rakovitskaya O, Kolmo E, et al. The effect of fennel (Foeniculum Vulgare) seed oil emulsion in infantile colic: a randomized, placebo-controlled study. Altern Ther Health Med 2003; 9:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/36\">",
"      Savino F, Cresi F, Castagno E, et al. A randomized double-blind placebo-controlled trial of a standardized extract of Matricariae recutita, Foeniculum vulgare and Melissa officinalis (ColiMil) in the treatment of breastfed colicky infants. Phytother Res 2005; 19:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/37\">",
"      Aviner S, Berkovitch M, Dalkian H, et al. Use of a homeopathic preparation for \"infantile colic\" and an apparent life-threatening event. Pediatrics 2010; 125:e318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/38\">",
"      Wille D, Hauri-Hohl M, Vonbach P, et al. Too much of too little: xylitol, an unusual trigger of a chronic metabolic hyperchloremic acidosis. Eur J Pediatr 2010; 169:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/39\">",
"      Pomonis JD, Jewett DC, Kotz CM, et al. Sucrose consumption increases naloxone-induced c-Fos immunoreactivity in limbic forebrain. Am J Physiol Regul Integr Comp Physiol 2000; 278:R712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/40\">",
"      Segato FN, Castro-Souza C, Segato EN, et al. Sucrose ingestion causes opioid analgesia. Braz J Med Biol Res 1997; 30:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/41\">",
"      Markestad T. Use of sucrose as a treatment for infant colic. Arch Dis Child 1997; 76:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/42\">",
"      Barr RG, Young SN, Wright JH, et al. Differential calming responses to sucrose taste in crying infants with and without colic. Pediatrics 1999; 103:e68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/43\">",
"      Sethi KS, Sethi JK. Simethicone in the management of infant colic. Practitioner 1988; 232:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/44\">",
"      Danielsson B, Hwang CP. Treatment of infantile colic with surface active substance (simethicone). Acta Paediatr Scand 1985; 74:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/45\">",
"      Metcalf TJ, Irons TG, Sher LD, Young PC. Simethicone in the treatment of infant colic: a randomized, placebo-controlled, multicenter trial. Pediatrics 1994; 94:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/46\">",
"      Balapatabendi M, Harris D, Shenoy SD. Drug interaction of levothyroxine with infant colic drops. Arch Dis Child 2011; 96:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/47\">",
"      Weissbluth M, Christoffel KK, Davis AT. Treatment of infantile colic with dicyclomine hydrochloride. J Pediatr 1984; 104:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/48\">",
"      Illingworth RS. Evening colic in infants: A double-blind trial of dicyclomine hydrochloride. Lancet 1959; 2:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/49\">",
"      Grunseit F. Evaluation of the efficacy of dicyclomine hydrochloride ('Merbentyl') syrup in the treatment of infant colic. Curr Med Res Opin 1977; 5:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/50\">",
"      Williams J, Watkins-Jones R. Dicyclomine: worrying symptoms associated with its use in some small babies. Br Med J (Clin Res Ed) 1984; 288:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/51\">",
"      Miller JJ, McVeagh P, Fleet GH, et al. Effect of yeast lactase enzyme on \"colic\" in infants fed human milk. J Pediatr 1990; 117:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/52\">",
"      St&aring;hlberg MR, Savilahti E. Infantile colic and feeding. Arch Dis Child 1986; 61:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/53\">",
"      Savino F, Pelle E, Palumeri E, et al. Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 2007; 119:e124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/54\">",
"      Savino F, Cordisco L, Tarasco V, et al. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 2010; 126:e526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/55\">",
"      Huhtala V, Lehtonen L, Heinonen R, Korvenranta H. Infant massage compared with crib vibrator in the treatment of colicky infants. Pediatrics 2000; 105:E84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/56\">",
"      Wiberg JM, Nordsteen J, Nilsson N. The short-term effect of spinal manipulation in the treatment of infantile colic: a randomized controlled clinical trial with a blinded observer. J Manipulative Physiol Ther 1999; 22:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/57\">",
"      Olafsdottir E, Forshei S, Fluge G, Markestad T. Randomised controlled trial of infantile colic treated with chiropractic spinal manipulation. Arch Dis Child 2001; 84:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/58\">",
"      Ernst E. Chiropractic spinal manipulation for infant colic: a systematic review of randomised clinical trials. Int J Clin Pract 2009; 63:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/59\">",
"      Hayden C, Mullinger B. A preliminary assessment of the impact of cranial osteopathy for the relief of infantile colic. Complement Ther Clin Pract 2006; 12:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/60\">",
"      Vik T, Grote V, Escribano J, et al. Infantile colic, prolonged crying and maternal postnatal depression. Acta Paediatr 2009; 98:1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/61\">",
"      Rautava P, Lehtonen L, Helenius H, Sillanp&auml;&auml; M. Infantile colic: child and family three years later. Pediatrics 1995; 96:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/62\">",
"      Canivet C, Jakobsson I, Hagander B. Infantile colic. Follow-up at four years of age: still more \"emotional\". Acta Paediatr 2000; 89:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/63\">",
"      Hemmi MH, Wolke D, Schneider S. Associations between problems with crying, sleeping and/or feeding in infancy and long-term behavioural outcomes in childhood: a meta-analysis. Arch Dis Child 2011; 96:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/64\">",
"      R&auml;ih&auml; H, Lehtonen L, Korhonen T, Korvenranta H. Family life 1 year after infantile colic. Arch Pediatr Adolesc Med 1996; 150:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/65\">",
"      Lehtonen L, Korhonen T, Korvenranta H. Temperament and sleeping patterns in colicky infants during the first year of life. J Dev Behav Pediatr 1994; 15:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/66\">",
"      Savino F, Castagno E, Bretto R, et al. A prospective 10-year study on children who had severe infantile colic. Acta Paediatr Suppl 2005; 94:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/67\">",
"      R&auml;ih&auml; H, Lehtonen L, Korhonen T, Korvenranta H. Family functioning 3 years after infantile colic. J Dev Behav Pediatr 1997; 18:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/68\">",
"      Kirjavainen J, Kirjavainen T, Huhtala V, et al. Infants with colic have a normal sleep structure at 2 and 7 months of age. J Pediatr 2001; 138:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/69\">",
"      St James-Roberts I, Peachey E. Distinguishing infant prolonged crying from sleep-waking problems. Arch Dis Child 2011; 96:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/70\">",
"      Castro-Rodr&iacute;guez JA, Stern DA, Halonen M, et al. Relation between infantile colic and asthma/atopy: a prospective study in an unselected population. Pediatrics 2001; 108:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15177/abstract/71\">",
"      Rao MR, Brenner RA, Schisterman EF, et al. Long term cognitive development in children with prolonged crying. Arch Dis Child 2004; 89:989.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 612 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-806F72AFFC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15177=[""].join("\n");
var outline_f14_52_15177=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H35\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Parental support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Reducing parental stress",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Formulas",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Hypoallergenic",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Soy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Fiber-enriched",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Other formula types",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Maternal diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Feeding techniques",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Carrying or front carrier",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Alternate sensory stimulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Decreasing stimulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Focused counseling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Herbal remedies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Homeopathic remedies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Sucrose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Simethicone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Antispasmodics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Lactase enzymes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Probiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Infant massage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Spinal manipulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Cranial osteopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Temperament and behavior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Sleep patterns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Family functioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Asthma and atopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Cognitive development",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/612\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/612|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/27/445\" title=\"table 1\">",
"      Differential diagnosis of prolonged crying",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/54/23403\" title=\"table 2\">",
"      Colic management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/35/44603\" title=\"table 3\">",
"      Suggested colic strategies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/36/44615?source=related_link\">",
"      Ankyloglossia (tongue-tie) in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/27/10680?source=related_link\">",
"      Clinical features and etiology of colic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14808?source=related_link\">",
"      Clinical manifestations of food allergy: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=related_link\">",
"      Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42633?source=related_link\">",
"      Normal growth patterns in infants and prepubertal children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/53/38738?source=related_link\">",
"      Patient information: Colic (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/7/1140?source=related_link\">",
"      Patient information: Colic (excessive crying) in infants (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_52_15178="Immune function in older adults";
var content_f14_52_15178=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Immune function in older adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/52/15178/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15178/contributors\">",
"     Antoine Azar, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15178/contributors\">",
"     Zuhair K Ballas, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/52/15178/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15178/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?14/52/15178/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?14/52/15178/contributors\">",
"     Anna M Feldweg, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?14/52/15178/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H5900175\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normal functions of the immune system include defense against infections and detection and destruction of malignant or autoreactive cells. As the immune system ages and these capabilities decline, there is increased susceptibility to infections and cancer and an increased incidence of autoimmune disorders. The study of age-related changes in immune function is a relatively new area of investigation, which is limited by incomplete understanding of the complexities of immune mechanisms in general [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/1\">",
"     1",
"    </a>",
"    ]. At present, most research is focused on defining normal changes in immune function at the basic science level, and much of the available data are from animal studies. In addition, there are no clinical interventions that have been definitively shown to counter immunologic aging.",
"   </p>",
"   <p>",
"    This topic will review the changes observed in different components of the immune system with aging. The theoretical implications of these changes on health maintenance and vaccination of older adults are also discussed. Normal aging of other systems, nutrition in older adults, infections in older adults, and geriatric health maintenance (including current recommendations for vaccination) are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38282?source=see_link\">",
"     \"Normal aging\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/12/31946?source=see_link\">",
"     \"Geriatric nutrition: Nutritional issues in older adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/54/32618?source=see_link\">",
"     \"Evaluation of infection in the older adult\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/18/38186?source=see_link\">",
"     \"Geriatric health maintenance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25009826\">",
"    <span class=\"h1\">",
"     IMMUNOSENESCENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunosenescence refers to the changes that occur in the immune system with increasing age. The clinical consequences of immunosenescence include an increased risk of infections, malignancy, and autoimmune disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10659458\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumonia and influenza are among the top ten causes of death in individuals aged 65 and older [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/2\">",
"     2",
"    </a>",
"    ]. Nosocomial infections are also significantly increased in elderly individuals. This could be the result of decreased immunologic function, in addition to a decreased efficacy of vaccines in the elderly. However, there are several other factors that are likely to contribute to increased infections in elderly individuals: malnutrition, comorbid conditions (eg, diabetes, chronic obstructive pulmonary disease), diminished mucosal barriers, decreased cough reflex, and mechanical changes to the urinary tract system, among others [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical presentation of infections in older patients may be different from that in younger patients. Older adults with severe infections tend to have fewer symptoms, and fever is absent or blunted in 20 to 30 percent. This suggests a decreased ability to mount inflammatory cytokine responses in the face of infection. Signs of infection in the elderly can be nonspecific and include falls, delirium, anorexia, or generalized weakness [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/54/32618?source=see_link\">",
"     \"Evaluation of infection in the older adult\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    \"Failure to thrive\" is a term that has been extrapolated from the pediatric description. In the elderly, it is used to describe a gradual decline in physical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cognitive function, usually accompanied by weight loss and social withdrawal that occurs without immediate explanation. Failure to thrive in the elderly has been defined as a syndrome manifested by weight loss greater than 5 percent of baseline, decreased appetite, poor nutrition, and inactivity, often accompanied by dehydration, depressive symptoms, impaired immune function, and low cholesterol levels [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/5\">",
"     5",
"    </a>",
"    ]. Failure to thrive is not considered a normal consequence of aging, an equivalent to dementia, or a descriptor of the later stages of a terminal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/6\">",
"     6",
"    </a>",
"    ]. One important treatable cause of failure to thrive is undetected chronic infections, such as tuberculosis, endocarditis, or bronchiectasis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/26/34215?source=see_link\">",
"     \"Failure to thrive in elderly adults: Evaluation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/29/42455?source=see_link\">",
"     \"Failure to thrive in elderly adults: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10659465\">",
"    <span class=\"h2\">",
"     Malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cancer incidence and mortality markedly increase after age 65, leveling off around age 85 to 90. Both innate and adaptive arms of the immune system are involved in the first defense against aberrant tumor cells. Patients with primary and acquired immunodeficiency are at increased risk for certain tumors, which is an indication of the immune system&rsquo;s role in defense against malignancy. However, carcinogenesis is a complex phenomenon, and the exact role of immunosenescence is difficult to establish. An increased mutational load and carcinogen exposure are likely other contributors to increased malignancy in the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10659472\">",
"    <span class=\"h2\">",
"     Autoimmune disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is an increase in the production of autoantibodies with age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/8\">",
"     8",
"    </a>",
"    ]. In one study of healthy elderly individuals, 28 percent had a positive antiphospholipid antibody, 22 percent had a positive rheumatoid factor, and 14 percent had elevated antinuclear antibodies (ANA) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/9\">",
"     9",
"    </a>",
"    ]. The mechanisms for heightened autoantibody production are not clear, but decreased regulatory T cell function and decreased clearance of apoptotic cells by macrophages are two potential explanations.",
"   </p>",
"   <p>",
"    As is the case with infections, autoimmune disorders, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and Sj&ouml;gren's syndrome, may present with atypical symptoms in the elderly. SLE can present as vague symptoms of weight loss, muscle pain and cognitive or affective deterioration [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/9\">",
"     9",
"    </a>",
"    ]. In a study of patients with RA, older patients were more likely than younger patients to present with symptoms similar to polymyalgia rheumatica and were less likely to have subcutaneous nodules or rheumatoid factor at disease onset [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/10\">",
"     10",
"    </a>",
"    ]. Joint scores were also lower.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3021291\">",
"    <span class=\"h2\">",
"     Effect of malnutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adequate nutrition is fundamental to healthy aging. Malnutrition is not uncommon in older adults and is associated with increased morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In a Swedish study, malnutrition was present in 60 to 80 percent of patients over 60 years of age admitted to the hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/13\">",
"     13",
"    </a>",
"    ]. In general, energy requirements decrease with age due to a decline in lean body mass and decreased physical activity. Despite this, older adults are at risk for malnutrition due to dental or swallowing problems that might interfere with eating, loss of smell or taste sensations, chronic illnesses that interfere with digestion or absorption of food and increase nutritional requirements, medication side effects, depression and social isolation,",
"    <span class=\"nowrap\">",
"     functional/visual/cognitive",
"    </span>",
"    impairments, and economic barriers to obtaining high-quality food [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/12/31946?source=see_link\">",
"     \"Geriatric nutrition: Nutritional issues in older adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Malnutrition is associated with immune defects, in particular a decrease in T cell function [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/15\">",
"     15",
"    </a>",
"    ]. Malnutrition is also associated with an increased risk of and a worse outcome with infections [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/16\">",
"     16",
"    </a>",
"    ]. Deficiencies of vitamins A and E [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/17\">",
"     17",
"    </a>",
"    ], vitamin C [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/18\">",
"     18",
"    </a>",
"    ], vitamin B12 and folate [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/19,20\">",
"     19,20",
"    </a>",
"    ], vitamin B6 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/21\">",
"     21",
"    </a>",
"    ], vitamin D [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/22\">",
"     22",
"    </a>",
"    ], as well as zinc, selenium, magnesium [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/23\">",
"     23",
"    </a>",
"    ], and copper [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/24\">",
"     24",
"    </a>",
"    ], have been described in the elderly, although the precise effects of these deficiencies on immune function are not well-defined. (See",
"    <a class=\"local\" href=\"#H1558093\">",
"     'Nutritional supplements and diet'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10659962\">",
"    <span class=\"h1\">",
"     CHANGES IN SPECIFIC COMPONENTS OF THE IMMUNE SYSTEM",
"    </span>",
"    &nbsp;&mdash;&nbsp;All immune cells originate from hematopoietic stem cells (HSCs) in the bone marrow, and there is a general decline in the total bone marrow hematopoietic tissue with aging [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/25\">",
"     25",
"    </a>",
"    ]. HSCs, like other cells, undergo progressive loss of telomeric DNA with successive divisions. It is estimated that 50 to 200 bp of telomeric DNA is lost with each cell division [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/26\">",
"     26",
"    </a>",
"    ]. The sequential loss and shortening of telomeric DNA with advancing age lead to an increase in apoptosis (noninflammatory, programmed cell death). In addition to telomere shortening, acquired defects in genomic or mitochondrial DNA also contribute to the decline in HSCs. Overall, the proliferative capacity of HSCs from older people is two to four times less than those from younger subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/25\">",
"     25",
"    </a>",
"    ]. Differences in regenerating capacity are particularly important during times of illness or other physiologic stress.",
"   </p>",
"   <p>",
"    Production of pro-B cells is significantly decreased with aging, resulting in a smaller number of B cells leaving the bone marrow, while T cell precursors seem to be less affected [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/27\">",
"     27",
"    </a>",
"    ]. In contrast, age-related changes do not affect erythroid and myeloid progenitors and enhanced myelopoiesis is observed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/28\">",
"     28",
"    </a>",
"    ]. Other age-related changes in the bone marrow are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38282?source=see_link&amp;anchor=H23810861#H23810861\">",
"     \"Normal aging\", section on 'Hematopoietic system'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The immune system is divided into innate and adaptive immunity. Innate immunity refers to immune responses that are present from birth and not learned, adapted, or refined as a result of exposure to",
"    <span class=\"nowrap\">",
"     microorganisms/antigens.",
"    </span>",
"    In contrast, adaptive immunity, which consists of the responses of T and B lymphocytes, is generated and then refined during the lifetime of an individual as a result of antigen exposure. Aging affects both innate and adaptive immunity, although innate immune mechanisms are better preserved overall [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10833849\">",
"    <span class=\"h2\">",
"     Innate immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The innate immune system consists of epithelial barriers (skin, gastrointestinal and respiratory mucosa), macrophages, neutrophils, natural killer (NK) cells, NKT cells, dendritic cells (DC), and complement proteins. Nonspecific defense mechanisms, such production of mucus in the proper quantity and viscosity, local antimicrobial peptides, and normal ciliary function are also part of normal defenses. Several age-related changes in the components of the innate immune system have been characterized (",
"    <a class=\"graphic graphic_table graphicRef69360 \" href=\"UTD.htm?3/0/3084\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Overall, although some innate immune mechanisms are decreased, other mechanisms appear to be more active in older individuals. The result of these changes is a propensity to develop chronic inflammatory states. Thus, the result of aging of the innate immune system may be most accurately characterized as a state of immune dysregulation characterized by low-grade, chronic inflammatory changes [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/30\">",
"     30",
"    </a>",
"    ]. Chronic viral infections, such as cytomegalovirus (CMV) infection, may also contribute to this phenomenon, as discussed below (see",
"    <a class=\"local\" href=\"#H25009937\">",
"     'Immune risk profile'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Toll-like receptors",
"      </strong>",
"      &mdash; Toll-like receptors (TLRs) are receptors that are responsible for the recognition of pathogen-associated molecular patterns and thus play a very important role in recognizing infecting organisms. It is still unclear as to whether TLR expression is reduced with aging. However, TLR function was found to be decreased in aged mice [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/31\">",
"       31",
"      </a>",
"      ]. In humans, cytokine production by monocytes as a result of TLR",
"      <span class=\"nowrap\">",
"       1/2",
"      </span>",
"      activation decreases with age [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/32\">",
"       32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=see_link\">",
"       \"Toll-like receptors: Roles in disease and therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Macrophages",
"      </strong>",
"      &mdash; Macrophages are an important first line defense against invading microorganisms. Macrophages function by recognizing, ingesting, and killing organisms, presenting processed antigens to T cells, and releasing mediators that activate other inflammatory cells. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/37/16986?source=see_link&amp;anchor=H9421079#H9421079\">",
"       \"An overview of the innate immune system\", section on 'Monocytes and macrophages'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25432?source=see_link&amp;anchor=H2#H2\">",
"       \"Antigen presenting cells\", section on 'Professional APCs'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      There is a significant decrease in bone marrow macrophage precursors with aging [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/33\">",
"       33",
"      </a>",
"      ]. In addition, macrophages from aged rats and mice were found to have reduced production of nitric oxide and the reactive oxygen species that are essential for their killing activity [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/34\">",
"       34",
"      </a>",
"      ]. The decreased macrophage activity in elderly individuals may result in a longer duration of infection by extracellular bacteria, as well as delayed wound healing. Deficient production of tumor necrosis factor (TNF) alpha by skin macrophages was found to underlie impaired responses to DTH testing with age [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Neutrophils",
"      </strong>",
"      &mdash; Neutrophils are short-lived cells, important in acute inflammation and in defense against bacterial and fungal organisms. Aging does not affect the total number of neutrophil precursors in the bone marrow, or the number of circulating neutrophils in the blood. However, the phagocytic ability of neutrophils is reduced in elderly humans as compared to younger adults. Studies of superoxide generation by neutrophils in elderly patients have reached varying conclusions, depending upon the conditions used in vitro [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/36,37\">",
"       36,37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Natural killer cells",
"      </strong>",
"      &mdash; Natural killer cells are large granular lymphocytes that secrete cytokines and are capable of destroying tumor cells and viral-infected cells. They are defined as being CD56",
"      <sup>",
"       +",
"      </sup>",
"      CD3",
"      <sup>",
"       -",
"      </sup>",
"      . Peripheral blood NK cells are comprised of around 10 percent CD56",
"      <sup>",
"       bright",
"      </sup>",
"      and 90 percent CD56",
"      <sup>",
"       dim",
"      </sup>",
"      subsets. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30889?source=see_link&amp;anchor=H2#H2\">",
"       \"NK cell deficiency syndromes: Clinical manifestations and diagnosis\", section on 'Biology of NK cells'",
"      </a>",
"      .):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      CD56",
"      <sup>",
"       bright",
"      </sup>",
"      CD16",
"      <sup>",
"       dim",
"      </sup>",
"      NK cells function primarily in producing cytokines, such as interferon gamma (IFN-&gamma;) and chemokines, and have minimal cytotoxic activity.",
"     </li>",
"     <li>",
"      CD56",
"      <sup>",
"       dim",
"      </sup>",
"      CD16",
"      <sup>",
"       bright",
"      </sup>",
"      NK cells are highly cytotoxic, and produce lower amounts of cytokines.",
"      <br/>",
"      <br/>",
"      Unlike other lymphocytes, the NK cell percentage and number tend to increase with age [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/38\">",
"       38",
"      </a>",
"      ]. More than one study noted that the percentage and number of CD56",
"      <sup>",
"       bright",
"      </sup>",
"      NK cells gradually decline with age, while CD56",
"      <sup>",
"       dim",
"      </sup>",
"      NK cells progressively increase [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/39,40\">",
"       39,40",
"      </a>",
"      ]. Consequently, the ability to produce IFN-&gamma; was modestly impaired in NK cells from older subjects compared with adult controls, while NK cell cytolytic activity was well preserved in the older population (as such and in antibody-dependent cellular cytotoxicity) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/41\">",
"       41",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      NK cells may play an important role in controlling infections in elderly individuals. A study on 108 elderly individuals in nursing homes found a correlation between a low NK cell activity and both increased infection rate and death due to infections [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/42\">",
"       42",
"      </a>",
"      ]. In another study, centenarians had preserved or increased NK cell activity, consistent with the concept that these cells are important for successful aging [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Natural killer T cells",
"      </strong>",
"      &mdash; Natural killer T (NKT) cells are a subset of T cells (ie, CD3",
"      <sup>",
"       +",
"      </sup>",
"      ) that shares some characteristics of NK cells [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/44\">",
"       44",
"      </a>",
"      ]. NKT cells are heterogeneous but the majority express an invariant T cell receptor (TCR) alpha chain encoded by",
"      <span class=\"nowrap\">",
"       V&alpha;24/J&alpha;Q",
"      </span>",
"      gene segments (these cells are called invariant NKT cells, iNKT) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/45\">",
"       45",
"      </a>",
"      ]. NKT cells can be a potent source of interferon-gamma (IFN-&gamma;) and interleukin (IL)-4 and can thus modulate adaptive immune responses. Lymphocytes from elderly individuals were reported to have a decreased percentage of iNKT and these iNKT were more likely to secrete IL-4 rather than IFN-&gamma;, compared with lymphocytes from young subjects [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/46-48\">",
"       46-48",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30889?source=see_link&amp;anchor=H2#H2\">",
"       \"NK cell deficiency syndromes: Clinical manifestations and diagnosis\", section on 'Biology of NK cells'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Dendritic cells",
"      </strong>",
"      &mdash; Dendritic cells are the most potent antigen presenting cells. They play a critical role in the initiation of the immune response by capturing and processing antigens and presenting the processed antigens to other immune cells. They also stimulate the immune system by secreting a number of cytokines, and form an important link between innate and adaptive immunity. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25432?source=see_link&amp;anchor=H2#H2\">",
"       \"Antigen presenting cells\", section on 'Professional APCs'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The number of dendritic cells (both myeloid and plasmacytoid dendritic cell subsets) does not seem to be affected by aging (",
"      <a class=\"graphic graphic_table graphicRef69360 \" href=\"UTD.htm?3/0/3084\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/38\">",
"       38",
"      </a>",
"      ]. The extent of immunosenescence of human dendritic cells remains an area of uncertainty [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/49\">",
"       49",
"      </a>",
"      ]. There is a suggestion, however, that aging is associated with a numerical and functional decline in plasmacytoid but not myeloid dendritic cells, that the TLR function in dendritic cells from the elderly may be decreased, and that such a decrease might determine the adequacy of response to influenza vaccine [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/50,51\">",
"       50,51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10833871\">",
"    <span class=\"h2\">",
"     Adaptive immunity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adaptive immunity consists of B and T lymphocytes, which mediate humoral and cellular immune responses, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10833693\">",
"    <span class=\"h3\">",
"     Cellular immunity: T cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several key changes that occur to T cells during aging (",
"    <a class=\"graphic graphic_table graphicRef78986 \" href=\"UTD.htm?31/40/32395\">",
"     table 2",
"    </a>",
"    ). One of the most striking changes of immunosenescence is the involution of the thymus gland.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10833700\">",
"    <span class=\"h4\">",
"     Thymic involution",
"    </span>",
"    &nbsp;&mdash;&nbsp;Naive T cells are generated from precursors that leave the bone marrow and migrate to the thymus for maturation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31098?source=see_link&amp;anchor=H1231136#H1231136\">",
"     \"Normal B and T lymphocyte development\", section on 'T cell development'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The thymus gland is most active early in life, reaches maximum size within the first year of life, then undergoes a steady decline with age. By age seven, the part of the thymus with active cell replication (thymopoietic space) represents less than 10 percent of the total thymic space. The functional thymic cortex and medulla are progressively replaced by fatty tissue. These changes are almost complete by age 40 to 50 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/52\">",
"     52",
"    </a>",
"    ]. As a result of thymic involution, the number of na&iuml;ve T cells exiting the thymus is significantly decreased, and gets progressively lower between the age groups of 40 to 54, 55 to 69, and 70 to 90 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H922404\">",
"    <span class=\"h4\">",
"     Changes in T cell subsets",
"    </span>",
"    &nbsp;&mdash;&nbsp;An overall decline in T cell function is apparent with aging, as evidenced by a decline in T cell number and diversity and reduced T cell expansion, differentiation, and signaling intensity (",
"    <a class=\"graphic graphic_table graphicRef78986 \" href=\"UTD.htm?31/40/32395\">",
"     table 2",
"    </a>",
"    ). Specific changes include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      T cell receptor diversity dramatically decreases after age 65, resulting in a significantly reduced repertoire [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/53\">",
"       53",
"      </a>",
"      ]. A diverse repertoire is critical for protection from a variety of new infections, especially viral infections. As a result, the ability of T cells to mount an immune response against new antigens declines with age. A study of 44 centenarians found that 84 percent had nondetectable T cell receptor excision circles (TRECs - biomarkers for de novo T cell synthesis), and that these subjects had a low number of na&iuml;ve T cells [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/54\">",
"       54",
"      </a>",
"      ]. In contrast, numbers of terminally differentiated cells in centenarians were not different from those in young or middle-aged subjects. These findings suggest that production of new T cells is dramatically reduced in the very old, and T cell populations are largely composed of persistent long-lived lymphocytes. Age-related defects in the signaling pathways of na&iuml;ve CD4 T cells have been identified [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is a decrease in the numbers of CD4 T cells, an increase in CD8 T cells, and a decrease in the costimulatory molecule CD28 with aging. Reduction in CD28 results in an impaired ability of T cells to proliferate and secrete IL-2 [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/56\">",
"       56",
"      </a>",
"      ]. Because CD4 (helper) T cells are important in stimulating B cells, the ability of T cells to help B cells proliferate and produce antibodies diminishes with age [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/57\">",
"       57",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=see_link&amp;anchor=H9#H9\">",
"       \"The adaptive cellular immune response\", section on 'T cell activation via the two signal model'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      T regulatory cells (Tregs) are a subset of T cells that keep the immune system &ldquo;in check&rdquo; by maintaining homeostasis, limiting autoimmune responses, and modulating the inflammatory response to infectious agents and tumors. There is a decrease in Treg function after the age of 50, which may be a contributing factor to the increase in autoimmunity and malignancy seen in older individuals (",
"      <a class=\"graphic graphic_table graphicRef78986 \" href=\"UTD.htm?31/40/32395\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/58\">",
"       58",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/58/41897?source=see_link&amp;anchor=H11#H11\">",
"       \"T helper subsets: Differentiation and role in disease\", section on 'Modulation by regulatory T cells'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Studies have been conflicting about the types of cytokines produced by aging T cells. One study showed an increased number of both TH1 and TH2 cells in the old and nonagenarians when compared to young individuals, with an increase in the",
"    <span class=\"nowrap\">",
"     TH2/TH1",
"    </span>",
"    ratio [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/59\">",
"     59",
"    </a>",
"    ]. Other studies suggested an increase in TH2 cytokines in the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/60,61\">",
"     60,61",
"    </a>",
"    ], while previous studies had suggested increased TH1 cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10833707\">",
"    <span class=\"h3\">",
"     Humoral immunity: B cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;B cells produce their own surface membrane immunoglobulin and differentiate into plasma cells, which then make immunoglobulin for the blood or secretions. These immunoglobulins are the mediators of humoral immunity. B cells respond to antigen exposure (ie, through infections or vaccinations) by producing antibodies, which then bind to antigens to fight concurrent infections or prevent future infections. Na&iuml;ve B cells produce primarily immunoglobulin M (IgM); upon stimulation with antigen, B cells switch to the production of IgG, IgA, or IgE. The ability of B cells to respond to antigens and produce antibodies is a main measure of their functional capacity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=see_link\">",
"     \"The humoral immune response\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The numbers of B cells precursors in the bone marrow (pre-B cells), as well as peripheral B cells, decrease with age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/63\">",
"     63",
"    </a>",
"    ]. Immunoglobulin levels, on the other hand, do not change with aging, and may actually increase [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/64\">",
"     64",
"    </a>",
"    ]. However, quantities of specific antibodies (ie, those generated by encounters with antigens through infection or vaccination) decline with age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/65\">",
"     65",
"    </a>",
"    ]. Some studies have shown that, similar to T cells, the diversity of the B cell repertoire decreases with age; this decreased repertoire also correlated with a poor health status or &ldquo;frailty&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10833714\">",
"    <span class=\"h3\">",
"     Memory B and T cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;The generation of long-lasting protective memory is one of the most unique and important characteristics of the adaptive immune system. Memory is essential in allowing individuals to defend themselves from infections to which they have previously been exposed. As the thymic output declines, individuals rely more on re-expansion of experienced memory cells for defense against infections.",
"   </p>",
"   <p>",
"    Memory responses to recall challenge appear to be relatively well preserved with aging, compared with responses of na&iuml;ve B and T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/67\">",
"     67",
"    </a>",
"    ]. Data suggest that memory B and T cells, once elicited by antigen during youth, are quite resilient to the impact of immunosenescence [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. An example of this phenomenon was seen during the 2009 H1N1 influenza pandemic, in which the elderly were better protected from H1N1 infection than middle-aged adults, probably because of the persistence of memory lymphocytes producing neutralizing cross-reactive antibodies generated in response to an H1N1 virus that circulated prior to 1957 [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/70\">",
"     70",
"    </a>",
"    ]. The antibody avidity for 2009 H1 was higher in the elderly than in middle-aged adults [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conversely, animal studies suggest that T cell memory generated for the first time in old animals is defective [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H921793\">",
"    <span class=\"h1\">",
"     ASSESSING IMMUNOSENESCENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunosenescence is part of normal aging, and as such, would be assumed to be present to varying degrees in all older adults. At present, assays for quantifying immunosenescence are largely research tools.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10660551\">",
"    <span class=\"h2\">",
"     Leukocyte telomere length",
"    </span>",
"    &nbsp;&mdash;&nbsp;Telomeres are protein-DNA complexes, 10 to 20 kb long, characterized by tandem repeats (TTAGGG). Telomeres play a role in preventing DNA degradation by protecting the chromosome end from recombination and fusion with another telomere or DNA end. The telomere length is an indication of the cell replication history and replicative capacity of normal somatic cells [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/73\">",
"     73",
"    </a>",
"    ]. Leukocyte telomere length is sometimes used as a biomarker of oxidative stress and injury [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25009937\">",
"    <span class=\"h2\">",
"     Immune risk profile",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most studies look at the effects of aging on the immune system, other lines of research have introduced the concept that immunosenescence itself may be a major contributor to the process of aging. The concept of &ldquo;immune risk profile&rdquo; (IRP) as a predictor of survival has emerged. Elderly individuals with certain immunologic findings (ie, a poor T-cell proliferative response to mitogens, low numbers of B cells, an inverted CD4:CD8 T cell ratio, and cytomegalovirus (CMV) seropositivity) can be characterized as having an IRP and these individuals demonstrate high mortality at two, four, and six years of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/75-77\">",
"     75-77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One group has hypothesized that herpesviruses, and CMV in particular, may be the driving force behind the development of an IRP by acting as a chronic antigenic stressor [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/78\">",
"     78",
"    </a>",
"    ]. In CMV negative patients, Epstein Barr virus (EBV) might have the same effect. It has been suggested that genetically long-lived individuals are less susceptible to the CMV-associated IRP findings [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/79\">",
"     79",
"    </a>",
"    ]. This hypothesis is consistent with the observation that centenarians have an &ldquo;inverted&rdquo; IRP [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H922040\">",
"    <span class=\"h1\">",
"     POTENTIAL INTERVENTIONS TO COUNTER IMMUNOSENESCENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no specific therapies that have been convincingly shown to counter normal immunosenescence. Still, adequate nutrition is likely essential for optimizing immune function and there are some data indicating that regular, moderate exercise is also important.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1558093\">",
"    <span class=\"h2\">",
"     Nutritional supplements and diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies demonstrating that vitamin or mineral supplements can boost immune function are lacking. Available data do indicate that vitamins (A, D, E, B6, B12, folate, and C), and trace elements (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    , zinc, copper, and iron) are necessary for normal immune function [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/81-83\">",
"     81-83",
"    </a>",
"    ]. In addition, the prevalence of certain nutritional deficiencies in the geriatric population (eg, vitamins D and B12) is sufficiently high that certain supplements are indicated. However, beyond achieving the recommended daily amounts of nutrients, there are no data to suggest that further supplementation can improve immune function.",
"   </p>",
"   <p>",
"    Few studies have evaluated the effect of dietary practices on specific immune functions. One study suggested that fruit and vegetable consumption improved antipneumococcal antibody response in subjects aged 65 to 85 years, although there were technical issues with the measurement of immune response and more work is needed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nutritional issues in older adults are reviewed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/12/31946?source=see_link\">",
"     \"Geriatric nutrition: Nutritional issues in older adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H923780\">",
"    <span class=\"h2\">",
"     Exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is some evidence that long-term, moderate exercise may improve aspects of immune functioning in older adults:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Available data suggest that CD8+ T cells and NK cell numbers (but not function) may be transiently elevated by acute exercise [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/85,86\">",
"       85,86",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One small controlled trial (14 patients in each arm) suggested that regular aerobic exercise can increase the immune response to influenza vaccination [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/87\">",
"       87",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    On the other hand, strenuous exercise can be immunosuppressive, and the impact of exercise probably depends upon the patient&rsquo;s underlying state of health, as well as the intensity and type of exercise performed [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/88\">",
"     88",
"    </a>",
"    ]. In addition, studies examining the clinically relevant endpoint of reductions in the frequency of infections have not been performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1557948\">",
"    <span class=\"h2\">",
"     Attention to vaccinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommendations have been issued for routine vaccination of healthy older adults (",
"    <a class=\"graphic graphic_figure graphicRef82634 \" href=\"UTD.htm?36/52/37701\">",
"     figure 1",
"    </a>",
"    ). Vaccines to protect against tetanus, influenza, pneumococcal infections, and zoster are particularly relevant to individuals older than 65. In 2010, the Advisory Committee on Immunization Practices (ACIP) began recommending that adults aged 65 years and older who anticipate having close contact with infants younger than one year of age (eg, grandparents, childcare providers, healthcare providers) and who have not previously received Tdap (tetanus toxoid,",
"    <strong>",
"     reduced",
"    </strong>",
"    diphtheria toxoid, and acellular pertussis) should receive a single dose of this vaccine. This is reviewed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=see_link&amp;anchor=H5#H5\">",
"     \"Tetanus-diphtheria toxoid vaccination in adults\", section on 'Indications for Td or Tdap vaccination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/18/38186?source=see_link&amp;anchor=H9#H9\">",
"     \"Geriatric health maintenance\", section on 'Immunizations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10662215\">",
"    <span class=\"h3\">",
"     Use of higher dose vaccines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increasing the dose of certain vaccines may improve effectiveness in older adults. A study of patients with asthma suggested that patients aged 60 and older produced adequate levels of seroprotective antibody to H1N1 vaccine in response to a 30 mcg dose, but not a 15 mcg dose [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/89\">",
"     89",
"    </a>",
"    ]. In response to this and other studies showing that the conventional vaccine produced marginal protection in older adults, the US Food and Drug Administration (FDA) approved a seasonal flu vaccine for the 2010 fall flu season that was specifically designed for people aged 65 and over. This preparation, Fluzone High-Dose, contains four times as much of the active antigen component as a conventional flu shot, resulting in a stronger antibody response in the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/90\">",
"     90",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=see_link&amp;anchor=H14#H14\">",
"     \"Seasonal influenza vaccination in adults\", section on 'Elderly patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10662079\">",
"    <span class=\"h3\">",
"     Role of vaccine boosters",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a study evaluating pre- and post-immunization titers for the tetanus, diphtheria, pertussis, and polio vaccines in 252 elderly individuals compared to a group of younger adults, protective titers were lower for the inactivated vaccines compared to the live polio vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/91\">",
"     91",
"    </a>",
"    ]. For the inactivated vaccines, post-immunization titers were significantly higher in patients with higher pre-immunization titers, indicating that routine booster programmes for these vaccines could help achieve better protection in older adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H923902\">",
"    <span class=\"h2\">",
"     Investigational vaccine techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several other strategies that could improve vaccine response in older adults:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Use of different adjuvants and vaccine formulations",
"      </strong>",
"      : Older adults may respond better to certain adjuvants and types of vaccines [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/89,92,93\">",
"       89,92,93",
"      </a>",
"      ]. As an example, young children are believed to respond to protein-conjugated vaccines better than polysaccharide vaccines, and conjugate vaccines have been traditionally used in children. However, these preparations may offer advantages in the elderly as well. In a study of vaccine-naive individuals older than 70, subjects were initially given either the 7-valent protein conjugated vaccine (PCV7) or the 23-valent polysaccharide vaccine (PPV23) [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/94\">",
"       94",
"      </a>",
"      ]. One year after receiving the pneumococcal vaccine, subjects in each group received a booster with either the PCV7 or PPV23 vaccine. Immune responses were compared for each of the seven serotypes common to both vaccines. Antibody concentrations and opsonophagocytic activity were higher in those who received an initial dose of PCV7. The authors concluded that an initial dose of PCV7 is likely to elicit higher and potentially more effective levels of antipneumococcal antibodies than is PPV23. In addition, PPV23 induced a state of hyporesponsiveness for subsequent vaccination, which was not observed with the PCV7.",
"      <br/>",
"      <br/>",
"      Currently, PPV23 is the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"       pneumococcal polysaccharide vaccine",
"      </a>",
"      approved for use in adults in the United States. In December 2011, a conjugate pneumococcal vaccine (PCV13 &ndash; Prevnar 13) has been approved for use in adults &ge;50 years of age, though it has not been recommended by the Advisory Committee on Immunization Practices (ACIP) for use in adults. The use of PCV13 might be beneficial for adults who did not adequately respond to the polysaccharide vaccine. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=see_link\">",
"       \"Pneumococcal vaccination in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Refining vaccination schedules",
"      </strong>",
"      : Another general strategy for optimizing the response to vaccines that create long-lasting immunity is to administer these earlier in life, when the immune system can create a more vigorous and lasting memory response [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/91\">",
"       91",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Changing the routes of administration",
"      </strong>",
"      : At least one study documented higher protective antibody levels to influenza vaccine in older adults with intradermal, rather than intramuscular, administration [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/95\">",
"       95",
"      </a>",
"      ]. However, specific preparations are needed for intradermal administration.",
"     </li>",
"     <li>",
"      <strong>",
"       Novel vaccines",
"      </strong>",
"      : Vaccines to prevent chronic viral infections, such as CMV, EBV, HSV, and perhaps also HIV are of interest in the field of immunosenescence, because these chronic infections are believed to contribute to the chronic inflammatory changes of aging, as well as to &ldquo;immunologic exhaustion&rdquo; [",
"      <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H923265\">",
"    <span class=\"h2\">",
"     Cytokine therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recombinant IL-7 is under investigation as an agent to increase thymic output of T cells [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/96\">",
"     96",
"    </a>",
"    ] . The use of this drug in aged mice resulted in reversal of thymic atrophy and increased thymic output. Simian IL-7 in aged Rhesus macaques resulted in increased numbers of na&iuml;ve CD4 and CD8 cells, central memory CD8 T cells, and T cell receptor excision circles (TRECs), which are biomarkers for de novo T cell synthesis.",
"   </p>",
"   <p>",
"    A phase I study of recombinant human IL-7 (rhIL-7) done on 16 human subjects with refractory cancer (age 20 to 71) suggested that rhIL-7 disproportionately increased the numbers of naive and central memory cells (but not effector T cells). CD8+ T cell repertoire diversity also increased. These effects were age-independent and persisted after therapy (for the study duration of 28 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/97\">",
"     97",
"    </a>",
"    ]. It has also been studied in patients with HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/98\">",
"     98",
"    </a>",
"    ], although not yet in normal aging adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18824197\">",
"    <span class=\"h1\">",
"     EVALUATION OF THE IMMUNE SYSTEM IN OLDER ADULTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many older adults have mild degrees of immunosuppression as a result of immunosenescence, and it can be difficult to determine if an evaluation of immune function is in order. However, immune dysfunction would present with the same types of disorders in an older adult as in a younger adult, and clinicians should be vigilant for certain patterns:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The hallmark of a weak immune system is recurrent infections. In patients of any age, several characteristics of infections raise the suspicion of an immune deficiency: higher than expected frequency, severity, duration, complications, and infections with unusual organisms. However, as mentioned above, the presentation of infections in older individuals can be subtle and atypical. In elderly patients, unexplained bronchiectasis may be a sign that the patient experienced multiple pulmonary infections throughout life.",
"     </li>",
"     <li>",
"      The combination of infectious, autoimmune and malignant disease is an indicator of immune dysregulation, and should prompt consideration of an immune evaluation in a patient of any age.",
"     </li>",
"     <li>",
"      Chronic diarrhea or malabsorption and poor wound healing are other potential presentations of immunodeficiency.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The approach to a patient with possible immunodeficiency begins with the consideration of whether a primary or secondary immune problem is more likely. In all age groups, secondary causes of immunodeficiency are more common than primary causes, and this is especially true in older adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18824070\">",
"    <span class=\"h2\">",
"     Secondary causes of immunodeficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary causes of immunodeficiency are much more common than primary immunodeficiency disorders in older adults. Common causes of secondary immunodeficiency include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Malnutrition (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/12/31946?source=see_link\">",
"       \"Geriatric nutrition: Nutritional issues in older adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Malignancy and drugs to treat malignancy (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29706?source=see_link&amp;anchor=H11#H11\">",
"       \"Secondary immune deficiency induced by drugs and biologics\", section on 'Antimetabolites and alkylating agents'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Immunosuppressive drugs (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29706?source=see_link&amp;anchor=H4#H4\">",
"       \"Secondary immune deficiency induced by drugs and biologics\", section on 'Antiinflammatory and immunosuppressive drugs'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Immunomodulatory agents: eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      (affecting B cells),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/31/28151?source=see_link\">",
"       etanercept",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/24/39303?source=see_link\">",
"       adalimumab",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/18/294?source=see_link\">",
"       anakinra",
"      </a>",
"      (affecting cellular immunity) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29706?source=see_link&amp;anchor=H21#H21\">",
"       \"Secondary immune deficiency induced by drugs and biologics\", section on 'Biological immune response modulators'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Drug-induced hypogammaglobulinemia (eg, certain antiepileptic medications) (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29706?source=see_link&amp;anchor=H18#H18\">",
"       \"Secondary immune deficiency induced by drugs and biologics\", section on 'Medications that cause hypogammaglobulinemia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Protein loss (especially if presenting with low IgG but normal IgA and IgM); eg, nephrotic syndrome, protein-losing enteropathy (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7561?source=see_link&amp;anchor=H2#H2\">",
"       \"Secondary immune deficiency due to miscellaneous causes\", section on 'Disorders of biochemical homeostasis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metabolic disease: Diabetes, severe liver disease, uremia",
"     </li>",
"     <li>",
"      HIV infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Evaluation of the immune system in the elderly therefore starts with screening for causes of secondary immunodeficiency. As in any area of medicine, the most important initial evaluation is a thorough history: detailed history regarding infections (location, complications, frequency, etc), weight loss (suggesting malnutrition, malignancy, or chronic inflammatory disease), a review of any chronic medical problems (eg, poorly controlled diabetes mellitus), and detailed medication history (including immunosuppressive and immunomodulatory medications, as well as antiepileptics, with particular attention to drug interactions).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18824077\">",
"    <span class=\"h2\">",
"     Primary causes of immunodeficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most primary immunodeficiency disorders present in childhood or early adulthood, there are some that may initially present in older adults, or may be recognized for the first time in later life, once multiple manifestations of immune dysfunction have developed. The most common example would be common variable immunodeficiency. Selective antibody deficiency (ie, the inability to mount an antipolysaccharide antibody response) may also be diagnosed later in life. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17866?source=see_link\">",
"     \"Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17209?source=see_link\">",
"     \"Selective antibody deficiency with normal immunoglobulins\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18824084\">",
"    <span class=\"h2\">",
"     Initial screening tests for immunodeficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once suspected, evaluation for immunodeficiency in older adults is similar to that in younger adults, with the exception that the emphasis should be on underlying malignancies and other causes of secondary immunodeficiency. We suggest the following initial tests to evaluate immune function in an older adult.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete blood count with differential and smear: Total circulating numbers of white blood cells, as well as the differential of the white blood cell count, do not change significantly with age.",
"     </li>",
"     <li>",
"      Creatinine, electrolytes, liver function tests, blood glucose",
"     </li>",
"     <li>",
"      Urinalysis (to detect proteinuria)",
"     </li>",
"     <li>",
"      Total serum protein, pre-albumin, albumin, cholesterol (decreased in malnutrition)",
"     </li>",
"     <li>",
"      Plasma zinc and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?13/37/13907?source=see_link\">",
"       selenium",
"      </a>",
"      levels",
"     </li>",
"     <li>",
"      Serum IgG, IgM, IgA, IgE: Levels of IgG, IgA, and IgM typically do not change with age and may increase slightly. An elevated IgE level is usually seen in atopic diseases but can also serve as a surrogate marker for a skewing of the immune system towards TH2 lymphocyte subsets which would be less efficient at fighting infections. Moreover, IgE can be elevated in parasitic infestations, in lymphomas, in HIV and in some inflammatory diseases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/6/31848?source=see_link\">",
"       \"The biology of IgE\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18825270\">",
"    <span class=\"h3\">",
"     Vaccine response",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability of a patient to respond to vaccination is the next step in evaluating immune function. In most cases, response to both protein and polysaccharide antigens is assessed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link&amp;anchor=H19688892#H19688892\">",
"     \"Laboratory evaluation of the immune system\", section on 'Measurement of antibody function'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Selective polysaccharide nonresponse is the most common form of functional antibody defect and is demonstrated by an inability to respond to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/8/12422?source=see_link\">",
"     pneumococcal polysaccharide vaccine",
"    </a>",
"    . At present, a clear definition of a normal response to pneumococcal polysaccharide vaccine in patients &gt; age 65 has not been established. Most studies have found that responses to pneumococcal polysaccharides are diminished in the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/99-101\">",
"     99-101",
"    </a>",
"    ]. However, at least one group reported that the 30-day response and 5-year persistence of antibodies to pneumococcal polysaccharide vaccine serotypes was preserved irrespective of age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/102\">",
"     102",
"    </a>",
"    ]. In another study, frailty impacted the quantitative response to vaccines more than numerical age [",
"    <a class=\"abstract\" href=\"UTD.htm?14/52/15178/abstract/103\">",
"     103",
"    </a>",
"    ]. Older adults who respond to the vaccine with titers that are slightly lower than protective sometimes generate protective titers after a second (booster) dose.",
"   </p>",
"   <p>",
"    If no abnormalities are uncovered by the testing described above and suspicion is still high, then further workup would be targeted toward underlying malignancies and toward presenting symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18136408\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immunosenescence refers to the changes that occur in the immune system with increasing age. The clinical consequences of immunosenescence include an increased risk of infections, malignancy, and autoimmune disorders. Malnutrition is relatively common among older adults and can contribute to declining immune function. (See",
"      <a class=\"local\" href=\"#H25009826\">",
"       'Immunosenescence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Aging affects both innate and adaptive immunity, although adaptive processes are affected more dramatically. (See",
"      <a class=\"local\" href=\"#H10659962\">",
"       'Changes in specific components of the immune system'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The innate immune system consists of epithelial barriers, antimicrobial peptides and mucus, as well as macrophages, neutrophils, natural killer (NK) cells, NKT cells, dendritic cells (DC), and complement proteins. Some innate immune mechanisms decline with age, while others appear to become more active. The clinical consequence of this increased activity results in a state of immune dysregulation characterized by low-grade, chronic proinflammatory changes. (See",
"      <a class=\"local\" href=\"#H10833849\">",
"       'Innate immunity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The adaptive immune system consists of B and T cell responses. With aging, na&iuml;ve T and B cells decline, while the functions of memory cells are relatively preserved. (See",
"      <a class=\"local\" href=\"#H10833871\">",
"       'Adaptive immunity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      T cells originate from the thymus, which is active in youth and then undergoes dramatic involution by middle age, with a continued gradual decline in function thereafter. The number of na&iuml;ve T cells exiting the thymus is significantly decreased, and na&iuml;ve T cells capable of responding to new infections and antigens drop in number, reducing the T cell repertoire. There is a corresponding decrease in the number of T regulatory cells, which keep the immune system &ldquo;in check&rdquo; by maintaining homeostasis, limiting autoimmune responses, and modulating the inflammatory response to infectious agents and tumors. (See",
"      <a class=\"local\" href=\"#H10833693\">",
"       'Cellular immunity: T cells'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      B cells numbers decrease with age, although immunoglobulin levels do not change or sometimes increase. Despite the preservation of the overall amount of immunoglobulin, specific antibody production declines and the ability of B and T cells to interact and respond vigorously to vaccinations and new infections becomes limited. (See",
"      <a class=\"local\" href=\"#H10833707\">",
"       'Humoral immunity: B cells'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At present, immunosenescence is not routinely measured in clinical practice, although several parameters, such as leukocyte telomere length and the &ldquo;immune risk profile,&rdquo; are used in research settings. (See",
"      <a class=\"local\" href=\"#H921793\">",
"       'Assessing immunosenescence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are currently no specific therapies that have been convincingly shown to counter normal immunosenescence. However, adequate nutrition is important, and there may be a role for regular, moderate exercise. In addition, research into how older adults respond to vaccination has resulted in several changes in vaccination guidelines and several potential strategies for creating vaccine preparations that are more effective in this age group. In addition, vaccination against common herpesviruses, such as CMV and EBV, may someday limit the contribution of these viruses to &ldquo;immunologic exhaustion.&rdquo; (See",
"      <a class=\"local\" href=\"#H922040\">",
"       'Potential interventions to counter immunosenescence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evaluation of the immune system in older adults is similar to that in younger adults, with a greater emphasis on disorders leading to secondary immunodeficiency. (See",
"      <a class=\"local\" href=\"#H18824197\">",
"       'Evaluation of the immune system in older adults'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/1\">",
"      Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol 2010; 104:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/2\">",
"      Heron M, Hoyert DL, Murphy SL, et al. Deaths: final data for 2006. Natl Vital Stat Rep 2009; 57:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/3\">",
"      Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 2:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/4\">",
"      Norman DC. Fever in the elderly. Clin Infect Dis 2000; 31:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/5\">",
"      Robertson RG, Montagnini M. Geriatric failure to thrive. Am Fam Physician 2004; 70:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/6\">",
"      Egbert AM. The dwindles: failure to thrive in older patients. Nutr Rev 1996; 54:S25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/7\">",
"      Malaguarnera L, Cristaldi E, Malaguarnera M. The role of immunity in elderly cancer. Crit Rev Oncol Hematol 2010; 74:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/8\">",
"      Aprahamian T, Takemura Y, Goukassian D, Walsh K. Ageing is associated with diminished apoptotic cell clearance in vivo. Clin Exp Immunol 2008; 152:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/9\">",
"      Ramos-Casals M, Brito-Zer&oacute;n P, L&oacute;pez-Soto A, Font J. Systemic autoimmune diseases in elderly patients: atypical presentation and association with neoplasia. Autoimmun Rev 2004; 3:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/10\">",
"      Deal CL, Meenan RF, Goldenberg DL, et al. The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum 1985; 28:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/11\">",
"      Drey M, Kaiser MJ. [Malnutrition in the elderly]. Dtsch Med Wochenschr 2011; 136:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/12\">",
"      F&uuml;l&ouml;p T, Larbi A, Hirokawa K, et al. Immunosupportive therapies in aging. Clin Interv Aging 2007; 2:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/13\">",
"      Persson MD, Brismar KE, Katzarski KS, et al. Nutritional status using mini nutritional assessment and subjective global assessment predict mortality in geriatric patients. J Am Geriatr Soc 2002; 50:1996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/14\">",
"      Volkert D, Saeglitz C, Gueldenzoph H, et al. Undiagnosed malnutrition and nutrition-related problems in geriatric patients. J Nutr Health Aging 2010; 14:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/15\">",
"      Kawakami K, Kadota J, Iida K, et al. Reduced immune function and malnutrition in the elderly. Tohoku J Exp Med 1999; 187:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/16\">",
"      Chandra RK. Nutrition and the immune system from birth to old age. Eur J Clin Nutr 2002; 56 Suppl 3:S73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/17\">",
"      Cunha DF, Cunha SF, Unamuno MR, Vannucchi H. Serum levels assessment of vitamin A, E, C, B2 and carotenoids in malnourished and non-malnourished hospitalized elderly patients. Clin Nutr 2001; 20:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/18\">",
"      Heseker H, Schneider R. Requirement and supply of vitamin C, E and beta-carotene for elderly men and women. Eur J Clin Nutr 1994; 48:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/19\">",
"      Clarke R, Refsum H, Birks J, et al. Screening for vitamin B-12 and folate deficiency in older persons. Am J Clin Nutr 2003; 77:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/20\">",
"      Andr&egrave;s E, Loukili NH, Noel E, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 2004; 171:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/21\">",
"      Spinneker A, Sola R, Lemmen V, et al. Vitamin B6 status, deficiency and its consequences--an overview. Nutr Hosp 2007; 22:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/22\">",
"      Gloth FM 3rd, Gundberg CM, Hollis BW, et al. Vitamin D deficiency in homebound elderly persons. JAMA 1995; 274:1683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/23\">",
"      Vaquero MP. Magnesium and trace elements in the elderly: intake, status and recommendations. J Nutr Health Aging 2002; 6:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/24\">",
"      Carmel R. Nutritional anemias and the elderly. Semin Hematol 2008; 45:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/25\">",
"      Geiger H, Rudolph KL. Aging in the lympho-hematopoietic stem cell compartment. Trends Immunol 2009; 30:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/26\">",
"      Vaziri H, Dragowska W, Allsopp RC, et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994; 91:9857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/27\">",
"      Cancro MP, Hao Y, Scholz JL, et al. B cells and aging: molecules and mechanisms. Trends Immunol 2009; 30:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/28\">",
"      Chambers SM, Goodell MA. Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev 2007; 3:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/29\">",
"      Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int 2009; 22:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/30\">",
"      Shaw AC, Joshi S, Greenwood H, et al. Aging of the innate immune system. Curr Opin Immunol 2010; 22:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/31\">",
"      Boehmer ED, Goral J, Faunce DE, Kovacs EJ. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J Leukoc Biol 2004; 75:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/32\">",
"      van Duin D, Mohanty S, Thomas V, et al. Age-associated defect in human TLR-1/2 function. J Immunol 2007; 178:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/33\">",
"      Ogawa T, Kitagawa M, Hirokawa K. Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages. Mech Ageing Dev 2000; 117:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/34\">",
"      Plowden J, Renshaw-Hoelscher M, Engleman C, et al. Innate immunity in aging: impact on macrophage function. Aging Cell 2004; 3:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/35\">",
"      Agius E, Lacy KE, Vukmanovic-Stejic M, et al. Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging. J Exp Med 2009; 206:1929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/36\">",
"      Gomez CR, Nomellini V, Faunce DE, Kovacs EJ. Innate immunity and aging. Exp Gerontol 2008; 43:718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/37\">",
"      Wessels I, Jansen J, Rink L, Uciechowski P. Immunosenescence of polymorphonuclear neutrophils. ScientificWorldJournal 2010; 10:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/38\">",
"      Panda A, Arjona A, Sapey E, et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009; 30:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/39\">",
"      Borrego F, Alonso MC, Galiani MD, et al. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol 1999; 34:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/40\">",
"      Hayhoe RP, Henson SM, Akbar AN, Palmer DB. Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset. Hum Immunol 2010; 71:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/41\">",
"      Le Garff-Tavernier M, B&eacute;ziat V, Decocq J, et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell 2010; 9:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/42\">",
"      Ogata K, An E, Shioi Y, et al. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin Exp Immunol 2001; 124:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/43\">",
"      Sansoni P, Cossarizza A, Brianti V, et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 1993; 82:2767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/44\">",
"      Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol 2011; 11:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/45\">",
"      Zajonc DM, Kronenberg M. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells. Immunol Rev 2009; 230:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/46\">",
"      DelaRosa O, Tarazona R, Casado JG, et al. Valpha24+ NKT cells are decreased in elderly humans. Exp Gerontol 2002; 37:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/47\">",
"      Jing Y, Gravenstein S, Chaganty NR, et al. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood. Exp Gerontol 2007; 42:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/48\">",
"      Peralbo E, DelaRosa O, Gayoso I, et al. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly. Biogerontology 2006; 7:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/49\">",
"      Agrawal A, Agrawal S, Gupta S. Dendritic cells in human aging. Exp Gerontol 2007; 42:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/50\">",
"      Jing Y, Shaheen E, Drake RR, et al. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 2009; 70:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/51\">",
"      Panda A, Qian F, Mohanty S, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010; 184:2518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/52\">",
"      Flores KG, Li J, Sempowski GD, et al. Analysis of the human thymic perivascular space during aging. J Clin Invest 1999; 104:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/53\">",
"      Naylor K, Li G, Vallejo AN, et al. The influence of age on T cell generation and TCR diversity. J Immunol 2005; 174:7446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/54\">",
"      Nasi M, Troiano L, Lugli E, et al. Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: implications for the neolymphogenesis at the limit of human life. Aging Cell 2006; 5:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/55\">",
"      Li G, Yu M, Lee WW, et al. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med 2012; 18:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/56\">",
"      Kaltoft K. Cytokine-driven immortalization of in vitro activated human T lymphocytes. CD28 expression correlates inversely with cell population doublings. Exp Clin Immunogenet 1998; 15:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/57\">",
"      Haynes L, Maue AC. Effects of aging on T cell function. Curr Opin Immunol 2009; 21:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/58\">",
"      Tsaknaridis L, Spencer L, Culbertson N, et al. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J Neurosci Res 2003; 74:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/59\">",
"      Uciechowski P, Kahmann L, Pl&uuml;m&auml;kers B, et al. TH1 and TH2 cell polarization increases with aging and is modulated by zinc supplementation. Exp Gerontol 2008; 43:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/60\">",
"      Cakman I, Rohwer J, Sch&uuml;tz RM, et al. Dysregulation between TH1 and TH2 T cell subpopulations in the elderly. Mech Ageing Dev 1996; 87:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/61\">",
"      Mansfield AS, Nevala WK, Dronca RS, et al. Normal ageing is associated with an increase in Th2 cells, MCP-1 (CCL1) and RANTES (CCL5), with differences in sCD40L and PDGF-AA between sexes. Clin Exp Immunol 2012; 170:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/62\">",
"      Sakata-Kaneko S, Wakatsuki Y, Matsunaga Y, et al. Altered Th1/Th2 commitment in human CD4+ T cells with ageing. Clin Exp Immunol 2000; 120:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/63\">",
"      Frasca D, Blomberg BB. Effects of aging on B cell function. Curr Opin Immunol 2009; 21:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/64\">",
"      Frasca D, Landin AM, Lechner SC, et al. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 2008; 180:5283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/65\">",
"      Lazuardi L, Jenewein B, Wolf AM, et al. Age-related loss of na&iuml;ve T cells and dysregulation of T-cell/B-cell interactions in human lymph nodes. Immunology 2005; 114:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/66\">",
"      Gibson KL, Wu YC, Barnett Y, et al. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009; 8:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/67\">",
"      Henson SM, Akbar AN. Memory T-cell homeostasis and senescence during aging. Adv Exp Med Biol 2010; 684:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/68\">",
"      Stacy S, Krolick KA, Infante AJ, Kraig E. Immunological memory and late onset autoimmunity. Mech Ageing Dev 2002; 123:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/69\">",
"      Kovaiou RD, Weiskirchner I, Keller M, et al. Age-related differences in phenotype and function of CD4+ T cells are due to a phenotypic shift from naive to memory effector CD4+ T cells. Int Immunol 2005; 17:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/70\">",
"      Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/71\">",
"      Monsalvo AC, Batalle JP, Lopez MF, et al. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 2011; 17:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/72\">",
"      Haynes L, Eaton SM, Burns EM, et al. Newly generated CD4 T cells in aged animals do not exhibit age-related defects in response to antigen. J Exp Med 2005; 201:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/73\">",
"      Kaszubowska L. Telomere shortening and ageing of the immune system. J Physiol Pharmacol 2008; 59 Suppl 9:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/74\">",
"      Risques RA, Arbeev KG, Yashin AI, et al. Leukocyte telomere length is associated with disability in older u.s. Population. J Am Geriatr Soc 2010; 58:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/75\">",
"      Pawelec G, Ferguson FG, Wikby A. The SENIEUR protocol after 16 years. Mech Ageing Dev 2001; 122:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/76\">",
"      Wikby A, Johansson B, Ferguson F, Olsson J. Age-related changes in immune parameters in a very old population of Swedish people: a longitudinal study. Exp Gerontol 1994; 29:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/77\">",
"      Pawelec G, Ouyang Q, Colonna-Romano G, et al. Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol 2002; 23:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/78\">",
"      Koch S, Larbi A, Ozcelik D, et al. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 2007; 1114:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/79\">",
"      Derhovanessian E, Maier AB, Beck R, et al. Hallmark features of immunosenescence are absent in familial longevity. J Immunol 2010; 185:4618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/80\">",
"      Strindhall J, Nilsson BO, L&ouml;fgren S, et al. No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol 2007; 42:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/81\">",
"      Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr 2007; 98 Suppl 1:S29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/82\">",
"      High KP. Micronutrient supplementation and immune function in the elderly. Clin Infect Dis 1999; 28:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/83\">",
"      Chandra RK. Impact of nutritional status and nutrient supplements on immune responses and incidence of infection in older individuals. Ageing Res Rev 2004; 3:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/84\">",
"      Gibson A, Edgar JD, Neville CE, et al. Effect of fruit and vegetable consumption on immune function in older people: a randomized controlled trial. Am J Clin Nutr 2012; 96:1429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/85\">",
"      DiPenta JM, Johnson JG, Murphy RJ. Natural killer cells and exercise training in the elderly: a review. Can J Appl Physiol 2004; 29:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/86\">",
"      Ogawa K, Oka J, Yamakawa J, Higuchi M. A single bout of exercise influences natural killer cells in elderly women, especially those who are habitually active. J Strength Cond Res 2005; 19:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/87\">",
"      Kohut ML, Arntson BA, Lee W, et al. Moderate exercise improves antibody response to influenza immunization in older adults. Vaccine 2004; 22:2298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/88\">",
"      Haaland DA, Sabljic TF, Baribeau DA, et al. Is regular exercise a friend or foe of the aging immune system? A systematic review. Clin J Sport Med 2008; 18:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/89\">",
"      Busse WW, Peters SP, Fenton MJ, et al. Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. J Allergy Clin Immunol 2011; 127:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/90\">",
"      Schubert C. New vaccine tailored to the weakened elderly immune system. Nat Med 2010; 16:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/91\">",
"      Kaml M, Weiskirchner I, Keller M, et al. Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. Vaccine 2006; 24:6808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/92\">",
"      Iob A, Brianti G, Zamparo E, Gallo T. Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy. Epidemiol Infect 2005; 133:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/93\">",
"      Li R, Fang H, Li Y, et al. Safety and immunogenicity of an MF59-adjuvanted subunit influenza vaccine in elderly Chinese subjects. Immun Ageing 2008; 5:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/94\">",
"      de Roux A, Schm&ouml;le-Thoma B, Schm&ouml;ele-Thoma B, et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 2008; 46:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/95\">",
"      Holland D, Booy R, De Looze F, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008; 198:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/96\">",
"      Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011; 11:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/97\">",
"      Sport&egrave;s C, Hakim FT, Memon SA, et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008; 205:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/98\">",
"      Levy Y, Lacabaratz C, Weiss L, et al. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 2009; 119:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/99\">",
"      Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009; 9:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/100\">",
"      Weinberger B, Herndler-Brandstetter D, Schwanninger A, et al. Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 2008; 46:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/101\">",
"      Schenkein JG, Park S, Nahm MH. Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency. Vaccine 2008; 26:5521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/102\">",
"      Musher DM, Manof SB, Liss C, et al. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J Infect Dis 2010; 201:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?14/52/15178/abstract/103\">",
"      Ridda I, Macintyre CR, Lindley R, et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 2009; 27:1628.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13568 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-60.18.131.125-92069A6D88-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15178=[""].join("\n");
var outline_f14_52_15178=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18136408\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5900175\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25009826\">",
"      IMMUNOSENESCENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10659458\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10659465\">",
"      Malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10659472\">",
"      Autoimmune disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3021291\">",
"      Effect of malnutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10659962\">",
"      CHANGES IN SPECIFIC COMPONENTS OF THE IMMUNE SYSTEM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10833849\">",
"      Innate immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10833871\">",
"      Adaptive immunity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10833693\">",
"      - Cellular immunity: T cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10833700\">",
"      Thymic involution",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H922404\">",
"      Changes in T cell subsets",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10833707\">",
"      - Humoral immunity: B cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10833714\">",
"      - Memory B and T cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H921793\">",
"      ASSESSING IMMUNOSENESCENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10660551\">",
"      Leukocyte telomere length",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25009937\">",
"      Immune risk profile",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H922040\">",
"      POTENTIAL INTERVENTIONS TO COUNTER IMMUNOSENESCENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1558093\">",
"      Nutritional supplements and diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H923780\">",
"      Exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1557948\">",
"      Attention to vaccinations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10662215\">",
"      - Use of higher dose vaccines",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10662079\">",
"      - Role of vaccine boosters",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H923902\">",
"      Investigational vaccine techniques",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H923265\">",
"      Cytokine therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18824197\">",
"      EVALUATION OF THE IMMUNE SYSTEM IN OLDER ADULTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18824070\">",
"      Secondary causes of immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18824077\">",
"      Primary causes of immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18824084\">",
"      Initial screening tests for immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18825270\">",
"      - Vaccine response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18136408\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/13568\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/13568|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/52/37701\" title=\"figure 1\">",
"      Vax schedule healthy adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/13568|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/0/3084\" title=\"table 1\">",
"      Age-related changes in innate immunity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/40/32395\" title=\"table 2\">",
"      Age-related changes in adaptive immunity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/37/16986?source=related_link\">",
"      An overview of the innate immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/53/25432?source=related_link\">",
"      Antigen presenting cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/28/17866?source=related_link\">",
"      Clinical manifestations, epidemiology, and diagnosis of common variable immunodeficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/54/32618?source=related_link\">",
"      Evaluation of infection in the older adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/26/34215?source=related_link\">",
"      Failure to thrive in elderly adults: Evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/29/42455?source=related_link\">",
"      Failure to thrive in elderly adults: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/18/38186?source=related_link\">",
"      Geriatric health maintenance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/12/31946?source=related_link\">",
"      Geriatric nutrition: Nutritional issues in older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=related_link\">",
"      Laboratory evaluation of the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30889?source=related_link\">",
"      NK cell deficiency syndromes: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/23/31098?source=related_link\">",
"      Normal B and T lymphocyte development",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/24/38282?source=related_link\">",
"      Normal aging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=related_link\">",
"      Pneumococcal vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=related_link\">",
"      Seasonal influenza vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7561?source=related_link\">",
"      Secondary immune deficiency due to miscellaneous causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/0/29706?source=related_link\">",
"      Secondary immune deficiency induced by drugs and biologics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17209?source=related_link\">",
"      Selective antibody deficiency with normal immunoglobulins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/58/41897?source=related_link\">",
"      T helper subsets: Differentiation and role in disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7014?source=related_link\">",
"      Tetanus-diphtheria toxoid vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6056?source=related_link\">",
"      The adaptive cellular immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/6/31848?source=related_link\">",
"      The biology of IgE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27624?source=related_link\">",
"      The humoral immune response",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/54/23401?source=related_link\">",
"      Toll-like receptors: Roles in disease and therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f14_52_15179="Definitions angina CASS";
var content_f14_52_15179=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59572&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59572&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Coronary artery surgery study definitions of angina",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Definite angina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Substernal discomfort precipitated by exertion, with a",
"typical radiation to the shoulder, jaw or inner aspect of the",
"arm relieved by rest or nitroglycerin in less than 10 minutes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Probable angina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Has most of the features of definite angina but may not",
"be entirely typical in some aspects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        \"Probably not\" angina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Defined as an atypical overall pattern of chest pain",
"that does not fit the description of definite angina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        \"Definitely not\"",
"angina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chest pain is unrelated to activity, appears to be",
"clearly of non-cardiac origin and is not relieved by nitroglycerin",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from CASS Investigators. National Heart Lung and Blood Institute Coronary Artery Study, Circulation 1981; 63(Suppl I):I-81.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15179=[""].join("\n");
var outline_f14_52_15179=null;
var title_f14_52_15180="Risk of severe reactivation of HBV";
var content_f14_52_15180=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F86868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F86868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk of severe reactivation of HBV",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Immunosuppression",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Risk of severe reactivation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        HBsAg+",
"       </td>",
"       <td class=\"subtitle2\">",
"        HBsAg-, anti-HBc+",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Cancer chemotherapy",
"       </td>",
"       <td>",
"        High",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Marked immunosuppressive treatments such as regimens that include rituximab or long-term corticosteroid",
"       </td>",
"       <td>",
"        High",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Other immunosuppressive treatments such as anti-TNF for rheumatologic, dermatologic, or gastroenterologic conditions",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Solid organ transplantation",
"       </td>",
"       <td rowspan=\"3\">",
"        High",
"       </td>",
"       <td>",
"        Increased cumulative risk over years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monitor for HBsAg reappearance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test for HBV DNA if ALT elevated",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Allogeneic bone marrow/hematopoietic stem cell transplant",
"       </td>",
"       <td rowspan=\"4\">",
"        High",
"       </td>",
"       <td>",
"        Moderate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Monitor for HBsAg reappearance, especially if donor is not immune to hepatitis B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Test for HBV DNA if ALT elevated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Consider vaccinating donor prior to transplantation",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Short course of corticosteroids (eg, for asthmatic attack or allergic reaction)",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Prophylactic antiviral is recommended for settings with a high risk of HBV reactivation. Monitoring and initiation of antiviral therapy as needed is recommended for settings with a low risk of HBV reactivation. Management should be individualized for settings with a moderate risk of HBV reactivation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15180=[""].join("\n");
var outline_f14_52_15180=null;
var title_f14_52_15181="Big endothelin outcome HF";
var content_f14_52_15181=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F58488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F58488&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Big endothelin-1 predicts outcome in heart failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 271px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Kaplan-Meier analysis shows that the cumulative event-free survival (free of death or prioritization for urgent transplant) in 218 patients with stable, chronic heart failure is higher in those with a big endothelin (ET)-1 concentration &lt;4.3 fmol/ml compared to those with a concentration &ge;4.3 fmol/ml (p &lt;0.0001).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Hulsmann M, Stanek B, Frey B. J Am Coll Cardiol 1998; 32:1695.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15181=[""].join("\n");
var outline_f14_52_15181=null;
var title_f14_52_15182="Management of acute symptomatic nephrolithiasis";
var content_f14_52_15182=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F83630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F83630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Management of acute symptomatic nephrolithiasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 405px; height: 500px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15182=[""].join("\n");
var outline_f14_52_15182=null;
var title_f14_52_15183="Circumcised penis PI";
var content_f14_52_15183=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F74651&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F74651&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Circumcised penis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of David G Weismiller, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f14_52_15183=[""].join("\n");
var outline_f14_52_15183=null;
